Scolaris Content Display Scolaris Content Display

Intervenciones para mejorar la movilidad después de la cirugía por fractura de cadera en adultos

Contraer todo Desplegar todo

Referencias

Baker 1991 {published data only}

Baker PA, Evans OM, Lee C. Treadmill gait retraining following fractured neck-of-femur. Archives of Physical Medicine and Rehabilitation 1991;72(9):649-52. CENTRAL

Binder 2004 {published data only}NCT00006194

Binder EF, Brown M, Sinacore DR, Steger-May K, Yarasheski KE, Schechtman KB. Effects of extended outpatient rehabilitation after hip fracture: a randomized controlled trial. Journal of the American Medical Association 2004;292(7):837-46. CENTRAL
Binder EF, Sinacore DR, Schechtman KB, Brown M. Effects of intensive exercise after hip fracture: results from a randomised, controlled trial [Abstract]. Journal of the American Geriatrics Society 2003;51(Suppl 4):S232. CENTRAL
Host HH, Sinacore DR, Bohnert KL, Steger-May K, Brown M, Binder EF. Training-induced strength and functional adaptations after hip fracture. Physical Therapy 2007;87(3):292-303. CENTRAL
NCT00006194. Effects of exercise on markers of inflammation in skeletal muscle in elderly hip fracture patients. clinicaltrials.gov/ct2/show/NCT00006194 (first received 8 September 2000). CENTRAL

Bischoff‐Ferrari 2010 {published data only}

Bischoff-Ferrari, H. Functioning and quality of life outcomes [personal communication]. Email to: N Fairhall 5 October 2019. CENTRAL
Bischoff-Ferrari H, Dawson-Hughes B, Orav E, Willett W, Egli A, Maetzel A, et al. The economic consequences of hip fractures: impact of home exercise and high-dose vitamin D. Journal of Bone and Mineral Research 2010;25(Suppl 1):[no pagination]. CENTRAL
Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Archives of Internal Medicine 2010;170(9):813-20. CENTRAL
Renerts K, Fischer K, Dawson-Hughes B, Orav EJ, Freystaetter G, Simmen HP, et al. Effects of a simple home exercise program and vitamin D supplementation on health-related quality of life after a hip fracture: a randomized controlled trial. Quality of Life Research 2019;28:1377-86. CENTRAL
Stemmle J, Marzel A, Chocano-Bedoya PO, Orav EJ, Dawson-Hughes B, Freystaetter G, et al. Effect of 800 IU versus 2000 IU Vitamin D3 with or without a simple home exercise program on functional recovery after hip fracture: a randomized controlled trial. Journal of the American Medical Directors Association 2019;20(5):530-6. CENTRAL

Braid 2008 {published and unpublished data}

Braid V, Barber M, Mitchell SL, Martin BJ, Granat M, Stott DJ. Randomised controlled trial of electrical stimulation of the quadriceps after proximal femoral fracture. Aging Clinical and Experimental Research 2008;20(1):62-6. CENTRAL
Braid V, Barber M, Mitchell SL, Martin BJ, Grant SJ, Granat M, et al. Proximal femoral fracture: a randomised controlled trial of electrical stimulation [abstract]. In: Extending the boundaries. Congress and Exhibition of the Chartered Society of Physiotherapy. Proceedings Book; 2001 Oct 19-21; Birmingham (UK). London (UK): The Chartered Society of Physiotherapy, 2001:15. CENTRAL
Braid V, Barber M, Mitchell SL, Martin BJ, Grant SJ, Granat M, et al. Proximal femoral fracture rehabilitation: a randomised controlled trial of electrical stimulation of the quadriceps [abstract]. Age and Ageing 2002;28 Suppl 1:28. CENTRAL
Braid V. [personal communication]. 3 March 2004. CENTRAL
Mitchell S. A randomised, controlled trial of electrical stimulation of the quadriceps in patients rehabilitating after a proximal femoral fracture. In: National Research Register, Issue 2, 2001. Oxford: Update Software. CENTRAL

Gorodetskyi 2007 {published data only}

Gorodetskyi IG, Gorodnichenko AI, Tursin PS, Reshetnyak VK, Uskov ON. Non-invasive interactive neurostimulation in the post-operative recovery of patients with a trochanteric fracture of the femur: a randomised, controlled trial. Journal of Bone and Joint Surgery - British Volume 2007;89(11):1488-94. CENTRAL

Graham 1968 {published data only}

Abrami G, Stevens J. Early weight bearing after internal fixation of transcervical fracture of the femur. Preliminary report of a clinical trial. Journal of Bone and Joint Surgery. British Volume 1964;46(2):204-5. CENTRAL
Graham J. Early or delayed weight-bearing after internal fixation of transcervical fracture of the femur. A clinical trial. Journal of Bone and Joint Surgery. British Volume 1968;50(3):562-9. CENTRAL

Hauer 2002 {published and unpublished data}

Hauer K, Pfisterer M, Schuler M, Bartsch P, Oster P. Two years later: a prospective long-term follow-up of a training intervention in geriatric patients with a history of severe falls. Archives of Physical Medicine and Rehabilitation 2003;84(10):1426-32. CENTRAL
Hauer K, Rost B, Rutschle K, Opitz H, Specht N, Bartsch P, et al. Exercise training for rehabilitation and secondary prevention of falls in geriatric patients with a history of injurious falls. Journal of the American Geriatrics Society 2001;49(1):10-20. CENTRAL
Hauer K, Specht N, Schuler M, Bartsch P, Oster P. Intensive physical training in geriatric patients after severe falls and hip surgery. Age and Ageing 2002;31(1):49-57. CENTRAL
Hauer K. [personal communication]. 5 March 2004. CENTRAL
Oster P, Hauer K, Specht N, Rost B, Baertsch P, Schlierft G. Muscle strength and coordination training for prevention of falls in elderly patients [Kraft- and Koordinationstraining zur Sturzpravention in Alter]. Zeitschrift Fur Gerontologie Und Geriatrie 1997;30:289-92. CENTRAL

Karumo 1977 {published data only}

Karumo I. A Randomized Trial of Postoperative Physiotherapy After Meniscectomy and Fractures of the Femoral Neck and Shaft [Thesis]. Helsinki, Finland: University of Helsinki, 1978. CENTRAL
Karumo I. Recovery and rehabilitation of elderly subjects with femoral neck fractures. Annales Chirurgiae et Gynaecologiae 1977;66(3):170-6. CENTRAL

Kimmel 2016 {published data only}

Kimmel LA, Liew SM, Sayer JM, Holland, AE. HIPS4HIPS (high intensity physiotherapy for hip fractures in the acute hospital setting): a randomised controlled trial. Medical Journal of Australia 2016;205(2):73-8. CENTRAL

Kronborg 2017 {published data only}

Kronborg L, Bandholm T, Palm H, Kehlet H, Kristensen MT. Effectiveness of acute in-hospital physiotherapy with knee-extension strength training in reducing strength deficits in patients with a hip fracture: a randomised controlled trial. PLOS One 2017;12(6):e0179867. CENTRAL
NCT00848913. Strength training after hip fracture surgery. clinicaltrials.gov/ct2/show/NCT00848913?term=NCT00848913 (first received 20 February 2009). CENTRAL

Lamb 2002 {published data only}

Lamb SE, Grimley Evans J, Morse RE, Trundle H. A randomised placebo controlled and double blind study of neuromuscular stimulation to improve mobility in the first three months after surgical fixation for proximal femoral fracture [abstract]. Journal of Bone and Joint Surgery. British Volume 1998;80(Suppl II):172. CENTRAL
Lamb SE, Oldham JA, Morse RE, Evans JG. Neuromuscular stimulation of the quadriceps muscle after hip fracture: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2002;83(8):1087-92. CENTRAL

Langford 2015 {published and unpublished data}

Langford D. Pain outcome [personal communication]. Email to: S Dyer 3 May 2016. CENTRAL
Langford DP, Fleig L, Brown KC, Cho NJ, Frost M, Ledoyen M, et al. Back to the future - feasibility of recruitment and retention to patient education and telephone follow-up after hip fracture: a pilot randomized controlled trial. Patient Preference and Adherence 2015;9:1343-51. CENTRAL

Latham 2014 {published data only}

Chang FH, Latham NK, Ni P, Jette AM. Does self-efficacy mediate functional change in older adults participating in an exercise program after hip fracture? A randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2015;96(6):1014-20. CENTRAL
Latham NK, Harris BA, Bean JF, Heeren T, Goodyear C, Zawacki S, et al. Effect of a home-based exercise program on functional recovery following rehabilitation after hip fracture: a randomized clinical trial. Journal of the American Medical Association 2014;311(7):700-8. CENTRAL
NCT00592813. Efficacy of a post-rehabilitation exercise intervention. clinicaltrials.gov/ct2/show/NCT00592813 (first received 14 January 2008). CENTRAL

Lauridsen 2002 {published data only}

Lauridsen UB, de la Cour BB, Gottschalck L, Svensson BH. Intensive physical therapy after hip fracture. Danish Medical Bulletin 2002;49(1):70-2. CENTRAL
Lauridsen UB, de la Cour BB, Gottschalck L, Svensson BH. Intensive physical therapy after trochanteric femoral fracture. A randomized clinical trial [Intensiv fysisk traening efter hoftenaer femurfraktur. En randomiseret klinisk undersogelse]. Ugeskrift for Laeger 2002;164(8):1040-4. CENTRAL
Parker MJ. [personal communication]. 6 August 2002. CENTRAL

Magaziner 2019 {published data only}

Magaziner J, Mangione KK, Orwig D, Baumgarten M, Magder L, Terrin M, et al. Effect of a multicomponent home-based physical therapy intervention on ambulation after hip fracture in older adults - the CAP randomized clinical trial. Journal of the American Medical Association 2019;322(10):946-56. CENTRAL
Magaziner J. Measurement of fall outcome [personal communication]. Email to S Dyer November 2019. CENTRAL

Mangione 2005 {published data only}

Mangione KK, Craik RL, Tomlinson SS, Palombaro KM. Can elderly patients who have had a hip fracture perform moderate- to high-intensity exercise at home. Physical Therapy 2005;85(8):727-39. CENTRAL
Mangione KK, Craik RL, Tomlinson SS, Palombaro KM. The effects of aggressive home exercise in patients post hip fracture. In: 56th Annual Scientific Meeting of the Gerontological Society of America; 2003 Nov 21-25; San Diego, California. 2003. CENTRAL
Mangione KK, Tomlinson S, Craik RL. Physical therapist interventions to optimize physical performance in patients after hip fracture. Journal of Geriatric Physical Therapy 2001;24(3):17. CENTRAL

Mangione 2010 {published data only}

Mangione KK, Craik RL, Palombaro KM, Tomlinson SS, Hofmann MT. Home-based leg-strengthening exercise improves function 1 year after hip fracture: a randomized controlled study. Journal of the American Geriatrics Society 2010;58(10):1911-7. CENTRAL
NCT00997776. Effect of leg strengthening exercise after hip fracture. clinicaltrials.gov/ct2/show/NCT00997776 (first received 19 October 2009). CENTRAL

Miller 2006 {published and unpublished data}

Crotty M. [personal communication]. 20 February 2009. CENTRAL
Crotty M. [personal communication]. 25 July 2003. CENTRAL
Miller MD, Crotty M, Whitehead C, Bannerman E, Daniels LA. Nutritional supplementation and resistance training in nutritionally at risk older adults following lower limb fracture: a randomized controlled trial. Clinical Rehabilitation 2006;20(4):311-23. CENTRAL

Mitchell 2001 {published and unpublished data}

Martin BJ. Randomised, controlled trial of additional quadriceps strength training in patients rehabilitating after a proximal femoral fracture. In: National Research Register, Issue 2, 2001. Oxford: Update Software. CENTRAL
Mitchell SL, Stott DJ, Martin BJ, Grant SJ. Randomised controlled trial of quadriceps training after proximal femoral fracture. Clinical Rehabilitation 2001;15(3):282-90. CENTRAL
Mitchell SL, Stott DJ, Martin BJ, Grant SJ. Randomised controlled trial of quadriceps training after proximal femoral fracture [abstract]. Age and Ageing 1999;28(Suppl 2):81. CENTRAL

Monticone 2018 {published data only}

Monticone M, Ambrosini E, Brunati R, Capone A, Pagliari G, Secci C, et al. How balance task-specific training contributes to improving physical function in older subjects undergoing rehabilitation following hip fracture: a randomized controlled trial. Clinical Rehabilitation 2018;32(3):340-51. CENTRAL

Moseley 2009 {published and unpublished data}

ACTRN12605000649617. Enhancing mobility after hip fracture. www.anzctr.org.au/ACTRN12605000649617.aspx (first received 09 September 2005). CENTRAL
Cameron IC. [personal communication]. 1 March 2002. CENTRAL
Moseley AM, Sherrington C, Lord SR, Barraclough E, St George RJ, Cameron ID. Mobility training after hip fracture: a randomised controlled trial. Age and Ageing 2009;38(1):74-80. CENTRAL

Oh 2020 {published data only}

Oh MK, Yoo JI, Byun H, Chun SW, Lim SK, Jang YJ, et al. Efficacy of combined antigravity treadmill and conventional rehabilitation after hip fracture in patients with sarcopenia. Journals of Gerontology: Series A 2020;75(10):e173-e181. CENTRAL [DOI: 10.1093/gerona/glaa158]

Ohoka 2015 {published and unpublished data}

Ohoka, T. Outcomes [personal communication]. Email to: S Dyer 8 May 2017. CENTRAL
Ohoka T, Urabe Y, Shirakawa T. Therapeutic exercises for proximal femoral fracture of super-aged patients: effect of walking assistance using body weight-supported treadmill training (BWSTT). Physiotherapy 2015;101(1):e1124-5. CENTRAL [0031-9406]

Oldmeadow 2006 {published data only}NCT00224367

NCT00224367. Does early ambulation after hip fracture surgery accelerate recovery?clinicaltrials.gov/ct2/show/record/NCT00224367 (first received 23 September 2005). CENTRAL
Oldmeadow LB, Edwards ER, Kimmel LA, Kipen E, Robertson VJ, Bailey MJ. No rest for the wounded: early ambulation after hip surgery accelerates recovery. ANZ Journal of Surgery 2006;76(7):607-11. CENTRAL

Orwig 2011 {published data only}

Orwig DL, Hochberg M, Yu-Yahiro J, Resnick B, Hawkes WG, Shardell M, et al. Delivery and outcomes of a yearlong home exercise program after hip fracture: a randomized controlled trial. Archives of Internal Medicine 2011;171(4):323-31. CENTRAL

Pol 2019 {published data only}

Pol MC, Ter Riet G, Van Hartingsveldt M, Kröse B, de Rooij SE, Buurman BM. Effectiveness of sensor monitoring in an occupational therapy rehabilitation program for older individuals after hip fracture, the SO-HIP trial: study protocol of a three-arm stepped wedge cluster randomized trial. BMC Health Services Research 2017;17(1):3. CENTRAL
Pol MC, Ter Riet G, Van Hartingsveldt M, Krose B, Buurman BM. Effectiveness of sensor monitoring in a rehabilitation programme for older patients after hip fracture: a three-arm stepped wedge randomised trial. Age and Ageing 2019;48(5):648-55. CENTRAL

Resnick 2007 {published and unpublished data}NCT00389844

NCT00389844. BHS5 - Testing the effectiveness of the exercise plus program (Hip5) [Testing the effectiveness of the exercise plus program on efficacy expectations, exercise behavior & activity of older adults following a hip fracture]. clinicaltrials.gov/ct2/show/NCT00389844 (first received 19 October 2006). CENTRAL
Resnick B, D'Adamo C, Shardell M, Orwig D, Hawkes W, Hebel JR. Adherence to an exercise intervention among older women post hip fracture. Journal of Clinical Sport Psychology 2008;2(1):41-56. CENTRAL
Resnick B, Magaziner J, Orwig, D, Zimmerman S. Evaluating the components of the Exercise Plus Program: rationale, theory and implementation. Health Education Research 2002;17(5):648-58. CENTRAL
Resnick B, Orwig D, D'Adamo C, Yu-Yahiro J, Hawkes W, Shardell M, et al. Factors that influence exercise activity among women post hip fracture participating in the Exercise Plus Program. Clinical Interventions In Aging 2007;2(3):413-27. CENTRAL
Resnick B, Orwig D, Hawkes W, Shardell M, Golden J, Werner M, et al. The relationship between psychosocial state and exercise behavior of older women 2 months after hip fracture. Rehabilitation Nursing 2007;32(4):139-49. CENTRAL
Resnick B, Orwig D, Yu-Yahiro J, Hawkes W, Shardell M, Hebel JR, et al. Testing the effectiveness of the exercise plus program in older women post-hip fracture. Annals of Behavioral Medicine 2007;34(1):67-76. CENTRAL
Resnick B. [personal communication]. 9 February 2004. CENTRAL
Resnick B. Testing the Exercise Plus Program following hip fracture. www1.od.nih.gov/behaviorchange/projects/maryland.htm (accessed 10 January 2004). CENTRAL
Yu-Yahiro JA, Resnick B, Orwig D, Hicks G, Magaziner J. Design and implementation of a home-based exercise program post-hip fracture: the Baltimore hip studies experience. Physical Medicine and Rehabilitation 2009;1(4):308-18. CENTRAL

Salpakoski 2015 {published and unpublished data}

Edgren J, Salpakoski A, Sihvonen SE, Portegijs E, Kallinen M, Arkela M, et al. Effects of a home-based physical rehabilitation program on physical disability after hip fracture: a randomized controlled trial. Journal of the American Medical Directors Association 2015;16(4):350.e1-7. CENTRAL
Salpakoski, A. Mobility and strength outcomes [personal communication]. Email to: N Fairhall 12 August 2019. CENTRAL
Salpakoski A, Tormakangas T, Edgren J, Kallinen M, Sihvonen SE, Pesola M, et al. Effects of a multicomponent home-based physical rehabilitation program on mobility recovery after hip fracture: a randomized controlled trial. Journal of the American Medical Directors Association 2014;15(5):361-8. CENTRAL
Sipilä S, Salpakoski A, Edgren J, Heinonen A, Kauppinen MA, Arkela-Kautiainen M, et al. Promoting mobility after hip fracture (ProMo): study protocol and selected baseline results of a year-long randomized controlled trial among community-dwelling older people. BMC Musculoskeletal Disorders 2011;12:277. CENTRAL
Turunen K, Salpakoski A, Edgren J, Törmäkangas T, Arkela M, Kallinen M, et al. Physical activity after a hip fracture: effect of a multicomponent home-based rehabilitation program—a secondary analysis of a randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2017;98(5):981-8. CENTRAL

Sherrington 1997 {published and unpublished data}

Sherrington C, Lord SR. Home exercise to improve strength and walking velocity after hip fracture: a randomised controlled trial. Archives of Physical Medicine and Rehabilitation 1997;78(2):208-12. CENTRAL
Sherrington C. [personal communication]. 15 January 2004. CENTRAL
Sherrington C. [personal communication]. 24 March 2004. CENTRAL

Sherrington 2003 {published and unpublished data}

Sherrington C, Lord SR, Herbert RD. A randomised trial of weight-bearing versus non-weight-bearing exercise for improving physical ability in inpatients after hip fracture. Australian Journal of Physiotherapy 2003;49(1):15-22. CENTRAL
Sherrington C, Lord SR, Herbert RD. The effects of exercise on physical ability following fall-related hip fracture: two randomised controlled trials. In: Proceedings of the Australian Physiotherapy Association 7th International Physiotherapy Congress; 2002 May 25-28; Sydney, Australia. 2002. CENTRAL
Sherrington C. [personal communication]. 15 January 2004. CENTRAL

Sherrington 2004 {published and unpublished data}

Sherrington C, Lord SR, Herbert RD. A randomised controlled trial of weight-bearing versus non-weight-bearing exercise for improving physical ability after hip fracture and completion of usual care [Abstract]. In: XVIth Conference of the International Society for Postural and Gait Research; 2003 March 23-27; Sydney, Australia. www.powmri.unsw.edu.au/ispg2003/ (accessed 24 July 03). CENTRAL
Sherrington C, Lord SR, Herbert RD. A randomized controlled trial of weight-bearing versus non-weight-bearing exercise for improving physical ability after usual care for hip fracture. Archives of Physical Medicine and Rehabilitation 2004;85(5):710-6. CENTRAL
Sherrington C, Lord SR, Herbert RD. The effects of exercise on physical ability following fall-related hip fracture: two randomised controlled trials. In: Proceedings of the Australian Physiotherapy Association 7th International Physiotherapy Congress; 2002 May 25-28; Sydney, Australia. 2002. CENTRAL
Sherrington C. [personal communication]. 9 February 2004. CENTRAL

Sherrington 2020 {published and unpublished data}

Sherrington C, Fairhall N, Kirkham C, Clemson L, Tiedemann A, Vogler C, et al. Exercise and fall prevention self-management to reduce mobility-related disability and falls after fall-related lower limb or pelvic fracture in older people: the RESTORE (Recovery Exercises and STepping On afteR fracturE) randomized controlled trial. Journal of General Internal Medicine 2020;35:2907–16. CENTRAL
Sherrington C. Outcomes in study participants with hip fracture. Personal communication with N Fairhall February 2020. CENTRAL

Stasi 2019 {published data only}

Stasi S, Papathanasiou G, Chronopoulos E, Dontas IA, Baltopoulos IP, Papaioannou NA. The effect of intensive abductor strengthening on postoperative muscle efficiency and functional ability of hip-fractured patients: a randomized controlled trial. Indian Journal of Orthopaedics 2019;53(3):407–19. CENTRAL

Suwanpasu 2014 {published data only}

Suwanpasua S, Aungsurochb Y, Jitapanyab C. Post-surgical physical activity enhancing program for elderly patients after hip fracture: a randomized controlled trial. Asian Biomedicine 2014;8(4):525-32. CENTRAL

Sylliaas 2011 {published data only}

Sylliaas H, Brovold T, Wyller TB, Bergland A. Progressive strength training in older patients after hip fracture: a randomised controlled trial. Age and Ageing 2011;40(2):221-7. CENTRAL

Sylliaas 2012 {published data only}

Sylliaas H, Brovold T, Wyller TB, Bergland A. Prolonged strength training in older patients after hip fracture: a randomised controlled trial. Age and Ageing 2012;41(2):206-12. CENTRAL

Taraldsen 2019 {published data only}

Taraldsen K, Thingstad P, Dohl O, Follestad T, Helbostad JL, Lamb SE, et al. Short and long-term clinical effectiveness and cost-effectiveness of a late-phase community-based balance and gait exercise program following hip fracture. The EVA-Hip Randomised Controlled Trial. PLoS One 2019;14(11):e0224971. CENTRAL
Taraldsen K. Faller outcome data [personal communication]. Email to: N Fairhall 22 June 2020. CENTRAL

Tsauo 2005 {published data only}

Tsauo J-Y, Leu W-S, Chen Y-T, Yang R-S. Effects on function and quality of life of postoperative home-based physical therapy for patients with hip fracture. Archives of Physical Medicine and Rehabilitation 2005;86(10):1953-7. CENTRAL

Van Ooijen 2016 {published data only}

Van Ooijen MW, Roerdink M, Timmermans C, Trekop M, Arendse S, Nijenhuis E, et al. Feasibility of C-mill gait-adaptability training in older adults after fall-related hip fracture: user's perspective and training content. European Geriatric Medicine 2014;5:S169. CENTRAL
Van Ooijen MW, Roerdink M, Trekop M, Janssen TW, Beek PJ. The efficacy of treadmill training with and without projected visual context for improving walking ability and reducing fall incidence and fear of falling in older adults with fall-related hip fracture: a randomized controlled trial. BMC Geriatrics 2016;16(1):215. CENTRAL
Van Ooijen MW, Roerdink M, Trekop M, Visschedijk J, Janssen TW, Beek PJ. Functional gait rehabilitation in elderly people following a fall-related hip fracture using a treadmill with visual context: design of a randomized controlled trial. BMC Geriatrics 2013;13:34. CENTRAL

Williams 2016 {published data only}

Williams NH, Roberts JL, Din NU, Totton N, Charles JM, Hawkes CA, et al. Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR): a phase II randomised feasibility study of a multidisciplinary rehabilitation package following hip fracture. BMJ Open 2016;6:e012422. CENTRAL
Williams NH, Roberts JL, Ud Din N, Charles JM, Totton N, Williams M, et al. Developing a multidisciplinary rehabilitation package following hip fracture and testing in a randomized feasibility study: fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR). Health Technology Assessment 2017;21(44):1-527. CENTRAL

Adunsky 2011 {published data only}

Adunsky A, Chandler J, Heyden N, Lutkiewicz J, Scott BB, Berd Y, et al. MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Archives of Gerontology and Geriatrics 2011;53(2):183-9. CENTRAL

Aftab 2020 {published data only}

Aftab A, Awan WA, Habibullah S, Lim JY. Effects of fragility fracture integrated rehabilitation management on mobility, activity of daily living and cognitive functioning in elderly with hip fracture. Pakistan Journal of Medical Sciences 2020;36(5):965-70. CENTRAL [DOI: 10.12669/pjms.36.5.2412]

Beckman 2021 {published data only}

Beckmann M, Bruun-Olsen V, Pripp AH, Bergland A, Smith T, Heiberg KE. Effect of an additional health-professional-led exercise programme on clinical health outcomes after hip fracture. Physiotherapy Research International 2021;26(2):e1896. CENTRAL [DOI: 10.1002/pri.1896]

Berggren 2019 {published data only}

Berggren M, Karlsson Å, Lindelöf N, Englund U, Olofsson B, Nordström P, et al. Effects of geriatric interdisciplinary home rehabilitation on complications and readmissions after hip fracture: a randomized controlled trial. Clinical Rehabilitation 2019;33(1):64-73. CENTRAL

Corna 2021 {unpublished data only}NCT04025866

Corna S,  Arcolin I,  Giardini M,  Bellotti L,  Godi M. Addition of aerobic training to conventional rehabilitation after hip fracture: a randomized, controlled, pilot feasibility study [with consumer summary]. Clinical Rehabilitation 2021;35(4):568-77. CENTRAL
NCT04025866. The addition of aerobic training to conventional rehabilitation after proximal femur fracture: a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT04025866 (first received 19 July 2019). CENTRAL

Dallimore 2015 {published data only}

Dallimore KM. Personal communication. Email to: S Dyer 19 May 2017. CENTRAL
Dallimore RK, Asinas-Tan M, Chan D, Hussain S, Willett C, Zainuldin R. A randomised double-blinded clinical study on the efficacy of multimedia presentation using an iPad for patient education of postoperative hip surgery patients in a public hospital in Singapore. Annals of the Academy of Medicine Singapore: Singapore Health and Biomedical Congress (SHBC); 2015 October 2-3 2015;44(10):S58. CENTRAL

Invernizzi 2019 {published data only}

Invernizzi M, de Sire A, D'Andrea F, Carrera D, Reno F, Migliaccio S, et al. Effects of essential amino acid supplementation and rehabilitation on functioning in hip fracture patients: a pilot randomized controlled trial. Aging Clinical and Experimental Research 2019;31(10):1517-24. CENTRAL

Kalron 2018 {published data only}

Kalron A, Tawil H, Peleg-Shani S, Vatine JJ. Effect of telerehabilitation on mobility in people after hip surgery: a pilot feasibility study. International Journal of Rehabilitation Research 2018;41(3):244-50. CENTRAL

Karlsson 2016 {published data only}

Karlsson Å, Berggren M, Gustafson Y, Olofsson B, Lindelöf N, Stenvall M. Effects of geriatric interdisciplinary home rehabilitation on walking ability and length of hospital stay after hip fracture: a randomized controlled trial. Journal of the American Medical Directors Association 2016;17(5):464 e9-e15. CENTRAL
Karlsson A, Lindelof N, Olofsson B, Berggren M, Gustafson Y, Nordstrom P, et al. Effects of geriatric interdisciplinary home rehabilitation on independence in activities of daily living in older people with hip fracture: a randomized controlled trial. Archives of Physical Medicine and Rehabilitation 2020;101:571-8. CENTRAL

Kim 2020 {published data only}

Kim P, Lee  H,  Choi W,  Jung S. Effect of 4 weeks of anti-gravity treadmill training on isokinetic muscle strength and muscle activity in adults patients with a femoral fracture: a randomized controlled trial. International Journal of Environmental Research and Public Health 2020;17(22):1-9. CENTRAL

Lahtinen 2017 {published data only}

Lahtinen A, Leppilahti J, Vähänikkilä H, Harmainen S, Koistinen P, Rissanen P, et al. Costs after hip fracture in independently living patients: a randomised comparison of three rehabilitation modalities. Clinical Rehabilitation 2017;31(5):672-85. CENTRAL

Laiz 2017 {published data only}

Laiz A, Malouf J, Marin A, Longobardi V, de Caso J, Farrerons J, et al. Impact of 3-monthly vitamin D supplementation plus exercise on survival after surgery for osteoporotic hip fracture in adult patients over 50 years: a pragmatic randomized, partially blinded, controlled trial. Journal of Nutrition, Health & Aging 2017;21(4):413-20. CENTRAL

Lehrl 2012 {published data only}

Lehrl S, Gusinde J, Schulz-Drost S, Rein A, Schlechtweg PM, Jacob H, et al. Advancement of physical process by mental activation: a prospective controlled study. Journal of Rehabilitation Research and Development 2012;49(8):1221-8. CENTRAL

Pfeiffer 2020 {published data only}

Pfeiffer K, Kampe K, Klenk J, Rapp K, Kohler M, Albrecht D, et al. Effects of an intervention to reduce fear of falling and increase physical activity during hip and pelvic fracture rehabilitation. Age and Ageing 2020;49(5):771–8. CENTRAL

Scheffers‐Barnhoorn 2019 {published data only}

Scheffers-Barnhoorn MN, Van Eijk M, Van Haastregt JC, Schols JM, Van Balen R, Van Geloven N, et al. Effects of the FIT-HIP intervention for fear of falling after hip fracture: a cluster-randomized controlled trial in geriatric rehabilitation. Journal of the American Medical Directors Association 2019;20(7):857-65. CENTRAL

Taraldsen 2015 {published data only}

Taraldsen K, Granat MH, Helbostad JL. Quantification of outdoor mobility by use of accelerometer-measured physical behaviour. BioMed Research International 2015;2015:910259. CENTRAL

Wang 2020 {published data only}

Wang K, Fan J, Li X, Yang S, Ren D, He C. Long-term intensive family rehabilitation training for postoperative functional recovery in elderly hip fracture patients. Chinese Journal of Tissue Engineering Research 2020;24(14):2158-63. CENTRAL

Wu 2010 {published data only}

Wu XB, Zhang Q, Song LX, Zhang YZ. Effect of early rehabilitation on the hip joint function in patients with comminuted posterior wall fractures of the acetabulum after internal fixation. Journal of Clinical Rehabilitative Tissue Engineering Research 2010;14(4):732-5. CENTRAL

Referencias de los estudios en espera de evaluación

Che 2020 {unpublished data only}

Che X, Zhang X, Li H, Xu P, Zhao D. Therapeutic effect of early rehabilitation training on the recovery of limb function in elderly patients with femoral neck fracture [Abstract]. Basic and Clinical Pharmacology and Toxicology 2020;127 (Suppl 3):300. CENTRAL

Wu XY 2019 {published data only}

Wu WY, Xu WG. Evaluation of the effect of early total weight-bearing training after cementless total hip arthroplasty. Chinese Journal of Tissue Engineering Research 2019;23(18):2827-32. CENTRAL

ACTRN12617001345370 {unpublished data only}

ACTRN12617001345370. Recumbent bike riding for people with fractured neck of femur: a feasibility trial. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373575 (first received 1 September 2017). CENTRAL

ACTRN12618000903280 {unpublished data only}

ACTRN12618000903280. The feasibility of prescribing a walking program to improve physical functioning of people living in the community after hip fracture [The feasibility of prescribing a walking program to improve physical functioning of people living in the community after hip fracture: a phase II randomised controlled trial]. anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12618000903280 (first received 25 May 2018). CENTRAL

Heiberg 2017 {unpublished data only}

Heiberg KE, Bruun-Olsen V, Bergland A. The effects of habitual functional training on physical functioning in patients after hip fracture: the protocol of the HIPFRAC study. BMC Geriatrics 2017;17(1):23. CENTRAL

ISRCTN32476360 {unpublished data only}32476360

ISRCTN32476360. Effects of transcutaneous electrical nerve stimulation on acute postoperative pain intensity, ambulation and mobility after hip fracture: a double-blinded, randomized trial. www.isrctn.com/ISRCTN32476360 (first received 05 July 2018). CENTRAL [DOI: 10.1186/ISRCTN32476360]

jRCTs052190018 {unpublished data only}

jRCTs052190018. A pilot study of training using the Balance Exercise Assist Robot for the patients after the proximal femoral fractures surgery at the convalescent rehabilitation ward. rctportal.niph.go.jp/en/detail?trial_id=jRCTs052190018 (first received, unknown. date registered 17 May 2019). CENTRAL

jRCTs052190022 {unpublished data only}

jRCTs052190022. A preliminary study of training using the Balance Exercise Assist Robot for the patients after the proximal femoral fractures surgery at the community-based integrated care ward. rctportal.niph.go.jp/en/detail?trial_id=jRCTs052190022 (first received, unknown. date registered 27 May 2019. CENTRAL

KCT0004122 {unpublished data only}

KCT0004122. A randomized feasibility study of inpatient rehabilitation using advanced techniques in older people with fragility hip fracture. cris.nih.go.kr/cris/search/detailSearch.do?seq=14311&search_page=L&search_lang=E&lang=E (first received: unknown; approved 17 June 2019). CENTRAL

Lima 2016 {unpublished data only}NCT02295527

Lima CA, Sherrington C, Guaraldo A, Moraes SA, Varanda RD, Melo J, et al. Effectiveness of a physical exercise intervention program in improving functional mobility in older adults after hip fracture in later stage rehabilitation: protocol of a randomized clinical trial (REATIVE Study). BMC Geriatrics 2016;16(1):198. CENTRAL

NCT01129219 {unpublished data only}NCT01129219

NCT01129219. Observation and progressive strength training after hip fracture. clinicaltrials.gov/ct2/show/NCT01129219 (first received 24 May 2010). CENTRAL

NCT01174589 {unpublished data only}NCT01174589

NCT01174589. Training of patients with hip fracture. clinicaltrials.gov/show/NCT01174589 (first received 3 August 2010). CENTRAL

NCT02305433 {unpublished data only}NCT02305433

NCT02305433. Effects of long-term intensive home-based physiotherapy on older people with an operated hip fracture or frailty (RCT) (HIPFRA) [Effects of long-term intensive home-based physiotherapy on older people with an operated hip fracture or frailty (RCT)]. clinicaltrials.gov/ct2/show/NCT02305433 (first received 2 December 2014). CENTRAL

NCT02407444 {unpublished data only}NCT02407444

NCT02407444. Treatment efficacy of leg cycling as part of physiotherapy treatment in elderly patients with hip fracture [A comparison of two physiotherapy treatment protocols, with and without cycling training, in elderly patients with hip fractures at their subacute stage following surgery]. clinicaltrials.gov/ct2/show/NCT02407444 (first received 3 April 2015). CENTRAL

NCT02815254 {unpublished data only}NCT02815254

ANCT02815254. The effect of exercise in elderly hip fracture patients: a clinical randomised trial. clinicaltrials.gov/ct2/show/NCT02815254 (first received 28 June 2016). CENTRAL

NCT02938923 {unpublished data only}NCT02938923

NCT02938923. Starting a testosterone and exercise program after hip injury (STEP-HI) [Combining testosterone therapy and exercise to improve function post hip fracture]. clinicaltrials.gov/ct2/show/NCT02938923 (first received 19 October 2016). CENTRAL

NCT03030092 {unpublished data only}NCT03030092

NCT03030092. Maximal strength training following hip fracture surgery: impact on muscle mass, balance, walking efficiency and bone density. clinicaltrials.gov/ct2/show/NCT03030092 (first received 24 January 2017). CENTRAL

NCT04095338 {unpublished data only}NCT04095338

NCT04095338. Assistive robotic in the elderly: innovative models in the rehabilitation of the elderly with hip fractures through technological innovation. clinicaltrials.gov/ct2/show/NCT04095338 (first received 19 September 2019). CENTRAL

NCT04108793 {unpublished data only}NCT04108793

NCT04108793. Effectiveness of home-based rehabilitation program in minimizing disability and secondary falls after a hip fracture: a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT04108793 (first received 30 September 2019). CENTRAL

NCT04207788 {unpublished data only}NCT04207788

NCT04207788. HIP fracture rehabilitation programme (HIP-REP) [HIp fracture rehabilitation programme for elderly with hip fracture]. clinicaltrials.gov/ct2/show/NCT04207788 (first received 23 December 2019). CENTRAL

NCT04228068 {unpublished data only}NCT04228068

NCT04228068. The stronger at home study [A home-based rehabilitation program for patients with hip fracture: a pilot randomized trial]. clinicaltrials.gov/ct2/show/NCT04228068 (first received 14 January 2020). CENTRAL

NTR6794 {unpublished data only}

NTR6794. Rehabilitation after hip fractures in elderly [COMplex Fracture Orthopedic Rehabilitation (COMFORT) - Real-time visual biofeedback on weight bearing versus standard training methods in the treatment of proximal femur fractures in elderly: a randomized controlled trial]. www.trialregister.nl/trial/6609 (date first received: unclear; date registered 20 October 2017). CENTRAL

UMIN000036379 {unpublished data only}

UMIN000036379. Randomized controlled trial with parallel design on the effects of maximum voluntary velocity training in patients after femoral neck fracture surgery. upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041346 (first received 02 April 2019). CENTRAL

Abrami 1964

Abrami G, Stevens J. Early weight bearing after internal fixation of transcervical fracture of the femur. Preliminary report of a clinical trial. Journal of Bone and Joint Surgery. British Volume 1964;46(2):204-5.

Avenell 2010

Avenell A, Handoll HH. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No: CD001880. [DOI: 10.1002/14651858.CD001880.pub5]

Avenell 2016

Avenell A, Smith TO, Curtain JP, Mak JC, Myint PK. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No: CD001880. [DOI: 10.1002/14651858.CD001880.pub6]

Bean 2004

Bean JF, Herman S, Kiely DK, Frey IC, Leveille SG, Fielding RA, et al. Increased velocity exercise specific to task (InVEST) training: a pilot study exploring effects on leg power, balance, and mobility in community-dwelling older women. Journal of the American Geriatrics Society 2004;52(5):799-804.

Beckmann 2020

Beckmann M, Bruun-Olsen V, Pripp AH, Bergland A, Smith T, Heiberg KE. Effect of exercise interventions in the early phase to improve physical function after hip fracture – a systematic review and meta-analysis. Physiotherapy 2020;108:90-97.

Bohannon 2017

Bohannon RW, Crouch R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. Journal of Evaluation in Clinical Practice 2017;23(2):377-81. [DOI: 10.1111/jep.12629]

Cameron 2018

Cameron ID, Dyer SM, Panagoda CE, Murray GR, Hill KD, Cumming RG, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database of Systematic Reviews 2018, Issue 9. Art. No: CD005465. [DOI: 10.1002/14651858.CD005465.pub4]

Chen 2019

Chen B, Hu N, Tan J‐H. Efficacy of home‐based exercise programme on physical function after hip fracture: a systematic review and meta‐analysis of randomised controlled trials. International Wound Journal 2019;17(1):45-54.

Cochrane Norway 2017

Cochrane Norway. How to write a plain language summary of a Cochrane intervention review. www.cochrane.no/sites/cochrane.no/files/public/uploads/ checklist for cochrane pls 28th feb 2017 0.pdf (accessed 15 November 2018).

Cohen 1998

Cohen J. Statistical Power Analysis in the Behavioral Sciences. 2nd edition. Hillsdale (NJ): Lawrence Erlbaum Associates, Inc, 1998.

Crotty 2010

Crotty M, Unroe K, Cameron ID, Miller M, Ramirez G, Couzner L. Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No: CD007624. [DOI: 10.1002/14651858.CD007624.pub3]

Curtis 2017

Curtis EM, Moon RJ, Harvey NC, Cooper C. The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone 2017;104:29-38.

de Morton 2008

de Morton NA, Berlowitz DJ, Keating JL. A systematic review of mobility instruments and their measurement properties for older acute medical patients. Health Quality of Life Outcomes 2008;6(44):[15 p.]. [DOI: 10.1186/1477-7525-6-44]

Diong 2016

Diong J, Allen N, Sherrington C. Structured exercise improves mobility after hip fracture: a meta-analysis with meta-regression. British Journal of Sports Medicine 2016;50:346-55.

Dreinhofer 2018

Dreinhöfer KE, Mitchell PJ, Bégué T, Cooper C, Costa ML, Falaschi P, et al. A global call to action to improve the care of people with fragility fractures. Injury 2018;49(8):1393-97. [DOI: 10.1016/j.injury.2018.06.032]

Dyer 2016

Dyer S, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, et al. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatrics 2016;16(1):158.

Edgren 2012

Edgren J, Rantanen T, Heinonen A, Portegijs E, Alén M, Kiviranta I, et al. Effects of progressive resistance training on physical disability among older community-dwelling people with history of hip fracture. Aging Clinical and Experimental Research 2012;24(2):171-5.

Griffin 2015

Griffin XL, Parsons N, Achten J, Fernandez M, Costa ML. Recovery of health-related quality of life in a United Kingdom hip fracture population. The Warwick Hip Trauma Evaluation--a prospective cohort study. Bone and Joint Journal 2015;97-B(3):372-82.

Gullberg 1997

Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporosis International 1997;7:407-13.

Handoll 2009

Handoll HH, Cameron ID, Mak JC, Finnegan TP. Multidisciplinary rehabilitation for older people with hip fractures. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No: CD007125. [DOI: 10.1002/14651858.CD007125.pub2]

Haywood 2014

Haywood KL, Griffin XL, Achten J, Costa ML. Developing a core outcome set for hip fracture trials. Bone and Joint Journal 2014;26(8):1016-23.

Higgins 2011

Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

Higgins 2021a

Higgins JP, Li T, Deeks JJ (editors). Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.

Higgins 2021b

Higgins JP, Eldridge S, Li T. Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.

Host 2007

Host HH, Sinacore DR, Bohnert KL, Steger-May K, Brown M, Binder EF. Training-induced strength and functional adaptations after hip fracture. Physical Therapy 2007;87(3):292-303.

Kuijlaars 2019

Kuijlaars IA, Sweerts L, Nijhuis-van der Sanden MW, Van Balen R, Staal JB, Van Meeteren NL. Effectiveness of supervised home-based exercise therapy compared to a control intervention on functions, activities, and participation in older patients after hip fracture: a systematic review and meta-analysis. Archives Physical Medicine Rehabilitation 2019;100(1):101-14.e6.

Lamb 2011

Lamb SE, Becker C, Gillespie LD, Smith JL, Finnegan S, Potter R, et al. Reporting of complex interventions in clinical trials: development of a taxonomy to classify and describe fall-prevention interventions. Trials 2011;12(125):[8 p.]. [DOI: 10.1186/1745-6215-12-125]

Lee 2017

Lee SY, Yoon B-H, Beom J, Ha Y-C, Lim J-Y. Effect of lower-limb progressive resistance exercise after hip fracture surgery: a systematic review and meta-analysis of randomized controlled studies. Journal of the American Medical Directors Association 2017;18(12):1096.e26-1096.e19.

Lee 2019

Lee SY, Jung SH, Lee S-U, Ha Y-C, Lim J-Y. Effect of balance training after hip fracture surgery: a systematic review and meta-analysis of randomized controlled studies. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2019;74(10):1679-85.

Lefebvre 2019

Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf MI. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.

Liu 2009

Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No: CD002759. [DOI: 10.1002/14651858.CD002759.pub2]

Magaziner 2000

Magaziner J, Hawkes W, Hebel JR, Zimmerman SI, Fox KM, Dolan M. Recovery from hip fracture in eight areas of function. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 2000;55(9):498-507.

McDonough 2021

McDonough CM, Harris-Hayes M, Kristensen MT, Overgaard JA, Herring TB, Kenny AM, et al. Physical therapy management of older adults with hip fracture. Journal of Orthopaedic Sports Physical Therapy 2021;51(2):CPG1-CPG81. [DOI: 10.2519/jospt.2021.0301]

Parsons 2018

Parsons N, Griffin XL, Achten J, Chesser TJ, Lamb SE, Costa ML. Modelling and estimation of health-related quality of life after hip fracture. A re-analysis of data from a prospective cohort study. Bone and Joint Research 2018;7(1):1-5.

Perera 2006

Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. Journal of the American Geriatrics Society 2006;54(5):743-9.

Peterson 2004a

Peterson MG, Ganz SB, Allegrante JP, Cornell CN. High-intensity exercise training following hip fracture. Topics in Geriatric Rehabilitation 2004;20(4):273-84.

Resnick 2009

Resnick B. Self-efficacy. In: , , editors(s). Middle Range Theories: Application to Nursing Research. 2nd edition. Philadelphia (PA): Lippincott William & Wilkins, 2009.

Review Manager 2020 [Computer program]

Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020. Available at revman.cochrane.org.

Roche 2005

Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ 2005;331(7529):1374-6.

Royal College of Physicians 2019

Royal College of Physicians. National Hip Fracture Database annual report 2019. London: RCP, 2019.

Sambunkak 2017

Sambunjak D, Cumpston M, Watts C. Module 6: Analysing the data. In: Cochrane interactive learning: conducting an intervention review. Cochrane, 2017. Available at training.cochrane.org/interactivelearning/module-6-analysing-data (accessed 17 August 2019).

Sànchez‐Riera 2017

Sànchez-Riera L, Wilson N. Fragility fractures and their impact on older people. Best Practice & Research. Clinical Rheumatology 2017;31(2):169–91.

Sawilowsky 2009

Sawilowsky S. New effect size rules of thumb. Journal of Modern Applied Statistical Methods 2009;8(2):467–74.

Schünemann 2017

Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Akl E, et al, on behalf of the Cochrane GRADEing Methods Group (formerly Applicability and Recommendations Methods Group) and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook.

Schünemann 2022

Schünemann HJ, Vist GE, Higgins JP, Santesso N, Deeks JJ, Glasziou P, et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from handbook.cochrane.org.

Sherrington 2019

Sherrington C, Fairhall NJ, Wallbank GK, Tiedemann A, Michaleff ZA, Howard K, et al. Exercise for preventing falls in older people living in the community. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No: CD012424. [DOI: 10.1002/14651858.CD012424.pub2]

Singh 2012

Singh NA, Quine S, Clemson LM, Williams EJ, Williamson DA, Stavrinos TM, et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: a randomized controlled trial. Journal of the American Medical Directors Association 2012;13(1):24-30.

Smith 2019

Smith TO, Collier T, Sheehan KJ, Sherrington C. The uptake of the hip fracture core outcome set: analysis of 20 years of hip fracture trials. Age and Ageing 2019;48(4):595-8.

Smith 2020

Smith TO, Gilbert AW, Sreekanta A, Sahota O, Griffin XL, Cross JL, et al. Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery. Cochrane Database of Systematic Reviews 2020, Issue 2. Art. No: CD010569. [DOI: 10.1002/14651858.CD010569.pub3]

Sun 2010

Sun X. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. British Medical Journal 2010;340:c117.

Unnanuntana 2018

Unnanuntana A, Jarusriwanna A, Nepal S. Validity and responsiveness of Barthel index for measuring functional recovery after hemiarthroplasty for femoral neck fracture. Archives of Orthopaedic Trauma Surgery 2018;138(12):1671-7. [DOI: 10.1007/s00402-018-3020-z]

Veronese 2018

Veronese N, Maggai S. Epidemiology and social costs of hip fracture. Injury 2018;49(8):1458-60.

Walters 2003

Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and Quality of Life Outcomes 2003;1(4):[8 p.]. [DOI: 10.1186/1477–7525-1-4]

Walters 2005

Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research 2005;14(6):1523–32.

Webber 2010

SC Webber, MM Porter, VH Menec. Mobility in older adults: a comprehensive framework. Gerontologist 2010;50(4):443–50. [DOI: 10.1093/geront/gnq013]

Wu J 2019

Wu J, Mao L, Wu J. Efficacy of balance training for hip fracture patients: a meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research 2019;14(1):83.

Zidén 2008

Zidén L, Frandin K, Kreuter M. Home rehabilitation after hip fracture. A randomized controlled study on balance confidence, physical function and everyday activities. Clinical Rehabilitation 2008;22(12):1019-33.

Referencias de otras versiones publicadas de esta revisión

Handoll 2003

Handoll HH, Parker MJ, Sherrington C. Mobilisation strategies after hip fracture surgery in adults. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No: CD001704. [DOI: 10.1002/14651858.CD001704]

Handoll 2004

Handoll HH, Sherrington C, Parker MJ. Mobilisation strategies after hip fracture surgery in adults. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No: CD001704. [DOI: 10.1002/14651858.CD001704.pub2]

Handoll 2007

Handoll HH, Sherrington C. Mobilisation strategies after hip fracture surgery in adults. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No: CD001704. [DOI: 10.1002/14651858.CD001704.pub3]

Handoll 2011

Handoll HH, Sherrington C, Mak JC. Interventions for improving mobility after hip fracture surgery in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No: CD001704. [DOI: 10.1002/14651858.CD001704.pub4]

Parker 1999

Parker MJ. Early weight bearing and mobilisation after internal fixation of intracapsular proximal femoral fractures in adults. Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No: CD001704. [DOI: 10.1002/14651858.CD001704]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Baker 1991

Study characteristics

Methods

Quasi‐randomised trial: by alternation; participants were allocated "sight unseen"

Participants

Caulfield Hospital, Victoria, Australia
Period of study: started 12 May 1985
40 participants
Inclusion: women with a hip fracture
Exclusion: rheumatoid arthritis, active cardiac disease, neurological condition that would influence gait pattern
Age: mean 83.5 years (range 69 to 97 years)
% male: none
Number lost to follow‐up: probably none, although 1 died.

Interventions

Early postoperative rehabilitation
1. Treadmill gait retraining programme. Use of Repco treadmill with velocity and distance controls. Adjustable side rails for partial weight‐bearing stage.
versus
2. Conventional gait retraining involving use of ambulatory aid (walking frame)

Both groups had participated in the same muscle strengthening programme beforehand. Other aspects of physical therapy was reported to be similar.

Outcomes

Length of follow‐up: until discharge from rehabilitation hospital

Mobility level at discharge (3 levels: house bound; limited outdoor activity; outdoor activity unlimited by symptoms)
Walking velocity

Knee extensor strength
Return to living at home
Length of hospital stay
Mortality (in hospital)

Notes

A subgroup of 6 'matched pairs' were studied in greater detail for gait analysis, strength and length of stay. These matched pairs are not included in this review.

Funding: none declared

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Quasi‐randomised trial involving alternation: "the first patient was allocated to the treadmill group, the second to the control group, and so on".

Allocation concealment (selection bias)

High risk

Predictable sequence even though researcher apparently "allocated patient 'sight unseen'"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No mention of blinding of therapists conducting the intervention and the participants. Impact of non‐blinding is unclear.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

There was no mention of blinding.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Not blinded; however, the assessment of the outcome is unlikely to be influenced by knowledge of group allocation

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Measure of mobility assessment was crude. Gait analysis was reported for 6 matched pairs: this decision was not explained fully.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

The group allocations for the only death and the 5 other participants requiring nursing home or special accommodation were not given.

Selective reporting (reporting bias)

High risk

The reason for reporting gait analysis outcomes for 6 matched pairs was not provided.

Free from baseline imbalance bias?

Unclear risk

Insufficient information

Free from performance bias due to non‐trial interventions?

Low risk

Explicit mention of comparability

Binder 2004

Study characteristics

Methods

Randomised trial: use of a computer‐generated algorithm and block design, stratified by type of surgery (hemiarthroplasty or internal fixation)

Participants

Community‐dwellers, St Louis, Missouri, USA
Period of study: August 1998 to May 2003
90 participants
Inclusion: physically frail people (modified Physical Performance Test score of 12 to 28 and ADL difficulty) aged 65 years or over with a surgically‐repaired proximal femoral fracture in the previous 16 weeks who had completed standard physical therapy. Informed consent
Exclusion: pathological fracture, contralateral hip fracture, dementia or cognitive impairment, inability to walk 50 feet, visual or hearing impairments interfering with participation, other major medical conditions (cardiopulmonary or neuromuscular disease), taking medication for osteoporosis, on hormone replacement therapy, terminally ill
Age: mean 80 years (range not given)
% male: 26
Number lost to follow‐up: 5 (2 due to personal reasons, 2 due to medical problems, 1 died)

Interventions

Started after end of standard physical therapy.
1. Six months of supervised exercise carried out 3 times weekly. For the first 3 months, small group (2 to 5 participants) progressive exercise for flexibility, balance, co‐ordination, movement speed, strength and endurance led by a physical therapist. After the first 3 months, progressive resistance training was added (progressed by end of 1 month to 3 sets of 8 to 12 repetitions at 85% to 100% of initial 1 RM voluntary strength.
versus
2. Low‐intensity, non‐progressive home exercise programme carried out 3 times weekly after a 1‐hour training session, plus monthly group sessions and weekly 10‐minute telephone calls.

Additional interventions for both groups: monitoring and instruction by dietitian if indicated, and vitamin D if indicated at baseline. All received calcium and multi‐vitamin tablets.

Outcomes

Length of follow‐up: 6 months

Physical Performance Test score (modified)
Functional Status Questionnaire score
Instrumental Activities of Daily Living score
Basic Activities of Daily Living score
Use of assistive gait devices
Knee extension strength
Fast walking speed
Single limb stance time
Berg Balance Scale
SF‐36 (health, physical function, social subscales)
Hip Rating Questionnaire
Adherence
Adverse events and subsequent fractures
Mortality

Notes

Host 2007 reported data only from intervention group participants (31/46 participants) who had completed at least 30 sessions in each of the two 3‐month exercise phases.

Measured adherence

Funding: National Institute of Aging grant R01 G15795, the Washington University General Clinical Research Center grant 5‐M01 RR00036, the Washington University Clinical Nutrition Research Center grant P30 DK56341, and the Barnes Jewish Hospital Foundation.

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Random assignment ... was performed on completion of the baseline assessments within strata, defined as the types of surgical repair procedure (hemiarthroplasty vs open reduction internal fixation), using a computer generated algorithm and block design."

Allocation concealment (selection bias)

Unclear risk

No clear indication of allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

There was blinding of outcome assessors: "the research staff who conducted the assessments were not involved in exercise training and were blinded to group assignment".

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Binding relating to attribution of study related/unrelated causes of medical problems or fractures is uncertain.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

There was blinding of outcome assessors: "the research staff who conducted the assessments were not involved in exercise training and were blinded to group assignment".

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

Five of the 90 participants were lost to follow‐up at 6 months. The last observation for these 5 participants was carried forward and an intention‐to‐treat analysis was conducted with data for the whole trial population.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Mortality follow‐up adequate

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Unclear risk

Five of the 90 participants were lost to follow‐up at 6 months. The last observation for these 5 participants was carried forward and an intention‐to‐treat analysis was conducted with data for the whole trial population.

Selective reporting (reporting bias)

Low risk

Pre‐trial completion information shows consistent primary outcome

Free from baseline imbalance bias?

Low risk

Comprehensive breakdown of characteristics without significant differences

Free from performance bias due to non‐trial interventions?

Low risk

Measures taken to counteract differences in social contact in the control group by weekly phone calls

Bischoff‐Ferrari 2010

Study characteristics

Methods

Randomised trial: 2x2 factorial design

Participants

Triemli City Hospital, Switzerland
Period of study: January 2005 to December 2007
173 participants
Inclusion: aged 65 years or over with a surgically‐repaired hip fracture, MMSE ≥ 15, able to walk 3 m, German speaking, creatinine clearance of more than 15 mL/min (to convert to millilitres per second, multiply by 0.0167)
Exclusion: prior fracture of same hip, metastatic cancer or chemotherapy in the last year, severe visual or hearing impairment, kidney stone in the past 5 years, hypercalcaemia, primary hyperparathyroidism or sarcoidosis

Age: mean 84 years (range 65 to 99)
% male: 21
Number lost to follow‐up: 22. Analysed as ITT

Interventions

Extended physiotherapy plus high/low dose cholecalciferol

1. Extended physiotherapy plus 800 IU/d cholecalciferol. Supervised 60 min during acute care (additional 30 min home programme instruction each day during acute care) plus unsupervised home programme over 12 months. Advised to maintain usual diet and avoid additional calcium and cholecalciferol supplements.

2. Standard physiotherapy (supervised 30 min/day during acute care plus no home programme) plus 2000 IU/d cholecalciferol

3. Extended physiotherapy plus 2000 IU/d cholecalciferol.

4. Control. Standard physiotherapy (supervised 30 min/day during acute care plus no home program) plus 800 IU/d cholecalciferol. Advised to maintain usual diet and avoid additional calcium and cholecalciferol supplements.

Only the comparison of standard versus extended physiotherapy eligible for inclusion in this review.

Outcomes

Length of follow‐up: 24 weeks

Mortality

Knee extensor

Timed Up & Go

EQ‐5D‐3L

Adverse effects: re‐fracture rate, re‐admission, admission to institution, falls, mild hypercalcaemia, nephrolithiasis

Adherence (total days and minutes of physiotherapy)

Notes

Measured adherence

Funding: this study was supported by Swiss National Foundations (NFP‐53), Vontobel Foundation, Baugarten Foundation and Swiss National Foundations professorship grant PP00B‐ 114864.

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐based randomisation

Allocation concealment (selection bias)

Unclear risk

Not clearly reported

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Outcome assessors blinded

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Outcome assessors blinded. All admission records were reviewed by 3 blinded co‐investigators to determine the main cause of re‐admission.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Outcome assessors blinded for health‐related quality of life. Blinding of personnel collecting fall data and answering hotline telephones was not specified.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Large degree of loss to follow‐up. Although analysed as ITT, the high degree of attrition incurs a high risk of bias.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Large loss to follow‐up

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

Large loss to follow‐up

Selective reporting (reporting bias)

Unclear risk

Mobility outcomes not clearly stated in study registration

Free from baseline imbalance bias?

Low risk

Groups balanced at baseline

Free from performance bias due to non‐trial interventions?

High risk

Extended physiotherapy had home visits which may have a confounding effect due to the social interaction

Method of ascertaining falls

Low risk

Falls recorded via monthly telephone calls and a patient diary. Also, a telephone hotline to report falls at any time

Braid 2008

Study characteristics

Methods

Randomised controlled trial

Participants

Two rehabilitation units at two hospitals (Glasgow Royal Infirmary and Hairmyres Hospital), UK
Period of study: November 1999 to November 2000
26 participants
Inclusion: people aged ≥ 65 years with hip fracture treated surgically (all internal fixation) up to 21 days previously, written informed consent
Exclusion: terminal disease, abbreviated mental score < 7/10, previous inability to walk, profoundly deaf, cardiac pacemaker, unstable medical conditions (e.g. pneumonia, heart failure)
Age: mean 81 years (range not stated)
% male: 8%
Number lost to follow‐up: 3 refusals + 2 deaths; also 2 telephone follow‐up only

Interventions

Postoperative rehabilitation

1. Supplementary electrical stimulation (ES) of quadriceps for 6 weeks: 5 days / week for inpatients; twice a week upon discharge. ES consisted of 7 seconds of stimulation of quadriceps followed by 23 seconds of relaxation for 36 repetitions; each session lasted 18 minutes. Delivery by physiotherapist assistant. Usual physiotherapy.
versus
2. Usual physiotherapy only. Inpatient physiotherapy consisted of supervised strengthening and range of motion exercises, balance training, work on transfers and progressive gait re‐education.

Expert physiotherapist established optimum electrical stimulation post‐baseline measurement but prior to randomisation (tolerance levels not provided for control group participants).

Intervention started in hospital, baseline measurements at median 10 to 11 days post‐surgery, and continued at home after hospital discharge.

Outcomes

Length of follow‐up: 14 weeks

Elderly Mobility Scale
Leg extension power
Barthel Index
Nottingham Health Profile (gait speed, emotional reactions, energy, pain, physical mobility, sleep, social isolation)
Mortality

Notes

Two other outcomes (Timed Up and Go test, isometric quadriceps strength) described in trial registration / abstracts but not in full report

Funding: Royal Infirmary Reserch Endowments Fund

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Randomisation was by computer‐generated random numbers"

Allocation concealment (selection bias)

Low risk

"[With] individual patient codes held in opaque sealed envelopes by an administrator independent from the study.”

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

“Measurements were made at baseline, at 6 weeks (the end of intervention) and 14 weeks by a single blinded assessor.”

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Only mortality was reported. “Measurements were made at baseline, at 6 weeks (the end of intervention) and 14 weeks by a single blinded assessor.” Assessment of mortality is not likely to be influenced by knowledge of group allocation.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

Although participant flow data provided, loss to follow‐up was proportionality greater in the intervention group.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Only mortality reported

Selective reporting (reporting bias)

Unclear risk

Consistent reporting of primary outcomes, but 'Timed Up and Go test' and isometric muscle data indicated in abstract and trial registration form are missing

Free from baseline imbalance bias?

Unclear risk

"There was a non‐significant trend for the control group to have a greater unfractured leg extensor power and higher Barthel scores at study entry." Proportionally fewer intervention group participants had independent mobility at baseline (27% versus 55%).

Free from performance bias due to non‐trial interventions?

Unclear risk

Although participants in both groups received standard physiotherapy while inpatients, it is not clear whether post‐discharge provision was similar.

Gorodetskyi 2007

Study characteristics

Methods

Randomised controlled trial

Participants

Moscow City Hospital NO71, Moscow, Russia
Period of study: February to November 2005
60 participants
Inclusion: people aged between 60 and 75 years who had undergone stabilisation (dynamic hip screw or external fixation) of an A2 femoral trochanteric fracture. Informed consent
Exclusion: limitations that might interfere with electrical stimulation including insulin pumps, pacemakers and neurostimulation implants; history of epilepsy or seizure; bilateral fractures; pathological fractures (excluding osteoporosis)
Age: mean 71 years (range 63 to 75)
% male: 33%
Number lost to follow‐up: 0

Interventions

Postoperative rehabilitation. Electrical stimulation or placebo (sham device) included in the standard rehabilitation started within 24 hours of surgery. Treatments and physiotherapy were carried out each morning and took 20 to 30 minutes to complete. Non‐steroidal anti‐inflammatory drug (ketorolac tromethamine) prescribed as needed.

1. Electrical stimulation (ES) for 10 days: use of a hand‐held, non‐invasive, interactive neurostimulation device (InterX 5000; Neuro Resource Group, Plano, Texas). (Device generates high peak amplitude averaging 17 volts on the skin with a low current of about 6 milliamperes (mA), and damped biphasic electrical impulses which are delivered to the tissue via a pair of concentric electrodes placed in direct contact with the target area. Device adjusts biphasic stimulus in accordance to the impedance of the underlying tissue by varying voltage to maintain constant peak current. Device applied for 20 to 30 minutes with electrodes at 3 sites close to surgical incision. Also corresponding areas on contralateral side. After adjustment for impedance, intensity increased to produce "comfortable sensation for patient").
versus
2. Sham device; same timing.

All the participants received standard interdisciplinary postoperative care including routine assessment and daily care by an orthopaedic surgeon supported by a physiotherapist and nurse.

Outcomes

Length of follow‐up: 10 days (end of treatment)

Pain score (VAS: 0 to 10: worst)
'Pain inventory': effects of pain on walking ability, sleep, mood and enjoyment of life (1: no interference; 10: absolute interference)
Analgaesic consumption
Surgeon's evaluation of participant's progress at 10 days in terms of improvement: none, minimal, average, substantial, full recovery

Notes

All participants were functionally independent before start of study.
Authors refer to reduced life expectancy in Russia.

Funding / conflict of interest: "The author or one or more of the authors have received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article. In addition, benefits have been or will be directed to a research fund, foundation, educational institution, or other nonprofit organisation with which one or more of the authors are associated".

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information. "Fixed randomisation scheme with sealed envelopes"

Allocation concealment (selection bias)

Unclear risk

"Fixed randomisation scheme with sealed envelopes"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

"The therapist who administered treatment was aware of the assignment of the patient to an active or sham device. However, all the assessing surgeons, patients and research personnel involved in determining and recording outcome measurements were blinded to this information. The sham device had an identical appearance and application to the active device with lights, buzzing and beeps, but did not produce interactive neurostimulation." Patient blinding may not be possible if they are familiar with neurostimulation.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

All the assessing surgeons, patients and research personnel involved in determining and recording outcome measurements were blinded to this information (active v sham device).

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Assessment of the outcome is not likely to be influenced by knowledge of group allocation.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

No loss to follow‐up

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

Not reported

Selective reporting (reporting bias)

Unclear risk

Possible but no trial protocol or trial registration available

Free from baseline imbalance bias?

Low risk

Intervention groups appeared well matched.

Free from performance bias due to non‐trial interventions?

Low risk

Same rehabilitation provided to all

Graham 1968

Study characteristics

Methods

Randomised trial: method not stated; stratified by age of participant

Participants

Western Infirmary, Glasgow, UK
Period of study: February 1961 to August 1966
273 participants (but possible that 604 participants were randomised)
Inclusion: people with a displaced intracapsular proximal femoral fracture (Garden type III or IV) treated by closed reduction and internal fixation with a sliding nail plate.
Exclusion (post randomisation): any reason (pulmonary or cardiac complications, deep venous thrombosis, general feebleness, re‐displacement of the fracture) at 2 weeks that the individual was not considered fit enough to walk at this time.
Age: not stated (within 56 to 95 for the 175 participants followed up for 3 years)
% male: not known
Number lost to follow‐up: disregarding post‐randomisation exclusions, 13 with incomplete follow‐up and 43 died at 1 year.

Interventions

Early postoperative rehabilitation. Operative treatment consisted of closed fracture reduction and internal fixation with a sliding nail plate. For the first 2 weeks postop, patients sat out of bed but were not permitted to stand or walk.
1. Early weight bearing at 2 weeks after surgery: unguarded walking
versus
2. Delayed weight bearing until 12 weeks after surgery

Outcomes

Length of follow‐up: 1 year for all, 3 years for subgroup

Mortality
Non‐union of the fracture (failure)
Avascular necrosis (segmental collapse)
Infection of the hip

Notes

An interim report for 124 trial participants at 3 months was available in 1964 (Abrami 1964), with a second report in 1968 (Graham 1968) which presented results for 273 participants at 1 year and results at 3 years for the 175 participants who had been followed up by then. Data from Abrami 1964 are not presented in the review.

Funding: none declared

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

According to earliest report: "After operation, but according to the sequence of their admission to hospital, patients in comparable five‐year age groups were randomly allocated to either the early or the late weight‐bearing groups" (Abrami 1964). But as reported by Graham 1968: "After admission to hospital each patient was allocated, by random selection, to an early or late weight‐bearing group within each decade from fifty‐six to ninety‐five years'. It was emphasised in the report that it was not alternation.

Allocation concealment (selection bias)

Unclear risk

No information

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No mention of blinding. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

No mention of blinding, nor of measures taken to safeguard knowledge of allocation at follow‐up data collection

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

No mention of blinding; however, assessment of the outcome is unlikely to be influenced by knowledge of group allocation

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Outcomes were not reported. Even so, there was incomplete long‐term follow‐up (only 175 of the 273 included participants ‐ after post‐randomisation exclusions) ‐ see next item.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Trial recruitment and randomisation were at hospital admission (604 admitted), but only those 273 patients who were judged as being suitable ‐ in that they could be expected to walk at the 2‐week clinical assessment ‐ were included in the analyses. The number of participants excluded at 2 weeks was not reported. Included participants were analysed in the group they were allocated at randomisation.

Selective reporting (reporting bias)

High risk

No indication of a protocol. Interim results generally reported. Differences between papers in account of trial (e.g. stratification)

Free from baseline imbalance bias?

High risk

Baseline data not given for randomised groups, nor for followed‐up participants, with the exception of gender and age group. All intracapsular fractures treated with same implant

Free from performance bias due to non‐trial interventions?

High risk

No information

Hauer 2002

Study characteristics

Methods

Randomised controlled trial using a protected random number system; stratified by hip‐ or lower‐extremity fracture surgery and non‐hip‐ or lower‐extremity fracture patients (see Notes)

Participants

Heidelberg, Germany
Period of study: not stated, but trial may have started around 1997
28 female participants
Inclusion: females aged ≥ 75 years (25 with a fall‐related hip fracture and 3 with elective hip surgery) who had experienced a recent injurious fall. Written informed consent and permission from orthopaedic surgeon
Exclusion: acute neurological impairment, severe cardiovascular disease, unstable chronic or terminal illness, major depression, severe cognitive impairment, severe musculoskeletal impairment
Age: mean 81 years (range not stated)
% male: none
Number lost to follow‐up: 4 (3 didn't start exercises and 1 dropped out)

Interventions

Started immediately upon hospital discharge.
1. 12‐week regimen of intensive physical training (lower extremity progressive resistance training, progressive functional and balance training). All exercise sessions took place in training groups (4 to 6 participants) supervised by a therapeutic recreation specialist. Each session: 1.5 hours of resistance training (with recovery breaks) and 45 minutes of balance/functional training. Intensity of strength training adjusted to 70% to 90% of individual maximal workload. Basic functions such as walking, stepping or balancing were trained progressively with increasing complexity.
versus
2. Placebo motor activity: 1‐hour sessions of activities such as flexibility exercise, callisthenics, ball games and memory tasks while seated.

Both regimens, taking place 3 times a week, started on average 4 to 5 weeks after surgery upon discharge from inpatient rehabilitation. Both groups received identical additional physiotherapy (mainly massage, stretching and application of heat or ice) twice weekly for 25 minutes: strength and balance training was excluded from these sessions.

Outcomes

Length of follow‐up: 6 months (12 weeks + 3 months)

Walking velocity and cadence
Independent weight bearing
Performance‐orientated motor assessment
Box step
Functional Reach
Timed Up and Go test
Chair and stair rises
Activities of daily living; sports and household activities
Muscle strength: leg‐press, leg‐extensor, leg flexor, ankle‐plantar flexion, hand grip strength (non‐trained muscle group)
Loss of independence
Subjective fear of falling
Subjective walking steadiness
Emotional state: depression, morale and handicap scales
Adherence

Notes

Measured adherence

This trial was excluded from versions of this review up to Issue 3, 2004 because the intervention began after the early postoperative period covered by this review, which then focused on early postoperative rehabilitation.

Trial actually included 57 people who had experienced an injurious fall. One report of the trial gave the results for the subgroup of 28 participants who had hip surgery. Of these, 25 had surgery for a fall‐related hip fracture and 3 had elective hip surgery. The patient characteristics of the latter 3 women were confirmed as being essentially similar to those of the 25 women with hip fracture. A 2‐year follow‐up of the trial is available but only for the whole trial population.

Further information, including method of randomisation, received from lead trialist on 05 March 2004 and 24 June 2004

Funding: grant from Ministerium fur Wissenschaft, Forschung und Kunst Baden‐Wuerttemberg and the University of Heidelberg

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Randomization was performed .... using a protected random number system"

Allocation concealment (selection bias)

Low risk

"Randomization was performed by an external person who did not participate in the study using a protected random number system"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Care providers providing the intervention and the participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

"Main outcome variables were documented by a person blinded to the patients' group assignment."

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

"Main outcome variables were documented by a person blinded to the patients' group assignment."

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Efforts had been made to collect outcome data for the 4 dropouts, 3 of whom did not start the exercises and 1 who discontinued their exercises. However, these data were not available.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

While all participants were accounted for, there were incomplete data on complications (although: 'minor') and long‐term follow‐up.

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

Efforts had been made to collect outcome data for the 4 dropouts, 3 of whom did not start the exercises and 1 who discontinued their exercises. However, these data were not available.

Selective reporting (reporting bias)

Unclear risk

Unclear. However, the 3 main reports of the trial were consistent in the reported outcomes and the author provided clarification on some of the outcome measures used.

Free from baseline imbalance bias?

Low risk

Baseline characteristics were similar in the 2 groups.

Free from performance bias due to non‐trial interventions?

Low risk

There was no cause for concern.

Karumo 1977

Study characteristics

Methods

Randomised trial: use of random numbers

Participants

University Central Hospital, Helsinki, Finland
Period of study: May 1973 to October 1974
100 participants
Inclusion: people aged > 50 years with femoral neck fracture treated surgically (internal fixation or prosthesis), capable of independent 'getting about' before fracture
Exclusion: none given
Age: mean 73 years (range not stated; all over 50 years)
% male: 25%
Number lost to follow‐up: 13 (excluded from 9‐week follow‐up because of inadequate follow‐up), 4 (excluded from 3‐month mortality data)

Interventions

Early postoperative rehabilitation, started first postoperative day onwards
1. Intensive (performed twice daily) physiotherapy regimen
versus
2. Same regimen performed once daily (conventional care)

Routine physiotherapy was on average 30 minutes per day. For the intensive group, the physiotherapy time was doubled. Both groups were under supervision of the study physiotherapist. Regimen was continued for 14 days. From first postoperative day, training in walking on crutches; training in sitting in chair; flexion‐extension movements of knee, hip and ankle. Most participants were allowed full weight bearing from the beginning. (For those with internal fixation, crutch use for up to 2 to 3 months.) From second postoperative week, training in walking up and down stairs.

Outcomes

Length of follow‐up: 9 weeks (for strength)

Walking ability
Ability to move and sit up in bed on first postoperative day
Abductor muscle strength at 9 weeks
Residence at 9 weeks
Mortality
"Mechanical" postoperative complications
Medical complications, including thromboembolism and postoperative infection
Length of hospital stay

Notes

Of the 100 people recruited for the trial, 13 had inadequate follow‐up and the results of these participants are not presented.

Most of the results for the trial were presented split according to whether the participant had a prosthesis or internal fixation, rather than by the trial interventions.

A thesis (1978, University of Helsinki) was located by Lesley Gillespie (10 June 2004). Requests for a copy met with no success.

Funding: none declared

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Using random numbers the patients selected for the study were divided before the operation into two physiotherapy groups."

Allocation concealment (selection bias)

Unclear risk

No report

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No mention of blinding. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

No mention of blinding

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

No mention of blinding; however, assessment of the outcome is unlikely to be influenced by knowledge of group allocation.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Results for 13 participants with inadequate follow‐up were not presented.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Results for 13 participants with inadequate follow‐up were not presented.

Selective reporting (reporting bias)

High risk

Mobility data split by treatment group were not presented.

Free from baseline imbalance bias?

High risk

There was a lack of information on baseline characteristics and comparability; data were not provided for 13 participants with inadequate follow‐up. The report referred to a non‐significantly greater number of participants in the routine physiotherapy group being treated with Jewett nails.

Free from performance bias due to non‐trial interventions?

Low risk

Appears so; the same physiotherapist provided both interventions.

Kimmel 2016

Study characteristics

Methods

Randomised controlled trial. Randomly assigned by computer program

Participants

The Alfred Hospital, a level 1 trauma centre, Melbourne, Australia
Period of study: March 2014 to January 2015
92 participants
Inclusion: at least 65 years old, admitted with an isolated subcapital or intertrochanteric hip fracture, treated by internal fixation or hemiarthroplasty
Exclusion: subtrochanteric or pathological fracture; postoperative orders for non‐weight bearing on the operated hip; unable to move independently or needed a gait aid prior to admission; admitted from nursing home
Age: mean (SD) = 81.3 (8.2)
% male: 36
Number lost to follow‐up: 13 (died = 1, unable to contact via telephone at 6 months = 12)

Interventions

1. Intervention group: usual care* in the morning plus 2 additional daily sessions, 7 days per week. One session (delivered by allied health assistant) practised the achievements of the morning session. One session (delivered by physiotherapist) aimed to improve the functional advances achieved during the earlier physiotherapy session; e.g. increased independence, progression of gait aid (e.g. from frame to crutches) and increasing the distance walked.

2. Control: usual care* in the morning

*Usual care: participants in both groups received daily physiotherapy according to usual practice in the trauma centre, 7 days per week. Treatment was individualised and involved bed‐based limb exercises (e.g. strength exercises, such as knee extension, and active hip exercises) and gait re‐training. The goal was early, independent transfer and mobility, with the objective of discharge directly home or to fast stream rehabilitation.

Outcomes

Length of follow‐up: Mobility and Modified Iowa Level of Assistance outcomes = Day 5 postop (or discharge, if discharged before Day 5); QOL 6 months.

Modified Iowa Level of Assistance score (hip‐fracture‐specific outcome, with 6 domains, including bed and chair transfer, ambulation, ascending/descending 1 step, and gait aid used, 0 (independent in all activities without a gait aid) to 36 (unable to attempt any of the activities). Day 5 or day of discharge (if earlier)

Timed Up and Go test Day 5 or day of discharge (if earlier)

Length of stay (acute, inpatient rehabilitation, combined)

Inpatient complication

Re‐admission

SF‐12, EQ‐5D (6 months)

Discharge destination

Death

Notes

Resource use collected: physiotherapy hours of service, acute / rehab / combined hospital length of stay

Funding: Victorian Department of Health (Workforce Innovation and Allied Health)

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Participants were randomly assigned by computer program"

Allocation concealment (selection bias)

Unclear risk

Allocation concealment not specified. Insufficient information to permit judgement

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear. The usual care physiotherapist was blinded to allocated group.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Blinding specified for Modified Iowa Level of Assistance, Timed Up and Go test.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Blinding not specified, but likely as data were collected from Victorian Orthopaedic Trauma Outcomes Registry, for SF‐12, EQ‐5D and Glasgow Outcome Scale. Blinding not specified for length of stay, inpatient complications, re‐admissions. Outcome measurement is unlikely to be influenced by lack of blinding.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Health‐related quality of life data derived from data in the Victorian Orthopaedic Trauma Outcomes Registry. Can assume this was collected by personnel blinded to the study.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

Timed Up and Go test performed only for people who could walk, so only 40/92 (42%) of participants contributed to this measure. All participants contributed to other measures at 5 days postop.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

13/92 (14%) lost to follow‐up at 6 months

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Low risk

15% lost to follow‐up at 6 months for health‐related quality of life

Selective reporting (reporting bias)

Low risk

All outcomes specified in trial registry and methods section were reported in the results

Free from baseline imbalance bias?

High risk

There were statistically significant between‐group differences in anaesthetic type (general versus spinal), proportion of men, and having a carer at home.

Free from performance bias due to non‐trial interventions?

Low risk

Care and experience of care providers was consistent across groups

Kronborg 2017

Study characteristics

Methods

Randomised trial (randomisation was stratified for fracture type (trochanteric/femoral neck))

Participants

Acute orthopaedic ward at a university hospital, Copenhagen, Denmark
Period of study: October 2013 to May 2015
90 participants
Inclusion: home‐dwelling, primary hip fracture surgery, aged 65 years or older, able to speak and understand the Danish language, independent pre‐fracture indoor walking ability equal to a New Mobility Score ≥ 2
Exclusion: multiple fractures, weight‐bearing restrictions, people unwilling to participate in appropriate rehabilitation or unable to co‐operate in tests, terminal illness, and treatment with total hip arthroplasty or parallel pins
Age: mean (SD) 79.6 (7.56)
% male: 23
Number lost to follow‐up: 10 (restrictions after X‐ray n = 1, re‐fracture n = 1, discharge without notice n = 2, declined assessment n = 1, death n = 2, transferred n = 2, incomplete follow‐up test of fractured limb n = 1)

Interventions

1. Intervention: routine physiotherapy* plus additional daily individual progressive knee‐extension strength training with 3 sets of 10 repetitions performed with an intensity of 10 repetition maximum (10 RM), defined as ±2 RM of the fractured limb using ankle weight cuffs.

2. Control: routine physiotherapy*

*Routine physiotherapy: basic mobility and exercise therapy primarily aimed at lower extremities following a guideline with 12 specific lower limb exercises, progressed individually and conducted daily on weekdays with 1 to 2 contacts per day (weekends included postoperative day 1 to 3 only). Repetitions and intensity were not standardised. Also basic mobility activities, balance and stair climbing aimed at regaining physical function corresponding with levels of pre‐fracture habitual activity, and progression of walking aids.

Outcomes

Change in maximal isometric knee‐extension strength (N·m/kg) in the fractured limb in percentage of non‐fractured limb (Maximal Voluntary Torque per kilo body mass) from inclusion to postoperative day 10 or discharge (follow‐up), using belt‐fixed handheld dynamometer

Timed Up and Go test, measured as early as possible after surgery when participant could walk independently with rollator and at follow‐up using a rollator as a standardised walking aid

Independent mobility at discharge (scored using Cumulated Ambulation Score)

Length of admission (postoperative day of discharge)

Discharge destination

Pain. Hip‐fracture‐related pain at rest and during outcome assessment, evaluated by Verbal Ranking Scale (score 0 to 4) using the highest pain level reported from each session

Death

Notes

The stratification on fracture type was violated in the last 10 included participants due to slow inclusion of participants with a femoral neck fracture, allowing more participants with trochanteric fractures (n = 52) to enter the study compared to femoral neck fractures (n = 38). Measured gait speed and independent mobility, but no data presented.

Measured adherence

Funding: grants from The IMK Foundation (LK), The Research Foundation of the Capital Region (MTK), The Research Foundation of the Danish Physical Therapy

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"[Randomly] allocated to two different postoperative in‐hospital rehabilitation interventions by a neutral person (blinded to outcomes and patient characteristics) via a computer‐generated list"

Allocation concealment (selection bias)

Low risk

"[Notes] placed in sealed envelopes and marked with participant numbers only"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Outcome assessor was blinded to group assignment.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Method of assessing death was unclear.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

Timed Up and Go test and timed 10 m walk were performed only for people who could walk;unclear what percentage of participants contributed to these measures

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

10/90 (11%) lost to follow‐up

Selective reporting (reporting bias)

High risk

Protocol appended to paper. Thigh and lower leg circumference is an outcome in protocol, but not reported. Protocol states Timed Up and Go test, 10‐Metre Walk Test, New Mobility Score, and isometric strength would be assessed at 16 weeks, but these were not reported in results paper. Data not presented for 10m walk time, but between‐group difference is reported.

Free from baseline imbalance bias?

Low risk

No imbalance noted

Free from performance bias due to non‐trial interventions?

Low risk

Care and experience of care providers appears consistent across groups

Lamb 2002

Study characteristics

Methods

Randomised trial: use of sequentially‐numbered, sealed, opaque envelopes; stratified by pre‐injury mobility

Participants

John Radcliffe Nuffield Orthopaedic Hospital, Oxford, UK
Period of study: not stated, earliest report located 1998
27 female participants
Inclusion: women aged ≥ 75 years who had surgical fixation (not total hip replacement) of a hip fracture, living in own home or a relative's home or in sheltered housing before their injury. Written informed consent
Exclusion: history of stroke or Parkinson's disease, clinical depression or acute mental illness, cognitive impairment: 6 or lower on the Hodkinson Mental Test Score. Other fracture, respiratory or cardiac failure sufficient to prevent walking 50 feet (15.25 m), systolic blood pressure > 200 mmHg or diastolic blood pressure > 100 mmHg, surgical complications, pathological fracture. At medication assessment at day 6: on hypnotics, sedatives, muscle relaxant or medications likely to affect muscular function during postoperative period.
Age: mean 84 years (range: not stated)
% male: none
Number lost to follow‐up: 3 excluded. One had myasthenia gravis (confirmed independently as not related to trial), one a severe chest infection and the third participant withdrew consent after a few days.

Interventions

Early postoperative rehabilitation, started at 7 days after surgery.
1. Patterned neuromuscular (electrical) stimulation of the quadriceps muscle for 3 hours a day for 6 weeks. Stimulus intensity was the minimum required for visible muscle contraction. Each stimulus delivered 0.3 micro coulomb of charge.
versus
2. Placebo stimulation for same time period.

Interventions started in hospital 1 week after surgery and continued at participants' homes after hospital discharge at 10 to 14 days. A trained assistant, who was independent of the study, showed the participants how to apply the stimulator.

Outcomes

Length of follow‐up: 12 weeks after randomisation (13 weeks after surgery)

Recovery of mobility
Walking velocity
Leg extensor power
Compliance
Pain (1: no pain to 6: severe pain)
Side effects (none)

Notes

Patterned neuromuscular (electrical) stimulation is "a variable frequency stimulus (mean frequency 8.9 Hz) derived from the discharge of a fatiguing motor unit of the quadriceps".

The stimulator was designed for home use, being portable and independent of an electric supply. Difficulties found by the participants in changing the batteries meant that weekly visits were required by study personnel.

Funding: Research into Ageing and the PPP Healthcare Charitable Trust.

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Randomization lists were prepared in advance of the study with a random number table.”

Allocation concealment (selection bias)

Low risk

“Assignments were placed in sealed, numbered, opaque envelopes that were opened in a strict sequence after eligibility had been established and consent obtained.”

Blinding of participants and personnel (performance bias)
All outcomes

Low risk

Good attempt made to blind participants with placebo stimulation.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

“The investigator responsible for measuring outcomes and all participants were blind to the treatment assignment."

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Only complications reported, blinding indicated, and assessment of this outcome is unlikely to be influenced by knowledge of group allocation.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

No data, including group allocation, presented for the 3 people who did not complete the study

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

Only complications reported

Selective reporting (reporting bias)

Unclear risk

Probably, but no trial protocol or trial registration available

Free from baseline imbalance bias?

Unclear risk

Incomplete report of baseline data as those for the 3 post‐randomisation exclusions were not available. No major differences in the available data for those followed up.

Free from performance bias due to non‐trial interventions?

Low risk

No obvious differences. Both arms included similar usual care.

Langford 2015

Study characteristics

Methods

Randomised trial

Participants

Acute orthopedic unit in metro Vancouver teaching hospital, Vancouver, BC, Canada

Period of study: November 2013 to September 2014

30 participants

Inclusion: community‐dwelling adults with a recent fall‐related hip fracture ≥ 60 years of age, recruited following surgical repair. English speaking

Exclusion: fracture related to metastatic disease or bisphosphonate use, did not return home in the community after hospital discharge, medical contraindications restricting activity and exercise, hearing or speech impairments precluding telephonic communication, or physician‐diagnosed dementia.

Age: mean 82.5 years (range 61 to 97)

% male: 37%

Number lost to follow‐up: 4 (postoperative complications n = 3, moved to residential care n = 1)

Interventions

Additional post‐discharge physiotherapist telephone support and coaching

1. Telephone support and coaching: usual care plus 1‐hour in‐hospital individualised education session using the hip fracture recovery manual and 4 educational videos (FReSH Start), plus up to 5 phone calls in the first 4 months post‐fracture from research physiotherapist (average 151 minutes of phone time). Phone calls focused on goal setting regarding recovery goals, mobility goals, adherence to exercise programme and community reintegration.

2. Usual care: usual care plus 1‐hour in‐hospital individualised education session using the hip fracture recovery manual and 4 educational videos (FReSH Start).

Usual care included follow‐up physician and surgeon visits, and usual rehabilitation and home care as appropriate.

Outcomes

Length of follow‐up: 4 months

Mobility (observed): 4‐Metre Walk Test

Mobility (self‐reported): use of mobility aid

Quality of life (EQ‐5D‐5L)

Strength: grip Strength

Adverse events: falls (risk and number), re‐admissions (30‐day)

Pain

Notes

Funding: nil

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Web‐based randomisation service. Stratified randomisation by sex and age group

Allocation concealment (selection bias)

Low risk

An independent statistician from an off‐site consulting firm generated the allocation sequence.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and the participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

Participants, the research physiotherapist and study co‐ordinator were aware of treatment allocation. Outcome assessment completed by research physiotherapist

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Participants, the research physiotherapist and study co‐ordinator were aware of treatment allocation. Outcome assessment completed by research physiotherapist. Unclear how this affected objective outcomes

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

High risk

Health‐related quality of life: participants, the research physiotherapist and study co‐ordinator were aware of treatment allocation. Outcome assessment completed by research physiotherapist. Risk of bias for health‐related quality of life = high

Falls: ascertained by the same method in both groups, self‐reported by participant. Blinded assessors monitored monthly via telephone. Risk of bias for falls = unclear

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

27% of intervention group participants were lost to follow‐up (3 postop complications, 1 residential care admission). No control group participants were lost to follow‐up.

The disproportionate loss in intervention and control groups may affect the outcome and it is possible those lost due to complications had different mobility.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

27% of intervention group participants were lost to follow‐up (3 postop complications, 1 residential care admission). No control group participants were lost to follow‐up.

The disproportionate loss in intervention and control groups may affect the outcome and it is possible those lost due to complications would have been more likely to be re‐admitted.

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

27% of intervention group participants were lost to follow‐up (3 postop complications, 1 residential care admission). No control group participants were lost to follow‐up. Those excluded due to complications more likely to have reduced quality of life and greater risk of falls.

Selective reporting (reporting bias)

Low risk

Outcomes not reported in published manuscript were provided by author.

Free from baseline imbalance bias?

Low risk

No significant differences at baseline; additional outcomes provided by author.

Free from performance bias due to non‐trial interventions?

Unclear risk

Incomplete assurance of comparability of other care provided to the 2 groups.

Method of ascertaining falls

Low risk

Monitored falls via prospective self‐reported daily falls diary and monthly telephone calls by a research assistant blinded to group allocation.

Latham 2014

Study characteristics

Methods

Randomised trial

Participants

Greater Boston, Massachusetts, USA

Period of study: September 2008 to October 2012

232 participants enrolled

Inclusion: primary diagnosis of hip fracture, > 60 years, discharged from rehabilitation ≤ 20 months of baseline assessment, can understand and communicate in English, able to safely and independently move from sitting to standing ± mobility device, have a functional limitation (defined as a limitation in at least 1 of the tasks listed in the Short Form‐36 physical function scale)

Exclusion: significant cognitive deficits (i.e. a Mini Mental State Examination score of < 20), severe depression (i.e. a score of ≥ 10 on the short form of the Geriatric Depression Scale), a terminal illness (survival expected to be < 1 year), significant pulmonary or cardiovascular contraindications or preexisting conditions that precluded participation in an exercise programme, legally blind, currently receiving rehabilitation therapy, lived outside of the study’s catchment area in New England, had a bilateral hip fracture, hip fracture was the result of a malignancy, it had been more than 24 months since the hip fracture at enrolment in the study, or had a rapidly progressive

neurological disease.

Age: mean 78.0 (SD 9.9) years

% male: 31%

Number lost to follow‐up: 53

Interventions

6‐month programme

1. Home exercise intervention: exercise intervention 3 times per week for 6 months. Training by physical therapist with monthly telephone calls. Cognitive and behavioural strategies used. Participants given DVD of programme and DVD player if necessary. Programme: simple functional tasks based on Strong for Life programme using Thera‐Bands for resistance. Standing exercises with steps and weighted vests. Based on Increased Velocity Exercise Specific to Task (INVEST), Sherrington and Lord programmes.

2. Attention control: same frequency of contact as intervention group but with registered dieticians. Nutrition education for cardiovascular health based on the Dietary Guidelines for Americans. Single home visit of 1 hour, followed by a series of telephone calls of approximately 30 minutes’ duration, and mailings.

Outcomes

Length of follow‐up: 6 months (at end of intervention), 9 months (3 months post‐intervention)

Mobility (observed): Short Physical Performance Battery

Mobility (self‐reported): Activity Measure‐Post Acute Care (AM‐PAC) mobility

Function: AM‐PAC daily activity

Balance (observed): Berg Balance Scale

Strength: knee extension force

Other outcomes not included in review: self‐efficacy, modified falls self‐efficacy, outcomes expectations for exercise scale

Notes

Measured adherence

Funding: National Institute of Nursing Research. Thera‐Band products were donated by Thera‐Band.

Conflict of Interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computerised central randomisation scheme generated by the study biostatistician

Allocation concealment (selection bias)

Unclear risk

Inadequate information to support judgement

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Function assessed by blinded assessors

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Blinded assessors

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Losses and reasons balanced between groups. 21.7% loss from intervention group versus 24.1% loss from control group, but reasons balanced and accounted for in multiple ways in analysis

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Losses and reasons balanced between groups. 21.7% loss from intervention group versus 24.1% loss from control group, but reasons balanced and accounted for in multiple ways in analysis

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Low risk

Losses and reasons balanced between groups. 21.7% loss from intervention group versus 24.1% loss from control group, but reasons balanced and accounted for in multiple ways in analysis

Selective reporting (reporting bias)

Low risk

Outcomes reported as per trial registration

Free from baseline imbalance bias?

Low risk

Groups balanced at baseline

Free from performance bias due to non‐trial interventions?

Low risk

No obvious other differences between groups.

Lauridsen 2002

Study characteristics

Methods

Randomised trial: use of consecutively‐drawn, numbered, sealed, opaque envelopes

Participants

Rehabilitation Unit, Hvidovre Hospital, Copenhagen, Denmark
Period of study: not stated
88 participants
Inclusion: women aged 60 to 89 years transferred to a rehabilitation unit within 3 weeks after surgical treatment (osteosynthesis or partial hip replacement) of an "uncomplicated" hip fracture, full mobility prior to fracture, full weight bearing allowed, no concomitant disabling disorders, informed consent
Exclusion: women who fell ill during the trial with symptoms that hindered training for more than 2 days; women discharged before attaining the planned functional capacity. (These appear to be post‐randomisation exclusion criteria.)
Age: median 80 years (range 61 to 89 years)
% male: none
Number lost to follow‐up: none (37 dropouts still accounted for in analyses)

Interventions

Early postoperative rehabilitation
1. Participants were offered 6 hours per week of intensive physiotherapy, comprising 2 hours on Monday, Wednesday and Friday
versus
2. Standard physiotherapy of 15 to 30 minutes per weekday

Qualitative content of the 2 programmes were identical: bench exercises, gait, balance, co‐ordination, stair climbing and, in some cases, hydrotherapy.

Training was stopped when the planned functional capacity was attained unaided (walk 50 or more metres without resting in 2 minutes or less, using walking stick or quadruped if necessary; climb 1 flight of stairs; manage sit‐to‐stand transfer; move in and out of bed; manage bathing, dressing and lavatory visits) or when participants withdrew from study.

Outcomes

Length of follow‐up: until discharge from hospital

Use of walking aids
Orthopaedic complication
Length of hospital stay
Duration of training and length of training period
Dropouts from training

Notes

Details of the method of randomisation provided on contact with lead trialist, but no other information gained.

The current account of the trial is based on the report in the Danish Medical Bulletin. A colleague, Pernille Jensen, based in Denmark, checked through the paper written in Danish (in Ugeskr Laeger) and confirmed that, with the exception of a few small details, the English paper was a straight translation.

Participants in the intervention arm spent significantly more total hours training and significantly more hours per day training than those in the control arm.

Measured adherence

Funding: none declared

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

"Patients were randomised"

Allocation concealment (selection bias)

Low risk

Letter from authors to Martyn Parker (06 August 2002): "numbered sealed opaque envelopes drawn consecutively"

Blinding of participants and personnel (performance bias)
All outcomes

High risk

"A blinded evaluation was performed by an external observer when the treating physiotherapist considered that the objective [attainment of functional capacity] had been obtained." However, this was after a non‐blinded person had assessed achievement of functional goals.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

"A blinded evaluation was performed by an external observer when the treating physiotherapist considered that the objective [attainment of functional capacity] had been obtained." However, this was after a non‐blinded person had assessed achievement of functional goals.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Blinding not specified. Unclear how assessment of adverse effects is influenced by potential knowledge of group allocation

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Data provided for all participants for intention‐to‐treat analysis as well as per‐protocol analysis

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Data provided for all participants for intention‐to‐treat analysis as well as per‐protocol analysis

Selective reporting (reporting bias)

Unclear risk

Possible but no confirmation

Free from baseline imbalance bias?

Low risk

Baseline comparability evident

Free from performance bias due to non‐trial interventions?

Unclear risk

Incomplete assurance of comparability of other care provided to the 2 groups

Magaziner 2019

Study characteristics

Methods

Parallel, 2‐group, randomised clinical trial

Participants

Conducted at 3 clinical centres in the USA: Arcadia University, University of Connecticut Health Center, and University of Maryland, Baltimore
Period of study: September 2013 to October 2017
210 participants
Inclusion: minimal trauma, closed, non‐pathologic hip fracture with surgical repair; age 60 years and older; community‐dwelling at time of fracture and randomisation; ambulating without human assistance 2 months before the fracture; and walking less than 300 m during the 6‐Minute Walk Test at the time of randomisation
Exclusion: medical contraindications for exercise, low potential to benefit from the intervention, and practical impediments to participation
Age: mean (SD) 80.75 (8.4)
% male: 23
Number lost to follow‐up: 13

Interventions

For both treatment groups, physical therapists provided 60‐minute in‐home intervention visits on non‐consecutive days for 16 weeks. The first 75 participants = 3 visits per week during the first 8 weeks and 2 visits per week during the remaining 8 weeks (40 assigned visits). Participants randomised after the protocol change = 2 visits per week (32 assigned visits). Participants in both groups received 2000 IU of vitamin D3, 600 mg of calcium and a multivitamin daily for 40 weeks. A registered dietician provided nutritional counselling at baseline. Additional dietician consults were provided by telephone if participants lost 2% or more of weight over 4 weeks.

1. Intervention: strength training using portable progressive resistance device, 3 sets of 8 repetitions at 8 RM or body weight, per leg, for 4 muscle groups (leg press, hip abduction, hip extension and heel raises). Intensity reassessed every 2 weeks. Endurance training (outdoor ambulation, indoor walking or other upright activity), aiming for 20 minutes at 50% of heart rate reserve.

2. Active control: "These activities were selected because they are common physical therapy interventions but were not expected to have an effect on walking ability". Seated active range‐of‐motion exercises (neck, trunk, upper and lower limbs), progressed from 3 to 20 repetitions per exercise, target volume > 20 minutes. Sensory‐level TENS unit application to lower extremity muscle groups, frequency = 80 pulses/second, pulse duration = 50 microseconds, and amplitude to produce a minimally detectable tingling sensation to each muscle complex for 7 minutes. Target volume = 21 minutes per session.

Outcomes

16 weeks:

6‐Minute Walk Test

Short Physical Performance Battery

Balance subscale of Short Physical Performance Battery, and 2 additional single leg stands (eyes open and eyes closed) as used in the National Health and Aging Trends Study (NHATS)

Quadriceps Muscle Strength

Modified Physical Performance Test

Gait speed (fast walking, 50 feet)

Notes

ClinicalTrials.gov Identifier: NCT01783704

Protocol modified during study: reduced target sample size from 300 to 210, expanded eligibility criteria, removed 1 outcome time point (40 weeks), reduced intervention intensity from 3 days/week to 2 days/week

Measured adherence

Funding: Dr Beamer reported receiving grants from the NIA/NIH and Veterans Affairs. Dr Binder reported receiving grants from Astellas Pharma and an interview stipend from Pfizer. Dr Miller reported being a full‐time employee of Novartis Institutes for Biomedical Research. Ms McBride reported receiving grants from the University of Maryland School of Medicine. Dr Craik reported receiving grants from the NIH and personal fees from the University of Maryland School of Medicine, as well as serving on the external advisory board of the Pepper Center at the University of Maryland School of Medicine. No other disclosures were reported.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The random allocation sequence...was implemented using a secure web‐based system. Treatments were assigned according to separate randomization schedules for each clinical site, in randomly ordered blocks of randomly selected sizes of 2, 4, 6, or 8, with equal numbers of participants assigned to each treatment within each block".

Allocation concealment (selection bias)

Low risk

Randomisation "implemented using a secure web‐based system"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Unclear risk

Quote: "Assessors who measured outcomes were blinded to treatment group; participants were instructed not to discuss group assignments with assessors". 3 cases of unblinding of assessment staff were reported, all in the training group.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Unclear if assessors were blinded for phone calls: quote: "Information on reportable adverse events, including serious or unexpected adverse events or injury that occurred under supervision by study staff, was obtained by telephone interview every 4 weeks". Bias unlikely for mortality

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Less than 20% loss to follow‐up

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

Less than 20% loss to follow‐up

Selective reporting (reporting bias)

Low risk

Authors specify certain outcomes are not reported in this paper, including cost‐effectiveness, quality of life (Short Form‐36 not reported), and activities of daily living (Pepper Assessment Tool for Disability)

Free from baseline imbalance bias?

Low risk

Groups balanced at baseline

Free from performance bias due to non‐trial interventions?

Low risk

For both treatment groups, physical therapists provided 60‐minute in‐home intervention visits on non‐consecutive days for 16 weeks. At study initiation, physical therapists were randomly assigned to treatment groups.

Mangione 2005

Study characteristics

Methods

Randomised trial: use of a list of computer‐generated random numbers

Participants

Community‐dwellers in the vicinity of Arcadia University, USA
Period of study: not stated
41 participants
Inclusion: people aged 65 years or over living at home after successful hip fracture surgery (partial or total hip replacement or internal fixation) who were willing to go to Arcadia University for assessment, discharged from other physical therapy, informed consent
Exclusion: medical contraindications (unstable angina; uncompensated heart failure; on renal dialysis) to resistance or aerobic exercise, stoke with hemiplegia, Parkinson's disease, life expectancy less than 6 months, Mini Mental State Exam score < 20, living in nursing home
Age (of 33 completers): mean 79 years (range 64 to 89 years)
% male (of 33 completers): 27
Number lost to follow‐up: 8 (1 unable to perform prescribed exercises, 2 withdrew consent, 1 diagnosis of progressive neuromuscular disorder, 4 hospitalisations of whom 2 died)

Interventions

The two intervention groups (1 and 2) received high‐intensity home‐based exercise supervised by a physical therapist in 20 visits over 12 weeks: twice‐weekly for 8 weeks and once‐weekly for 4 weeks. Each session lasted 30 to 40 minutes.
1. Resistance training group did 3 sets of 8 repetitions at 8 RM intensity using a portable resistance exercise machine for hip extensors, hip abductors, knee extensors and plantar flexors
versus
2. An aerobic training group did activities that increased the heart rate to 65% to 75% of age‐predicted maximum for 20 continuous minutes (walking, stair climbing or ROM exercises)
versus
3. Control group: bi‐weekly mailings on a variety of non‐exercise topics. Participants asked not to begin any new exercise programmes until the study was completed. They were told that they were eligible to receive either of the exercise interventions at the end of the study.

Outcomes

Length of follow‐up: 12 weeks; but only 8 weeks for the control group.

6‐Minute Walk Test distance
Maximum voluntary isometric force of the lower extremity
Fast gait speed
SF‐36 physical function
Mortality

Notes

Measured adherence

Funding: Foundation for Physical Therapy Research Grant

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"..assignment to a group was determined by referring to a list of computer‐generated random numbers"

Allocation concealment (selection bias)

Unclear risk

Unclear if allocation concealed

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

"The physical therapist examiner was masked to group assignment and performed all testing at baseline and after treatment. Different physical therapists provided the interventions and were masked to outcome testing results." There is no indication on whether the participants were told not to inform the assessor of their group allocation.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Outcomes are clearly reported and unlikely to be affected by lack of blinding.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

"The physical therapist examiner was masked to group assignment and performed all testing at baseline and after treatment. Different physical therapists provided the interventions and were masked to outcome testing results."

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Participant flow diagram provided but differential loss to follow‐up (6 from the resistance training group of 8 overall)

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Participant flow diagram provided

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Unclear risk

Participant flow diagram provided but differential loss to follow‐up (6 from the resistance training group of 8 overall)

Selective reporting (reporting bias)

Unclear risk

No protocol available. However, the 2 conference abstracts point to consistency in reporting.

Free from baseline imbalance bias?

High risk

Baseline data provided for only 33 of 41 participants. There were some between‐group differences, which may have been clinically significant. In particular, participants in the control group were more depressed and the time from surgery to the start of the study was around 7 weeks more in the 2 exercise groups compared with the control group (19.4 versus 19.7 versus 12.6 weeks).

Free from performance bias due to non‐trial interventions?

Unclear risk

Variation in delivery by the 6 physiotherapists may have occurred.

Mangione 2010

Study characteristics

Methods

Randomised controlled trial

Participants

Community‐dwellers in the Bucks and Montgomery county area (Pennsylvania), USA.

Period of study: June 2003 to January 2006

26 participants

Inclusion: community‐dwelling before fracture, successful fixation of a hip fracture within previous 6 months, aged ≥ 64 years, physician referral, discharged from physical therapy

Exclusion: medical history of unstable angina pectoris or uncompensated congestive heart failure, ongoing chemotherapy or renal dialysis, history of stroke with residual hemiplegia, Parkinson’s disease, absence of sensation in the lower extremities due to sensory neuropathy, life expectancy < 6 months, MMSE < 20, walking speed < 0.3 m/s or > 1.0 m/s.

Age: mean 80.7 years (SD 5.95)
% male: 19

Number lost to follow‐up at 10 weeks = 5, at 12 months after fracture = 10

Interventions

10‐week programmes delivered by licensed physical therapist.

1. Progressive resistance exercise: leg strengthening exercises, strengthening exercises for the hip extensors and abductors, knee extensors, and ankle plantar flexors bilaterally because of the role of these muscles in gait and transfers. 2x weekly for 20 weeks, total of 20 sessions of 30 to 40 minutes. Intensity: 8 repetition maximum (RM), volume: 3 sets of 8 RM.

2. Control: TENS ("Attentional control group"), at or above the sensory threshold but below the motor threshold, with no visible muscle contraction. Intensity not progressed. Bilateral gluteal muscles (hip extensors and abductors), knee extensors, and ankle plantar flexors were stimulated for 7 minutes for a total of 21 minutes each session. Guided imagery also.

Outcomes

Length of follow‐up: 10 weeks (end of intervention, used in analysis); study also reported outcomes 26 weeks after randomisation (12 months after fracture)

6‐Minute Walk Test

HRQoL: SF‐36 physical function

Fast gait speed

Strength (lower extremity torque)

Modified Physical Performance Score

Notes

Measured adherence

Adverse events not systematically assessed

"By having a physical therapist administer the placebo TENS and imagery each treatment session, it was possible to control for attention and motivation...".

Funding: National Institutes of Health, National Institute of Child Health and Human Development, National Institute on Aging Grant 1 R03 HD041944‐01A1

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Insufficient information for judgement. Quote: "using an unrestricted randomization method"

Allocation concealment (selection bias)

Low risk

Quote: "opaque sealed envelopes"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Participants possibly blinded due to placebo transcutaneous electrical nerve stimulation (TENS). Therapists not blinded; effect of non‐blinding unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Assessors were blinded to group allocation.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Method of assessing complications is unclear; however, it does not appear to be blinded.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Assessors were blinded to group allocation.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Less than 20% (19%) lost to follow‐up at 10 weeks; however, 31% lost to follow‐up at 26 weeks

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

Method of assessing complications is unclear

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

Less than 20% (19%) lost to follow‐up at 10 weeks; however, 31% lost to follow‐up at 26 weeks

Selective reporting (reporting bias)

Unclear risk

No trial registry or protocol paper; outcomes in methods section are reported in the results

Free from baseline imbalance bias?

Low risk

Groups comparable at baseline

Free from performance bias due to non‐trial interventions?

Low risk

Quote: “Licensed physical therapists conducted treatment sessions for both groups”. TENS used as an active control

Miller 2006

Study characteristics

Methods

Randomised controlled trial

Participants

Orthopaedic wards of Flinders Medical Centre, Adelaide, Australia
Period of study: recruitment September 2000 to October 2002
63 hip fracture patients (out of a total of 75 participants with fall‐related lower limb fracture)
Inclusion: age 70 years or over, fall‐related lower limb fracture, resident in Southern Adelaide, malnourished ( < 25thpercentile for mid‐arm circumference for older Australians), written consent by patient or next of kin.
Exclusion: unable to understand instructions for positioning of upper arm, could not full weight bear on side of injury > 7 days post admission, not independently mobile pre‐fracture, medically unstable > 7 days post admission, cancer, chronic renal failure, unstable angina, diabetes.
Age (of 75): mean 83.5 years
% male (of 75): 23
Number lost to follow‐up: 5 (3 dead at 12 weeks and 2 withdrew)

Interventions

Early postoperative rehabilitation. Intervention started from 7 days after fracture.
1. Resistance training supervised by a physiotherapist 3 times per week, 20 to 30 minutes per session, for 12 weeks. To ensure standardisation, the trial physiotherapists were instructed to deliver only the structured programme of therapy to participants. Programme incorporated progressive resistance training of the hip extensors and abductors (supine), knee extensors (supine or sitting) and ankle dorsi‐ and plantar‐flexors (supine or sitting). Training was increased as soon as 2 sets of 8 repetitions of the exercise could be completed in good form, judged by physiotherapist.
versus
2. Resistance training plus nutrition: Fortisip (Nutricia Australia Pty Ltd) oral protein and energy supplement (1.5 kcal/mL, 16% protein, 35% fat, 49% carbohydrate) to provide 45% of estimated energy intakes. (Individually prescribed and delivered.) Four doses of equal volume given by nurses from drug trolley, continued after hospital discharge at twice per day or more. Once weekly visits on weeks 7 to 12.
versus
3. Attention control. Usual care and general nutrition and exercise advice. Tri‐weekly visits on weeks 1 to 6, once weekly on weeks 7 to 12. Discussions during these visits were limited to general information (e.g. benefits of regular exercise and nutrient‐dense meals). All participants were encouraged to continue prescribed treatments.

All participants received usual clinical care (including general nutrition and exercise advice, usual dietetic and physiotherapy care, transfer to residential care, rehabilitation facility or directly home).

Outcomes

Length of follow‐up: 12 weeks (mobility outcomes); 12 months (mortality and re‐admissions)
Gait speed
Quadriceps strength
Quality of life (SF‐12 physical component score and mental component score)
Hospital re‐admission
Mortality (reported for hip fracture patients at 12 months. Three‐month time point not used as data reported for non‐hip fracture patients)
Length of hospital stay (acute, rehabilitation, total)

Notes

Measured adherence

Trial population also included 25 other participants (23 with hip fracture) who were allocated to the nutrition‐only intervention group. Data from this group are not included in this review. Of the 14 participants with other lower limb fractures: 6 were pelvic and 8 were of the femur, tibia or fibula.
Further information on trial, including mortality data for hip fracture patients, provided to Alison Avenell by Maria Crotty for the nutrition supplementation review (Avenell 2010).

Started in acute orthopaedic ward and continued after discharge home. Median length of stay (acute and rehab) = 24 days.

Funding: NHMRC Public Health Postgraduate Research Scholarship, Flinders University‐Industry Collaborative Research Grant and Nutricia Australia Pty Ltd.

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Participants were randomized by using a stratified (admission accommodation: community or residential care), block randomization method (blocks of 12) following baseline assessment.” From summary data provided 25 July 2003: "computer generated table of random numbers"

Allocation concealment (selection bias)

Low risk

"The Pharmacy department maintained a computer generated allocation sequence in sealed opaque envelopes."

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Care providers and patients not blinded. Impact of non‐blinding unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

"Research staff blinded to treatment allocation performed outcome assessments (weight, quadriceps strength, gait speed, quality of life) 12 weeks after commencement of trial interventions."

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Unclear whether research staff were blinded for these outcomes; however, mortality outcomes not likely to be influenced by knowledge of group allocation, uncertain for adverse events

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Denominators for gait analysis, quadriceps strength etc. not provided

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

Participant flow diagram provided (for 12 weeks), but inconsistent data provided at 1 year in a summary provided by trialists

Selective reporting (reporting bias)

Unclear risk

Protocol not available

Free from baseline imbalance bias?

Unclear risk

“No significant differences were identified across the four treatment groups.” However, twice as many cognitively‐impaired participants (17) in attention control group compared with combined intervention group (8); 12 in exercise group.

Free from performance bias due to non‐trial interventions?

Unclear risk

No information. More attention control group participants (11) were referred for dietetic intervention, as part of usual care, compared with exercise (6) and nutrition and exercise (5) groups.

Mitchell 2001

Study characteristics

Methods

Randomised controlled trial

Participants

Geriatric Orthopaedic Unit (Lightburn Hospital) connected with Glasgow Royal Infirmary, UK
Period of study: February 1997 to August 1998
80 participants
Inclusion: people aged ≥ 65 years with hip fracture treated surgically, written informed consent
Exclusion: abbreviated mental score < 6/10, previously unable to walk, medically unstable
Age: mean 80 years (range not stated)
% male: 16%
Number lost to follow‐up: 16 (refused or unavailable); also, 7 died and 13 with new comorbidity precluding assessment were not included in final analyses.

Interventions

Early postoperative rehabilitation
1. Twice weekly quadriceps strengthening exercises in both legs for 6 weeks whilst a hospital inpatient on a rehabilitation ward. Sessions involved 6 sets of 12 repetitions of knee extension (both legs), progressing from 50% of participant's 1 RM (weeks 1 and 2), 70% (weeks 3 and 4) and up to 80% (weeks 5 and 6). Participant’s 1 RM (maximum load an individual can lift through full range of knee extension) established initially and at 3 and 5 weeks. Plus usual care.
versus
2. Usual care only. Consisted of conventional physiotherapy for approximately 20 minutes per day, 5 days a week. Initial bed exercises, progressing to bed and chair transfers, gait re‐education and balance training, to practice of functional activities in gym including use of parallel bars.
Participants transferred to a rehabilitation unit at about 15 days (median 15 versus 16 days) after surgery for a hip fracture.

Outcomes

Length of follow‐up: 6 weeks and 16 weeks (16 weeks used in analysis)

Elderly mobility scale
Leg extension power
Walking velocity
Barthel Index
'Get up and go' test
Functional reach
Length of hospital stay
Mortality

Notes

Measured adherence

Funding: none declared

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Randomisation was performed using computer‐generated random numbers"

Allocation concealment (selection bias)

Low risk

"[Group] allocation for each study patient concealed in a sealed envelope and held by a third party who was not otherwise involved in the study"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

“Recordings were made by a single research assistant who was not blinded to study group allocation.” While “an independent blinded assessor performed repeat measurements of leg extensor in a convenience sample of 18” participants at 6 weeks plus 2 days gave reassuring results, this was not considered an adequate protection against bias.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Blinding unclear; however, mortality outcome is usually unlikely to be influenced by knowledge of group allocation.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Bias could have occurred given the high loss to follow‐up at 16 weeks (intervention: 50% versus control: 40%).

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Bias could have occurred given the high loss to follow‐up at 16 weeks (intervention: 50% versus control: 40%).

Selective reporting (reporting bias)

Low risk

Comprehensive report of outcome including consistent primary outcome

Free from baseline imbalance bias?

Low risk

In all key characteristics

Free from performance bias due to non‐trial interventions?

Low risk

Care other than the trial interventions appears comparable in the 2 groups.

Monticone 2018

Study characteristics

Methods

Randomised controlled trial

Participants

Scientific Institute of Lissone of the Clinical and Scientific Institutes Maugeri
Period of study: July 2012 to December 2015
52 participants
Inclusion: internal fixation due to extracapsular hip fractures, such as trochanteric, subtrochanteric, pertrochanteric, intertrochanteric, basal and lateral femoral fractures, 7 to 10 days before admission to rehabilitation unit; good understanding of Italian, age > 70 years
Exclusion: previous hip and lower limb surgery, systemic illness, cognitive impairment (Mini Mental State Examination < 24), recent myocardial infarctions, cerebrovascular events, chronic lung or renal diseases
Age: mean (SD) 77.45 (7.0)
% male: 29
Number lost to follow‐up: 3 weeks = 2, 12 months = 5

Interventions

1. Intervention: individual sessions, 90‐minute sessions, 5 times a week for 3 weeks, in‐hospital programme. Balance task‐specific exercises while standing (open and closed eyes, aiming for symmetrical leg loading, proprioceptive pillows under feet, shrinking the support base, or maintaining the tandem position). Walking on a rectilinear trajectory while changing speed and direction, or while performing motor‐cognitive tasks. Additional exercises included moving from a sitting to a standing position, ascending/descending stairs and climbing obstacles.

versus

2. Control: individual sessions, 90‐minute sessions, 5 times a week for 3 weeks, in‐hospital programme. Open kinetic chain exercises in the supine position aimed at improving range of hip motion, increasing hip and lower limb muscle strength, and maintaining the length and elasticity of thigh tissues.

Both groups: gait training with crutches, ergonomic advice

Intervention and control delivered by 1 physiatrist and 2 physiotherapists (i.e. 2 physiatrists and 4 physiotherapists total)

Outcomes

Assessments after randomisation, 3 weeks (used in analysis) and 12 months

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (3 subscales: physical function (primary outcome), pain and stiffness). Subscales scored 0 (best) to 100 (worst health status). Italian version

Pain intensity: 0 to 10 rating scale

Italian Berg Balance Scale

Functional Independence Measure

Short Form‐36 (subscales reported in paper)

Global Perceived Effect Scale at end of treatment

Notes

Funding: nil

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"The principal investigator randomized the subjects to one of the two treatment programmes using a list of blinded treatment codes, generated in MATLAB"

Allocation concealment (selection bias)

Low risk

"An automatic assignment system made in MATLAB to conceal the allocation"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists were not blinded. Attempts were made to blind participants. Quote: "The physiatrists, the physiotherapists and the patients were not blinded. To partially limit expectation bias and to reduce problems of crossover, patients were not made aware of the study’s hypothesis and were told that the trial was intended to compare two common approaches to hip fractures postsurgical rehabilitation, whose efficacy had not yet been established".

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

Blinding of the secretarial staff collecting data was not specified. Effect of any non‐blinding is unknown; however, baseline assessment was conducted after randomisation, which increases risk of bias.

Quote: "The principal investigator obtaining and assessing the data and the biostatistician making the analyses were both blinded to the treatment allocation". However, the paper states it was secretarial staff that collected the data.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

"Using a specific form, the patients were asked to report any serious and/or distressing symptoms they experienced during the study that required further treatment". Blinding of the secretarial staff collecting data was not specified. Effect of apparent non‐blinding on adverse event outcomes is unclear

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Less than 20% of outcome data missing (8% missing, with 2/26 lost to follow‐up in intervention group and 3/26 in control group)

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Less than 20% of outcome data missing (8% missing, with 2/26 lost to follow‐up in intervention group and 3/26 in control group)

Selective reporting (reporting bias)

Low risk

All outcomes in trial registration and methods section are reported

Free from baseline imbalance bias?

Low risk

No indication of baseline imbalance bias

Free from performance bias due to non‐trial interventions?

Low risk

Intervention and control delivered by equally experienced physiatrists and physiotherapists

Moseley 2009

Study characteristics

Methods

Randomised controlled trial

Participants

Inpatient rehabilitation units of 3 teaching hospitals, Sydney, Australia
Period of study: March 2002 to May 2005
160 participants
Inclusion: people with surgical fixation for hip fracture admitted to the inpatient rehabilitation unit from the acute orthopaedic ward. Approval to weight bear or partial weight bear; able to tolerate the exercise programmes; able to take 4‐plus steps with a forearm support frame and the assistance of 1 person; no medical contraindications that would limit ability to exercise; living at home or low‐care residential facility prior to the hip fracture, with the plan to return to this accommodation at discharge. People with cognitive impairment were included if a carer who was able to supervise the exercise programme was available.
Exclusion: high‐functioning patients discharged directly to home and low‐functioning patients discharged to a residential aged care facility from the acute orthopaedic ward. Patients with > 4 adjusted errors on the Short Portable Mental Status Questionnaire if no carer was available.
Age: mean 84 years (range: not stated)
% male: 19
Number lost to follow‐up: 10 (3 withdrew consent; 7 died)

Interventions

Postoperative rehabilitation, started after admission to inpatient rehabilitation unit. Continued at home post discharge.
1. Weight‐bearing exercise twice daily for a total of 60 minutes per day for 16 weeks. Five weight‐bearing exercises were prescribed in addition to walking on a treadmill with partial body weight support using a harness (for inpatients) or a walking programme (after hospital discharge). The 5 weight‐bearing exercises used for both legs included stepping in different directions, standing up and sitting down, tapping the foot and stepping onto and off a block. Hand support could be used if necessary. The exercises were progressed by reducing support from the hands, increasing block height, decreasing chair height and increasing the number of repetitions. This commenced as an inpatient programme, followed by home visits and a structured home exercise programme after inpatient discharge. The home exercise programme incorporated the 5 weight‐bearing exercises used in the inpatient phase, plus a walking programme. The frequency of home visits gradually decreased.
versus
2. Usual care (mainly non‐weight bearing exercise): participants undertook 5 exercises in sitting or lying position plus a small amount of walking using parallel bars or walking aids for a total of 30 minutes each day for 4 weeks. The exercises were progressed by increasing the repetitions and resistance. (This type of exercise programme is commonly prescribed after hip fracture). This commenced as an inpatient programme, followed by weekly home visits and a structured home exercise programme incorporating the same exercises. After 4 weeks, participants were provided with a tailored programme of limited weight‐bearing exercises for 12 weeks and encouraged to continue exercising; no further physiotherapy home visits were undertaken.

"All participants received usual post‐operative mobilisation programme usually provided by other health professionals (e.g. occupational therapists) and any gait aids were progressed as per usual protocols. No other physiotherapy treatments were administered during the trial."

Outcomes

Follow‐up: 16 weeks

Walking ability: able to walk unaided or with sticks
Gait: walking velocity
Strength: knee extension
Balance: step test, sway and functional reach, lateral stability, coordinated stability test, choice stepping reaction time
Physical Performance and Mobility Examination

Sit‐to‐stand time

Barthel Index
Quality of life: EuroQol‐5D
Pain (7‐point ordinal scale)
Subjectively‐assessed outcomes (use of 5‐point Likert scales): current mobility, strength and balance
Falls
Accommodation in the community
Use of community services
Length of hospital stay
Hospital re‐admission
Mortality (stated as unrelated to trial protocol)
Subjectively‐reported negative effects

Notes

Measured adherence

Funding: National Health and Medical Research Council of Australia

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Participants were randomly allocated.... Randomisation was stratified for recruitment site and pre‐fracture Barthel Index (i.e. ≥80/100 or <80/100). The allocation sequence was generated from computer software..."

Allocation concealment (selection bias)

Low risk

"The allocation sequence was .... concealed using consecutively numbered, sealed and opaque envelopes."

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

"Measurements were made by assessors who were blinded to group allocation."

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

The assessment of mortality and re‐admission outcomes are usually unlikely to be influenced by knowledge of group allocation.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Health‐related quality of life: blinded assessors

Falls recorded by participants on falls calendar and assessors blinded. Impact of unblinded participant reporting of falls unclear

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

Participant flow provided and full accounting of loss to follow‐up but differential loss to follow‐up (7 versus 3) could have made some difference

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

Participant flow provided but aside from death, these outcomes not reported for whole groups

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Unclear risk

Participant flow provided and full accounting of loss to follow‐up but differential loss to follow‐up (7 versus 3) could have made some difference

Selective reporting (reporting bias)

Low risk

Trial registration and consistently well‐reported trial

Free from baseline imbalance bias?

Low risk

"There were no clinically important differences between the groups." Also evident from the presented data

Free from performance bias due to non‐trial interventions?

Unclear risk

Possible; the trialists speculate that one reason for the general lack of differences between the two groups was that the therapists, who were not blinded to group allocation, may have modified the programme for participants in the control group.

Method of ascertaining falls

Unclear risk

Falls were obtained using a falls calendar collected at 4‐week and 16‐week assessments and via a postal survey at 10 weeks.

Oh 2020

Study characteristics

Methods

Randomised controlled trial

Participants

Department of Rehabilitation Medicine at a university hospital, South Korea
Period of study: September 2017 to April 2019
45 participants
Inclusion: men and women aged 65 to 90 years old who underwent surgery for femoral neck (intertrochanteric or subtrochanteric) fracture and had sarcopenia (diagnosed as low muscle mass combined with low muscle strength (handgrip strength) and/or low physical performance)

Exclusion: (i) hip surgery for infection, arthritis, implant loosening, or avascular necrosis; (ii) femoral shaft fracture, acetabular fracture, isolated fracture of the greater or lesser tuberosity, or periprosthetic fracture; (iii) pathologic fracture; (iv) combined multiple fracture; (v) revision surgery; and (vi) severe cognitive dysfunction (obey command ≤ 1 step). Refusal to participate in a clinical trial

Age: mean 79 years (range: not stated)
% male: 32
Number lost to follow‐up: 7 (2 withdrew consent; 3 lost to follow‐up; 2 died)

Interventions

Control: standardised rehabilitation treatment, 30 minutes/day each of 10 consecutive working days. Physiotherapist delivered passive hip and knee mobilisation, strengthening of the hip abductor and extensor muscles, transfer and gait training on the floor and stairs during every session. Plus 20 minutes of lower limb exercises in supine position.

Intervention: standardised rehabilitation treatment as above, identical to control group. Plus antigravity treadmill (AGT) for 20 minutes/day for each of 10 consecutive working days. Days 1 to 5 AGT was applied with 50% to 60% of body weight administered at a rate of 1.5 miles per hour. Days 6 to 10 AGT was applied with 70% to 80% of body weight administered at a rate of 1.5 to 1.8 miles per hour. 

Outcomes

Baseline, 3 weeks, 3 months, 6 months

Koval walking ability score

Functional ambulatory category 

Berg Balance Scale 

EuroQol‐5D 

Korean version of the modified Barthel Index 

Hand grip strength 

Notes

Funding: nil

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated randomisation lists generated by statistician not involved in the intervention

Allocation concealment (selection bias)

Low risk

Sealed, opaque envelopes

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists who provided the rehabilitation programme and the participants were not blinded to group. The effect on bias is unclear.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Researchers conducting outcome measurements were blinded to group.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Unclear whether researchers ascertaining mortality were blinded. Assessment of mortality outcome is usually unlikely to be influenced by knowledge of group allocation.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Researchers conducting outcome measurements were blinded to group.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

16% loss to follow‐up

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

16% loss to follow‐up

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Unclear risk

16% loss to follow‐up

Selective reporting (reporting bias)

Unclear risk

Trial registered prospectively; however, not translated from Korean for assessment at time of publication. May change to 'low risk' after assessment of trial registration

Free from baseline imbalance bias?

Unclear risk

Difference in type of surgery between groups (intervention group had 9 hemiarthroplasty, 9 open reduction and internal fixation (ORIF), 1 total hip joint replacement; control group had 17 hemiarthroplasty, 2 ORIF). Potential effect of this on outcome is unclear

Free from performance bias due to non‐trial interventions?

Low risk

Time in training and staff involved were the same in both groups

Ohoka 2015

Study characteristics

Methods

Randomised controlled trial

Participants

Matterhorn Rehabilitation Hospital, Kure, Japan

Period of study: not reported
27 participants
Inclusion: proximal femoral fracture, surgical management, 90 years of age or older

Exclusion: conservative treatment

Age: mean 90.2 years (range: 90 to 93, SD 1.4)
% male: 0
Number lost to follow‐up: 14 (7 withdrew, 2 excluded, 5 lost to final follow‐up)

Interventions

Additional exercise: treadmill training in addition to standard physiotherapy

1. Body weight‐supported treadmill training for 10 minutes, 4 times per week in addition to standard physical therapy 4 times a week

versus

2. Usual care. No body weight‐supported treadmill training. Standard physical therapy 6 times a week for 40 minutes a day

Outcomes

Follow‐up: at discharge (mean (SD) length of stay in intervention group = 84 (8.6) days, control 77.8 (5.5) days. Therefore, used 81 days (12 weeks) for follow‐up.

Gait speed: 10m walking time

Strength: isometric knee extension

Functional Independence Measure

Length of stay

Adverse events: surgical complications, re‐admission, persistent pain, falls

Notes

Published as conference abstract only. Author provided additional study details by email correspondence.

Funding: none declared

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Reported as 'simple randomisation' in correspondence with author

Allocation concealment (selection bias)

Low risk

Author correspondence: ‘central randomisation’

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Author reported 'single blind test'

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Author reported 'single blind test'. Unclear whether researchers ascertaining surgical complications and re‐admission were blinded. Assessment of these outcomes is usually unlikely to be influenced by knowledge of group allocation.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Insufficient information for assessment

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Large loss to follow‐up (52%)

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Large loss to follow‐up (52%)

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

Large loss to follow‐up (52%)

Selective reporting (reporting bias)

Unclear risk

No trial registration or protocol identified

Free from baseline imbalance bias?

Unclear risk

Not clearly reported (baseline mobility not available)

Free from performance bias due to non‐trial interventions?

High risk

Time spent in training sessions appears to be different between groups

Method of ascertaining falls

Unclear risk

Not reported

Oldmeadow 2006

Study characteristics

Methods

Randomised controlled trial

Participants

Acute trauma ward, the Alfred Hospital, Melbourne, Australia
Period of study: March 2004 to December 2004
60 participants
Inclusion: people admitted for surgical fixation of a hip fracture (20 had hemiarthroplasty), written informed consent from patient or carer
Exclusion: pathological fracture, postoperative orders for non‐weight bearing on operated hip, admission from nursing home, non‐ambulant pre‐morbidity
Age: mean 79 years (range 53 to 95 years)
% male: 32%
Number lost to follow‐up: none. Separate data provided for 10 failed early ambulators but also for whole early ambulation group

Interventions

Early postoperative rehabilitation. Participants received routine, standard postoperative medical and nursing clinical care. All participants were transferred to sit out of bed as early as possible after surgery (range 13 to 120 hours).
1. Early assisted ambulation started within 48 hours (postoperative day 1 or 2).
versus
2. Delayed assisted ambulation until after 48 hours (postoperative day 3 or 4).

The same physiotherapy ambulation re‐education programme, implemented for all participants, was implemented once daily over 7 days. Programme included walking re‐education, bed exercise and chest physiotherapy as indicated. The 2 physiotherapists providing treatments received instruction regarding the ambulation protocol to ensure standardisation.

Outcomes

Length of follow‐up: until discharge (1 week after surgery for functional outcomes)

Iowa Level of Assistance Scale (0 = independent; 1 = standby supervision; 2 = minimal assistance; 3 = moderate assistance; 4 = maximal assistance; 5 = failure) for transfers, ambulation and negotiation of 1 step
Walking distance, poor functional mobility (assistance required for transfers, negotiating 1 step), time to first walk
Discharge location
Length of hospital stay
Mortality (in hospital)

Notes

Mean time to surgery was 57 hours (6 to 264 hours)
Trial authors noted that clinical practice was to prescribe bedrest in the presence of cardiovascular challenge.

Funding: none declared

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Patients were randomly allocated, using a computer‐generated program, into one of two time to first ambulation intervals..."

Allocation concealment (selection bias)

Unclear risk

No mention of methods for safeguarding prior allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

"A blinded assessor carried out the testing."

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

High risk

No blinding for discharge arrangements (return to living at home), an outcome which is potentially susceptible to bias

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

Standard deviations not provided and incomplete results for level of assistance scale. While separate data were reported for the 10 failed early ambulators, results were reported for the whole early ambulation group.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Very short follow‐up with no post‐discharge data

Selective reporting (reporting bias)

High risk

Trial registration was retrospective

Free from baseline imbalance bias?

Low risk

Baseline comparability evident

Free from performance bias due to non‐trial interventions?

Low risk

"The two physiotherapists who provided the treatments received instruction regarding the ambulation protocol to ensure standardisation."

Orwig 2011

Study characteristics

Methods

Randomised controlled trial

Participants

Community‐dwelling women attending 1 of 3 Baltimore‐area hospitals, USA

Period of study: November 1998 through September 2004

180 participants

Inclusion: Community‐dwelling women, ≥ 65 years age, screened within 15 days of the fracture, completing at least 80% of the baseline survey, admitted within 72 hours of a non‐pathological hip fracture receiving surgical repair, walking without human assistance prior to the fracture, cognitively intact (i.e. score ≥ 20 on the Folstein Mini Mental State Examination) and received orthopedic surgeon clearance

Exclusion: pathologic fracture; cardiovascular, neurologic, and respiratory diseases that could interfere with exercising independently at home; diseases of the bone (e.g. Paget disease, osteomalacia); metastatic cancer; cirrhosis; end‐stage renal disease; hardware in the contralateral hip; and conditions that increase risk of falling while exercising independently

Age: mean (SD) 82.4 (7) years
% male: 0%
Number lost to follow‐up: 49 did not have 12‐month follow‐up

Interventions

1. Home exercise. Exercise sessions and a self‐efficacy‐based motivational component. Aerobic exercise using a Stairstep (progressed time and ankle weights), upper and lower limb strengthening programme (progressed with resistance and intensity, aiming for 3 sets of 10 reps), and stretching exercises (20‐ to 30‐minute warm‐up and cool‐down periods). Total of 56 exercise sessions over 12 months, frequency reduced over time, supplemented with telephone calls to remind participants to exercise and address any questions or concerns. Participants were expected to perform aerobic activity at least 3 days/week and strength training 2 days/week for 30 minutes.

2. Usual care. Plus information on bone health and management of osteoporosis.

Outcomes

Length of follow‐up: 12 months

Mortality

Discharge to community

Adverse events: re‐admission

Adverse events: persistent pain

Adverse events: falls

Adverse events: treatment‐related

*Additional outcomes displayed graphically not extracted

Adverse events: surgical complication

Other outcomes: discharge to nursing home

Notes

Measured adherence

Funding: this research was supported by the National Institute on Aging, Bethesda, Maryland (grants R37 AG09901, R01 AG18668, R01 AG17082, T32 AG00262), and the Claude D. Pepper Older Americans Independence Center (grants P60 AG12583 and P30 AG028747).

Conflict of interest: not reported

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote "PC‐PLAN software37 was used to randomize participants within blocks of 2 or 10"

Allocation concealment (selection bias)

Unclear risk

Allocation method not reported

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Participants and therapists not blinded to group allocation and the effect of this non‐blinding not clear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Study staff conducting assessments were blind to group assignment. Participants obviously not blinded in presence of self‐report outcomes (SF‐36)

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Study staff conducting assessments were blind to group assignment. Assessment of mortality outcome is usually unlikely to be influenced by knowledge of group allocation.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Falls ascertained by the same method in both groups. Study staff conducting assessments were blind to group assignment. Impact of unblinded participant reporting of falls unclear

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

69% and 77% completed all 3 follow‐up visits.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

69% and 77% completed all 3 follow‐up visits.

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

69% and 77% completed all 3 follow‐up visits.

Selective reporting (reporting bias)

High risk

Self‐efficacy reported as primary outcome but not included in trial report. Secondary outcomes not reported: dietary intake, time to weight bearing (possibly not enough space in publication, time to exercising reported)

Free from baseline imbalance bias?

Low risk

Groups balanced at baseline

Free from performance bias due to non‐trial interventions?

High risk

Home visits may have had a social effect with these community‐dwelling elderly women; some who had cognitive impairment (Mini Mental State Examination 21 to 25) were included in the trial.

Method of ascertaining falls

Unclear risk

Insufficent data available to make judgement. 'Monthly telephone calls were made to participants to ascertain falls'.

Pol 2019

Study characteristics

Methods

Three‐arm stepped‐wedge cluster‐randomised trial

Participants

Skilled nursing facilities, the Netherlands

Period of study: 1 April 2016 to 1 December 2017

240 participants

Inclusion: people > 65 years old with traumatic hip fracture admitted to a skilled nursing facility with an indication of short‐term rehabilitation, living alone and having an MMSE score of 15 or higher

Exclusion: terminally ill, were waiting for permanent placement in a nursing home, or did not give informed consent

Age: mean 84

% of male: 20

Number lost to follow‐up: 89

Interventions

1. Usual care: usual discharge planning, usual physiotherapy (focusing on mobility, muscle strength, balance, transfer and walking), usual occupational therapy (focusing on performance of daily functioning and safety at home)

2. Cognitive behavioural therapy (CBT): usual care, plus 4 weeks of weekly coaching based on CBT, including 5 steps: i) Educate on the importance of physical activity and daily exercise; ii) Ascertain the amount of movement and physical activity during the day and give feedback; iii) Define realistic goals for the performance of daily activities; iv) Agree on an activity plan with the patient and, if needed, practice exercises and activities safely; v) Evaluate progress.

3. CBT plus sensory monitoring: usual care, plus 4 weeks of CBT (above), plus 4 weeks of:

‐ wearing of the physical activity monitor (PAM)‐sensor, sensor monitoring, daily instructions how to wear the PAM

‐ weekly coaching based on CBT, including use of the PAM to: i) Ascertain objectively the amount of movement and number of activities during the day and give feedback; ii) Use as a starting point for discussion about the daily patterns and activities that are important to practice; iii) Make new plans for activities; and iv) Evaluate the progress.

Outcomes

Timepont used = after the intervention stopped, at approximately 4 months after the start of rehabilitation

Canadian Occupational Performance Measure (performance score)

Timed Up and Go test

Modified Katz ADL score

Fall Efficacy Scale International

EuroQol 5D

Service use: number of sessions/duration/content

Notes

This intervention was different to others in this review, yet met the inclusion criteria for a mobility strategy.

The study authors adjusted for clustering in their analyses.

Funding: Dutch grant Fonds Nuts Ohra (1401‐057). MP was supported by the Netherlands Organisation for Scientific Research (NWO) (023.003.059).

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Generated using STATA software

Allocation concealment (selection bias)

High risk

Quote: "After admission to the nursing home, the nursing home physicians will identify potential patients on the basis of the inclusion criteria.” Physicians likely to be aware of allocation of wards as well as participant characteristics, and admission occurred after allocation of wards. Recruitment period 12 months. If participants admitted after allocation of ward, allocation concealment not possible

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Participants and therapists not blinded to group allocation and the effect of this non‐blinding not clear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Assessors blinded to intervention group (although authors acknowledge potential for unblinding)

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Assessors blinded to intervention group (although authors acknowledge potential for unblinding).

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Large loss to follow‐up (37% at 4 months, 46% at 6 months). (Statistical modelling with imputation performed for 6‐month analysis)

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

Large loss to follow‐up (37% at 4 months, 46% at 6 months). (Statistical modelling with imputation performed for 6‐month analysis)

Selective reporting (reporting bias)

Unclear risk

Protocol states Canadian Occupational Performance Measure (COPM)‐physical and COPM‐social are both primary outcomes and will be reported combined. The results paper reports COPM‐p as the primary outcome and COPM‐s as the secondary outcome.

Free from baseline imbalance bias?

Low risk

No important baseline imbalance

Free from performance bias due to non‐trial interventions?

Low risk

No important issues

Cluster‐randomised trials

Low risk

Although recruitment did not occur prior to randomisation, baseline characteristics were reported as well‐balanced, adjustment was made for confounders at baseline and for missing values, no clusters were lost, clustering was adjusted for, and the results are comparable with other trials.

Resnick 2007

Study characteristics

Methods

Randomised trial using computer program. Allocation by independent project co‐ordinator

Participants

Community‐dwellers and independent ambulators (at time of fracture) who had completed Medicare‐funded rehabilitation recruited from 9 hospitals in the greater Baltimore area, USA
Period of study: August 2000 to September 2005 (last follow‐up)
155 participants (see Notes)
Inclusion: female, aged 65 years or over with a non‐pathological fracture which had occurred within 72 hours of hospital admission, who had surgical repair of their hip fracture. Community‐dwellers and independent walkers before fracture. Free of medical problems that would potentially put them at risk of falls when exercising alone at home alone (e.g. neuromuscular conditions). Score of 20 or higher on the Folstein Mini Mental State Examination. Informed consent.
Exclusion: angina, myocardial infarction, stroke, heart condition, pulmonary oedema, Paget's disease, uncontrolled diabetes, Parkinson's disease, multiple sclerosis, cancer, severe blindness, seizures, gastrointestinal haemorrhage (many criteria were limited to the previous 6 months). See trial registration document for full list (clinicaltrials.gov/ct2/show/NCT00389844).
Age: mean 81 years
% male: 0 (all female)
Number lost to follow‐up: 42 (25 withdrew, 10 impractical/other, 7 died)

Interventions

Planned to initiate the intervention as soon as Medicare‐covered rehabilitation services were completed (generally around 1 month); but start dictated by participants.

1. Exercise‐only component. Exercise sessions with an exercise trainer. Sessions incorporated aerobic exercise using a 'Stairstep' (a 4‐inch stair step with handles on either side for support and balance) for 3 days a week, strengthening exercises for main muscle groups relevant to hip fracture recovery for 2 days a week (11 exercises with Thera‐Band and/or ankle wrist cuff weights up to 3 sets of 10 then weight increased), and stretching exercises (these were part of the warm‐up and cool‐down periods). Time and repetitions individually prescribed. (No encouragement given.)
versus
2. The full 'Exercise Plus' programme, which includes the above together with the Plus component (motivational interventions: addition of education about the benefits of exercise from the same exercise trainer using a booklet, verbal encouragement through goal setting and positive reinforcement, medications/heat/ice (for pain), cueing with posters describing the exercises, a 'Goal Form' and a calendar of daily exercise activities.
versus
3. Routine care

In both treatment groups (1 and 2), visits from the trainer were initially twice a week and then decreased to once a month in the final 4 months of the programme, with weekly telephone calls for those exposed to the 'Plus' (motivation) component of the intervention during the weeks when no visit was scheduled. All visits lasted 1 hour. The maximum number of anticipated visits was 38.

Outcomes

Length of follow‐up: 12 months from injury
Mortality

Notes

Extensive account of rationale published in 2002. Trial funded by the National Institute on Aging and National Institutes of Health.

209 were randomised into 4 groups. The 'Plus' or motivation‐only group (54 participants) is not considered in this review (see Crotty 2010). One participant in the exercise‐only group was excluded because they did not receive surgery.

Measured adherence

Funding: National Institute on Aging grants R37 AG09901, R01‐AG18668, R01 AG17082; Claude D. Pepper Older Americans Independence Center P60‐AG12583; Thera‐Band Academy for contribution of Thera‐Band1 resistive bands.

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Randomization was performed using a freeware computer program. Patient assignment was blocked by hospital to assure equal probabilities within each hospital being assigned to each of the four study groups. Patients were assigned to groups at random with forced balancing of treatment groups within hospital."

Allocation concealment (selection bias)

Low risk

"The resulting randomization scheme was given to the project coordinator and patients assigned as they became available at the indicated hospital. The study nurses involved with recruitment and data collection were blind to randomization."

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

"Study participants were not informed of what specific arm of the intervention they were randomized to (i.e. exercise only, plus only, or exercise plus)." Safeguards were not described. Therapists were not blinded to group allocation.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

"The study nurses involved with recruitment and data collection were blind to randomization".

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

"The study nurses involved with recruitment and data collection were blind to randomization". Assessment of these outcome is usually unlikely to be influenced by knowledge of group allocation.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

While participant flow diagram was provided, more participants (10) in the exercise‐only group refused study follow‐up compared with 2 in the usual care group.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Participant flow diagram provided.

Selective reporting (reporting bias)

Unclear risk

Retrospective trial registration. Insufficient information but no report of overall health status and muscle strength (as stipulated beforehand)

Free from baseline imbalance bias?

Low risk

No obvious imbalance (all female)

Free from performance bias due to non‐trial interventions?

High risk

Time from fracture to first intervention visit from trainer ranged from 28 to 200 days. Participants indicated when they were willing to have their first visit.

Salpakoski 2015

Study characteristics

Methods

Randomised controlled trial

Participants

Community‐dwellers, following discharge from Central Finland Central Hospital
Period of study: not stated
81 participants randomised
Inclusion: age > 60 years; ambulatory and community‐dwelling; operated for femoral neck or pertrochanteric fracture (International Classification of Diseases code S72.0 or S72.1); living in the city of Jyväskylä or in 9 neighbouring municipalities.
Exclusion: living in an institution or confined to bed at the time of the fracture; suffering from severe memory problems (Mini Mental State Examination < 18); alcoholism, severe cardiovascular, pulmonary or progressive (i.e. neoplasm) disease, para‐ or tetraplegic or severe depression (Beck Depression Inventory > 29)
Age: mean 80, SD 7.09
% male: 22
Number lost to follow‐up: 4 (control: 2 dropouts; intervention: 1 dropout, 1 died)

Interventions

1. Intervention: 1 year. Promoting mobility after hip fracture (ProMo): standard care and a home‐based, year‐long programme including evaluation/modification of environmental hazards, guidance for safe walking, pain management, progressive home exercise programme and physical activity counselling. Exercise programme = lower‐limb strengthening exercises for the lower limbs (progressed, resistance bands), balance training in standing position, walking exercises and stretching, 30 minutes; strengthening and stretching = 3x/week, balance and walking exercises = 2 to 3x/week. Physical activity counselling = 2 x 30‐minute face‐to‐face sessions and 3 phone contacts, with personal physical activity plan.

2. Control: standard care, included written home exercise programme with 5 to 7 exercises for lower limbs

Outcomes

Follow‐up: 12 months

Short Physical Performance Battery

Berg Balance Scale

Timed 10 m walk

Perceived difficulties in negotiating stairs. “Are you able to negotiate 1 flight of stairs (5 stairs)?” 5‐item response

Difficulty walking 500 m

Leg extension power (Nottingham Leg Extensor Power Rig)

SF‐36 (HRQoL) (email correspondence: outcomes not available at time of writing)

Mortality

Independent activities of daily living, sum score

Notes

Measured adherence

Funding: nil

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"A computer‐generated group allocation list was generated by a statistician not involved in the recruitment or data collection. Randomization by sex and by surgical procedure (internal fixation vs arthroplasty) was performed in blocks of 10".

Allocation concealment (selection bias)

Low risk

"The study group assignments were enclosed in sealed envelopes"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Participants and therapists not blind to group allocation but impact of non‐blinding unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

The researchers who collected the outcome measures were blinded to group allocation.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Unclear how death and complications were recorded

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Less than 20% of outcome data missing

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Less than 20% of outcome data missing

Selective reporting (reporting bias)

Low risk

Reporting of outcomes as primary and secondary differs in protocol paper (Sipila 2011) and main results paper (Salpakoski 2015). In addition, some components of the primary outcome mobility‐related disability noted in protocol paper (difficulty walking outdoors, 500 m and 2 km) were not reported in results paper. Emailed author 15 July 2019 to ask if the outcomes were analysed. Email received with comprehensive results provided.

Free from baseline imbalance bias?

Low risk

No imbalance in baseline characteristics

Free from performance bias due to non‐trial interventions?

Low risk

No evidence that therapists delivering care to each group were different

Sherrington 1997

Study characteristics

Methods

Randomised trial: use of random numbers, balanced within blocks of 10 participants, to generate open list

Participants

South Western Sydney, Australia
Period of study: December 1994 to December 1995
44 participants
Inclusion: people aged 60 years or over with a fall‐related hip fracture who had lived in the community beforehand. Discharged from 1 of 4 acute hospitals to home or residential care within 9 months of their fracture. Contactable and consenting
Exclusion: severe cognitive impairment or too ill or immobile to participate as judged by carers
Age (of 42): mean 78.5 years (range 64 to 94 years)
% male: 21
Number lost to follow‐up: 2 (withdrew consent); also 2 excluded at initial assessment. Also mentions: "One further person in the control group was not able to complete all the physical aspects of the assessment because of pain from a fall, later diagnosed as a further fracture."

Interventions

All participants had a preliminary interview and physical assessment lasting about 1 hour. This took place on average 7 months (5 to 9 months) after their injury.
1. Home‐based, weight‐bearing exercises for 1 month. Individuals in the intervention group were provided with stepping block(s) made of old telephone directories wrapped up with tape and shown the exercises by a physiotherapist. They were advised on how many stepping blocks and repetitions to do at least once daily at the start (these ranged from 5 to 50) and told to increase the repetitions gradually. A photograph was taken to help remind the participant of the correct method and they were checked at 1 week (4 to 16 days). Participants also kept a diary.
versus
2. Control (no specific instructions: usual care)

Each telephone directory was 5 cm thick: approximately one‐third of a standard house step.

Outcomes

Length of follow‐up: 1 month (range 27 to 43 days)

Quadriceps strength
Sway and balance
Functional reach
Walking velocity
Subjectively‐assessed balance

Notes

Measured adherence

This trial was excluded in the versions of the review up to Issue 3, 2004 because participants were recruited 7 months after a hip fracture; this was previously outside the time period covered by this review, which then focused on early postoperative rehabilitation.

Additional information obtained from Cathie Sherrington 09 Febrary 2004 and 24 March 2004

Funding: nil

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"[Randomly] allocated in order of contact using a random number method within groups of ten subjects."

Allocation concealment (selection bias)

High risk

Trial investigator reported that "it was not concealed ‐ just a list of subject numbers and group allocation generated by a random number table; subjects were assigned to subject numbers in the order that contact was made with them."

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

Not blinded

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

The few results are unlikely to be affected.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

High risk

Not blinded

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

The post‐randomisation exclusion of 2 participants meant that intention‐to‐treat analysis was not done.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Few data but complete data provided on contact with trial investigator.

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Unclear risk

The post‐randomisation exclusion of 2 participants meant that intention‐to‐treat analysis was not done.

Selective reporting (reporting bias)

Unclear risk

Bias unlikely but protocol not available.

Free from baseline imbalance bias?

High risk

Statistically significantly more males in intervention group (8 versus 1). Males generally have poorer prognosis post hip fracture but also may have different baseline strength and attitude to exercises.

Free from performance bias due to non‐trial interventions?

Unclear risk

There was a lack of information on care‐programme comparability.

Sherrington 2003

Study characteristics

Methods

Randomised trial: use of random numbers, balanced within blocks of 6 participants.

Participants

Inpatient rehabilitation wards at Bankstown‐Lidcombe Hospital, Sydney, Australia
Period of study: January 1997 to December 1999
80 participants
Inclusion: people aged 60 years or over with a fall‐related hip fracture who were admitted to rehabilitation wards after surgery; written consent
Exclusion: unable to complete assessment and participate in exercise programme due to a) cognitive impairment (assessed by observation), b) major medical conditions, or c) complications from fracture (if directed to be non‐weight bearing or touch‐weight bearing due to problems with fracture fixation).
Age: mean 81 years (range 64 to 98 years)
% male: 32
Number lost to follow‐up: 3 (1 withdrew consent; 2 with actual or suspected problems with fracture fixation precluding their further participation)

Interventions

Early postoperative rehabilitation. Baseline assessment at mean 18.3 days from fracture. The programme commenced while the participant was on the rehabilitation ward and was carried out each weekday in the rehabilitation gymnasium. Participants (21) were advised to continue the programme at home if discharged before the final assessment.
1. Two‐week programmes of weight‐bearing (weight‐bearing position with support as required) exercise prescribed by a physiotherapist. Exercises were sit‐to‐stand, lateral step‐up, forward step‐up‐and‐over, forward foot taps, and a stepping grid. Exercises initially conducted with support of a walking frame or adjustable‐height tables. Exercises progressed by increasing the number of repetitions, lessening the hand support, increasing the height of blocks, decreasing height of surface from which the participants was standing up, etc.
versus
2. Non‐weight‐bearing (performed in the supine position) exercise prescribed by a physiotherapist. Exercises were hip abduction, hip flexion, hip/knee flexion/extension, end of range knee extension, ankle dorsiflexion/plantarflexion. Exercises were progressed by increasing the number of repetitions undertaken.

For both groups, the treating physiotherapist chose several initial exercises, then added extra exercises in keeping with the participant's capability. Number of repetitions was established on the basis of the participant's initial performance (ranged from 5 to 30 for a single exercise). Participants were encouraged to take prescribed pain relief before exercising.

All participants also received usual physiotherapy intervention involving practice of walking and assessment of tasks needed for discharge (bed mobility, sit‐to‐stand and stair climbing), and usual care from other health professionals (nursing staff, social workers, etc).

Outcomes

Length of follow‐up: 2 weeks

Walking ability: use of supports
Gait: walking velocity, step length, force plate weight‐bearing
Strength: hip abduction and flexion and knee extension
Balance: functional reach, step test and sway
Functional performance measures

Sit‐to‐stand x5
Compliance and assessment of exercises
Subjectively‐assessed (use of ordinal scales): risk of falling, balance, pain, sleep quality, health
Fracture fixation problems
Length of hospital stay

Notes

This trial, previously listed in Ongoing studies under Sherrington 2002, was performed as part of Cathie Sherrington's PhD work.

Additional information provided 15 January 2004 by Cathie Sherrington included further details of method of randomisation and data for self‐assessed outcomes.

Funding: National Health and Medical Research Council; Health Research Foundation Sydney South West; Arthritis Foundation of Australia.

Conflict of interest: none declared

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"Patients were randomised into one of two exercise groups using a random number table and randomisation in blocks of six."

Allocation concealment (selection bias)

Low risk

"Subjects were assigned into groups using a concealed randomisation method". Clarification of method by personal communication: "This method involved a list of group allocation by subject number on which group allocation for each subject was concealed by a separate piece of opaque paper. Once the subject had agreed to participate in the trial, one piece of paper was removed to reveal the group allocation for the subject in question without revealing the allocation for subsequent subjects."

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

Assessor was not blinded to group allocation.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Unlikely to be affected by the lack of blinding

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Unclear risk

Intention‐to‐treat analysis was done and a participant flow diagram provided. However, the denominators for various outcomes were quite varied.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

Very short follow‐up.

Selective reporting (reporting bias)

Unclear risk

Bias unlikely but protocol not available

Free from baseline imbalance bias?

Low risk

Baseline comparability evident

Free from performance bias due to non‐trial interventions?

Low risk

Care other than interventions under test comparable in both groups

Sherrington 2004

Study characteristics

Methods

Randomised trial: use of random numbers, balanced within blocks of 6 participants. Use of sealed opaque numbered envelopes

Participants

Community‐dwellers and residents of aged‐care facilities discharged from 6 hospitals in Sydney, Australia
Period of study: April 1998 to June 2000
120 participants
Inclusion: people who had completed usual care after a fall‐related hip fracture; consent
Exclusion: unable to complete assessment and participate in exercise programme due to a) severe cognitive impairment, b) medical conditions, or c) complications from fracture resulting in delayed healing and associated weight‐bearing restrictions.
Age: mean 79 years (range 57 to 95 years)
% male: 20
Number lost to follow‐up: 12 (7 withdrew consent ‐ refused assessment; 5 died)

Interventions

All participants had a preliminary assessment which took place, on average, 22 weeks after their injury.
1. Home‐based, weight‐bearing exercises (weight‐bearing position with support as required). Exercises were sit‐to‐stand, lateral step‐up, forward step‐up‐and‐over, forward foot taps, and a stepping grid. Exercises initially conducted with tables, chairs or walking aids used for support. Exercises progressed by increasing the number of repetitions, lessening the hand support, increasing the height of blocks, decreasing height of surface from which the participant was standing up, etc.
versus
2. Home‐based, non‐weight‐bearing exercises (performed in the supine position) prescribed by a physiotherapist. Exercises were hip abduction, hip flexion, hip/knee flexion/extension, end of range knee extension, ankle dorsiflexion/plantarflexion. Exercises were progressed by increasing the number of repetitions undertaken.
versus
3. Control (no specific instructions)

For both exercise groups, the prescribing physiotherapist chose several initial exercises and number of repetitions in keeping with the participant's capability. Individuals in the weight‐bearing group were provided with stepping block(s). Participants were advised on progression. Line drawings of the exercises were provided and they were checked at 1 week. Further assessment and prescription at 1 and 4 months. Participants also asked to keep a record of their exercises.

Exercises were prescribed for 4 months minimum. Advice for exercises etc. given to each participant as deemed appropriate by the physiotherapist conducting final assessment at 4 months.

Outcomes

Length of follow‐up: 4 months

Walking ability/mobility
Gait: walking velocity, step length
Strength: hip abduction and flexion and knee extension
Balance: step test, sway and functional reach
Functional performance measures: timed sit‐to‐stand, supine‐to‐sit and Physical Performance and Mobility Examination
Mortality
Subjectively‐assessed: risk of falling, balance, pain, sleep quality, health
Compliance and assessment of exercises (intervention groups only)
Falls

Notes

Trial was performed as part of Cathie Sherrington's PhD work

Additional information, including binary data for mobility and subjective outcomes, received 09 February 2004.

Funding: Health Research Foundation Sydney South West, Arthritis Foundation of Australia, and National Health and Medical Research Council Partnership in Injury Grant.

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"The randomization schedule was produced with a random number table, with subjects being randomized to groups in blocks of 6."

Allocation concealment (selection bias)

Low risk

"..subjects were allocated to groups using assignments sealed in opaque envelopes." Clarification of method by personal communication: "Group allocation enclosed in sealed opaque envelopes which were numbered by subject number which was allocated when the consent form was signed."

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

Assessors were not blinded. However, there was training with the aim of standardisation between the 3 testers.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Not blinded. Unlikely to be affected by the lack of blinding.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

High risk

Assessors were not blinded

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Intention‐to‐treat analysis was done and a participant flow diagram provided. Though percentages were presented in the trial report, full data were provided by contact with the lead trialist.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Intention‐to‐treat analysis was done and a participant flow diagram provided

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Low risk

Intention‐to‐treat analysis was done and a participant flow diagram provided. Though percentages were presented in the trial report, full data were provided by contact with the lead trialist.

Selective reporting (reporting bias)

Unclear risk

Bias unlikely but protocol not available.

Free from baseline imbalance bias?

Low risk

Visual inspection of the table of baseline characteristics was consistent with the claim in the report of there being no clinically important or statistically significant differences between the 3 study groups at the initial assessment.

Free from performance bias due to non‐trial interventions?

Low risk

A systematic approach was taken.

Sherrington 2020

Study characteristics

Methods

Randomised controlled trial, New South Wales (NSW), Australia

Participants

Community‐dwellers recruited after discharge from 11 hospitals and from community advertising in NSW, Australia
Period of study: April 2010 to December 2015.
336 participants (194 with hip fracture, 31 with pelvic fracture, 111 with other fracture)
Inclusion: community‐dwellers aged 60+ years within 2 years of lower‐limb or pelvic fracture
Exclusion: resided in a high‐care residential facility (nursing home); cognitive impairment (a Folstein Mini Mental State Examination score of < 24); had insufficient English language to understand study procedures; unable to walk more than ten metres despite assistance from a walking aid and/or another person; medical condition precluding exercise; currently receiving a treatment programme from a rehabilitation facility.
Age: mean 77.7 (8.7)
% male: 24
Number lost to follow‐up: 52

Interventions

1. Intervention: individualised physiotherapist‐prescribed home programme of weight‐bearing balance and strength exercises, fall prevention advice based on Stepping On programme. 10 home visits (more frequent in first 3 months) and 5 phone calls to implement, review and progress programme. Exercise programme prescribed for 20 to 30 minutes, 3x/week.

2. Control: usual care

Outcomes

12 months

Short Physical Performance Battery (score, plus individual components analysed: gait speed, balance, sit to stand x5)

Balance (sum of feet together, semi tandem and tandem stance times)

Falls

Acute Measure for Post Acute Care

Pain
Mortality

Quality of life

Notes

Inclusion criteria for study was recent lower‐limb or pelvic fracture. Only data from 194 participants with hip fracture were included in this review. Total n in study = 336.

Funding: Australian National Health and Medical Research Council

Conflict of interest: Lord: Physiological Profile Assessment instrument is commercially available in Australia; Australian National Health and Medical Research Council funding for salary

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Randomization order was determined using a computer generated random number schedule with randomly permuted block sizes of 2–6".

Allocation concealment (selection bias)

Low risk

Quote: "Allocation was concealed by using central randomization performed by an investigator not involved in assessments or recruitment and the treatment allocation tables were inaccessible to recruitment staff".

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Quote: "Study staff who conducted interviews and assessments, received calendars and questionnaires, made phone calls and entered data were unaware of group allocation". "Participants were instructed not to inform the assessors of their intervention status, and all exercise equipment was removed prior to the final assessment".

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Quote: "Study staff who conducted interviews and assessments, received calendars and questionnaires, made phone calls and entered data were unaware of group allocation".

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Health‐realated quality of life: blinded assessors.

Falls ascertained by the same method in both groups. Participants reporting falls were not blind to group. Blinded assessors recorded and confirmed falls with participants. Impact of unblinded participant reporting of falls unclear

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Less than 20% of data lost to follow‐up

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Less than 20% of data lost to follow‐up

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Low risk

Less than 20% of data lost to follow‐up

Selective reporting (reporting bias)

Low risk

Outcomes in trial registry either reported or draft paper states they will be reported in subsequent paper (EuroQol‐5D, Short Form‐12)

Free from baseline imbalance bias?

Low risk

No notable difference between groups.

Free from performance bias due to non‐trial interventions?

High risk

Pragmatic trial, yet social contact in intervention arm likely to confound any effect

Method of ascertaining falls

Low risk

Monthly falls calendar. Participants who did not return calendars or who reported a fall were telephoned by blinded research assistants

Stasi 2019

Study characteristics

Methods

Randomised controlled trial. Stratified by gender and age

Participants

Inpatient orthopaedic ward of KAT General Hospital of Attica, Athens, Greece (for 1 week), then participants' homes
Period of study: recruitment April 2012 to May 2016
100 participants
Inclusion: diagnosis of displaced femoral neck fracture (Garden's classification III or ΙV), aged between 70 and 84 years, with community‐dwelling status before hip fracture, not having undergone previous orthopaedic surgery on the fractured or the contralateral hip, body mass index between 19 and 35 kg/m2, able to walk outdoors for 2 neighbourhood blocks before fracture
Exclusion: nil
Age: mean (SD) 77.5 (4.2)
% male: 25
Number lost to follow‐up: 4

Interventions

1. Intervention: Weeks 1 to 3, intervention the same in both groups. From week 4, addition of intensive exercise programme to control programme, emphasising hip abductor strengthening of affected limb. Hip abductor strength training in standing and side‐lying positions, resistance progressed with cuff weights and loop elastic bands, 2 sets of 10 reps, progressing to 3 sets of 15 reps. Home sessions initially 40 minutes, increasing to approx. 55 minutes.

2. Control: 'Standard Physiotherapy', a 12‐week standard physiotherapy programme, initiated on the 2nd postoperative day, continuing for 1 week in hospital and 11 weeks at home. Physiotherapist delivered individualised programme daily in hospital and 3x/week at home, with participants instructed to do programme independently on other days. Programme included progressive functional movements, range of motion, gait training, strengthening (progressing to loop elastic bands). Home sessions initially 30 minutes, increasing to maximum of 45 minutes.

Difference between groups: intervention group had approx. 10 minutes extra per physio session. Isotonic hip abductor strengthening commenced week 4 (intervention group), 6 (control group). Resistance added earlier in intervention group.

At end of 12‐week intervention, both groups encouraged to continue exercise programme 3x/week for 3 months.

Outcomes

12 weeks and 24 weeks.

Hip abductor strength, dynamometer

Timed Up and Go test

Lower Extremity Functional Scale‐Greek version

Falls

Use of walking aid

Notes

Trial registered ISRCTN30713542

The study states results are reported as mean (SD). During analysis, we noted the study was an outlier for all outcomes. If we assumed standard error was reported instead of standard deviation, then converted standard error to standard deviation, the results were consistent with other studies. We used the converted data in the review’s analyses. 

In this study the difference in intervention between groups occurs at home.

Funding: nil

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "Randomization..was performed by an independent clinician according to the randomization list".

"Sex and age were used as stratification factors in the randomization process. The sex ratio was 3/1 (3 females to 1 male). The age ratio was 1/1/1 (three age sub‐groups), equally spaced using block size 4. The study’s randomization list was formed on the basis of these principles."

Allocation concealment (selection bias)

Unclear risk

Not specified

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No mention of blinding of therapists and participants; impact of this on results is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Quote: "All assessments were carried out by the same examiner, who was not involved in any way with the rehabilitation program and was blinded with respect to the group assignment".

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Unlikely to be affected by bias

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Less than 20% of data lost to follow‐up

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Less than 20% of data lost to follow‐up

Selective reporting (reporting bias)

Low risk

All outcome measures listed in trial registration are reported

Free from baseline imbalance bias?

Low risk

Appears balanced for reported outcomes. Note baseline values not presented for physical measures

Free from performance bias due to non‐trial interventions?

Low risk

Both groups received physiotherapy intervention 3x/week at home

Suwanpasu 2014

Study characteristics

Methods

Randomised controlled trial

Participants

King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Period of study: January 2012 to February 2013
46 participants
Inclusion: 60 to 93 years of age, diagnosed with femoral neck fracture, intertrochanteric fracture or subtrochanteric fracture
Exclusion: nil
Age: mean (SD) 75.2 (8.4)
% male: 34
Number lost to follow‐up:

Interventions

1. Intervention: physical activity‐enhancing programme, based on Resnick's self‐efficacy model (Resnick 2009). Four phases of physical training and efficacy‐based intervention, covering 5 sessions. Phases: assessment, preparation, practicing and evaluation. Face‐to‐face contact and 5 telephone calls during 7 weeks post‐surgery.

2. Control: standard care (physical activity for hip fracture booklet)

Outcomes

6 weeks after discharge

International Physical Activity Questionnaire

Notes

Contributed no outcomes to this review

Funding: Thai Red Cross Society and King Chulalongkorn Memorial Hospital

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "We used a simple block randomization technique with a coin flip to assign subjects"

Allocation concealment (selection bias)

Unclear risk

Allocation concealment not specified

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

Blinding not specified; outcome was self‐reported

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Less than 20% of data missing

Selective reporting (reporting bias)

Unclear risk

No protocol or trial registry. Only 1 outcome reported in methods and results

Free from baseline imbalance bias?

Unclear risk

Trend toward intervention group being older and having greater physical activity at baseline (between group difference, P = 0.06 for both). Few functional or health characteristics at baseline reported (mental test and physical activity only)

Free from performance bias due to non‐trial interventions?

High risk

Social contact in intervention arm likely to confound any effect. An appropriate comparator would have been social home visits but no physical intervention.

Sylliaas 2011

Study characteristics

Methods

Randomised controlled trial

Participants

Outpatient clinic, recruited from Ullevål University Hospital or Diakonhjemmet Hospital in Oslo, Norway.

Period of study: June 2007 and June 2009

150 participants

Inclusion: femoral neck fracture or a trochanteric fracture; 12 weeks after the operation: (i) age 65 years or older; (ii) living at home; (iii) able to undergo physical therapy for the hip fracture; and (iv) scoring 23 or more (out of 30) on the Mini Mental State Examination

Age: mean (SD) 82.4 (5.7)
% male: 17
Number lost to follow‐up: 12

Interventions

1. Intervention: 3 to 6 months after fracture: physiotherapist‐led programme, exercise class 2x/week and home programme at least once/week. 45‐ to 60‐minute exercise session, 15‐minute warm‐up on cycle or treadmill; 4 exercises (standing knee flexion, lunge, sitting knee extension and leg extension, with 3 sets of 15 reps at 70% of 1 RM, increasing to 8 to 10 reps at 80% of 1 RM at 3 weeks. Encouraged to walk approx. 30 minutes/day.

2. Control: participants were asked to maintain their current lifestyle. No restrictions were placed on their exercise activities.

Outcomes

12 weeks:

6‐Minute Walk Test

Berg Balance Scale

Sit to stand x10

Timed Up and Go test

Gait speed

Maximum step height

Nottingham Extended Activities of Daily Living scale

Short Form‐12 mental and physical domains

Notes

Funding: Eastern Regional Health Authority

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote "patients were assigned randomly by a computer‐generated list"

Allocation concealment (selection bias)

Low risk

Quote "using lots in sealed opaque envelopes"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Assessor blinded to group allocation

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Assessor blinded to group allocation

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Adequate follow‐up and ITT analysis. Less than 20% of data missing

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Adequate follow‐up and ITT analysis. Less than 20% of data missing

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Low risk

Adequate follow‐up and ITT analysis. Less than 20% of data missing

Selective reporting (reporting bias)

Unclear risk

No trial protocol identified

Free from baseline imbalance bias?

Low risk

Groups balanced at baseline

Free from performance bias due to non‐trial interventions?

High risk

Social contact in intervention arm likely to confound any effect. An appropriate comparator would have been social home visits but no physical intervention.

Sylliaas 2012

Study characteristics

Methods

Randomised controlled trial

Participants

Recruited from Ullevål University Hospital or Diakonhjemmet Hospital in Oslo, Norway.

Period of study: unclear

95 participants

Inclusion: in the intervention arm in previous trial (Sylliaas 2011; 12‐week intervention from 12 to 24 weeks post fracture); age at least 65 years; living at home; assessed as able to undergo physical therapy for the hip fracture by the responsible orthopaedic surgeon; scoring 23 or more (out of 30) on the Mini Mental State Examination.

Exclusion: admitted from nursing homes, metastatic cancer or had sustained the hip fracture as part of a multi‐trauma, in an institution 3 months after the fracture, absent from 3‐month follow‐up for Sylliaas 2011 study.

Age: mean (SD) 82.3 (5.8)
% male: 19
Number lost to follow‐up: 5

Interventions

1. Intervention: 6 to 9 months after fracture: physiotherapist led programme, exercise class 1x/week and home programme at least once/week. Exercise class: 15‐minute warm‐up on cycle or treadmill. 45‐ to 60‐minute exercise session; 4 exercises (standing knee flexion, lunge, sitting knee extension and leg extension, with 3 sets of 10 reps at 80% of 1 RM, progressed every 3 weeks. Home programme: standing knee flexion and lunge exercises, resistance added via weight belts. Walk approx. 30 minutes/day.

2. Control: participants were asked to maintain their current lifestyle. No restrictions were placed on their exercise activities.

Outcomes

12 weeks:

Timed Up and Go test

Berg Balance Scale

Sit to stand x10

Gait speed

6‐min walk test

Nottingham Extended Activities of Daily Living scale

SF‐12 mental and physical domains

Maximum step height

Notes

All participants were recruited from those who completed a preceding 3‐month progressive strength‐training programme twice a week, in the intervention arm of Sylliaas 2011. Due to the resulting unit of analysis issues, we did not include data from this study in the meta‐analysis.

Funding: Eastern Regional Health Authority funded the study

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "a new randomisation of the participants in the intervention arm was carried out". Assume this was the same method of randomisation as used in preceding trial (Sylliaas 2011), where "patients were assigned randomly by a computer‐generated list"

Allocation concealment (selection bias)

Low risk

Assume this was the same method of randomisation as used in preceding trial (Sylliaas 2011), "using lots in sealed opaque envelopes"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Assessor blinded to group allocation

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Adequate follow‐up and ITT analysis

Selective reporting (reporting bias)

Unclear risk

No trial protocol identified

Free from baseline imbalance bias?

Low risk

Groups balanced at baseline

Free from performance bias due to non‐trial interventions?

High risk

Social contact in intervention arm likely to confound any effect. An appropriate comparator would have been social home visits but no physical intervention.

Taraldsen 2019

Study characteristics

Methods

Randomised controlled trial

Participants

Hospital in central Norway

Period of study: February 2011 to March 2014

143 participants

Inclusion: community‐dwelling in Trondheim municipality prior to the fracture, 70 years or older, diagnosed and operated for intracapsular or extracapsular hip fractures and identified by experienced physiotherapists by use of hospital admission lists.

Exclusion: pathological fracture, less than 3 months' life expectancy, inability to walk 10 m (with or without walking aids) before the fracture, or participating in conflicting research project; at 4 months, participants were also excluded after a medical examination if they had contraindications for training (unstable medical conditions) or were bedridden

Age: mean (SD) 83.4 (6.1)

% of male: 31

Number lost to follow‐up: 20

Interventions

Additional home‐based exercise programme delivered 4 months following hip fracture in additional to usual rehabilitation and health care services

1. Received 2 exercise sessions a week for 10 weeks from physiotherapists at home. The programme targeted balance and gait and consisted of 5 individually‐tailored, weight‐bearing exercises, all entailing change in base of support: walking, stepping in a grid pattern, stepping up on a box, sit‐to‐stand, and lunge. Each exercise was described at 5 levels with increasing challenge.

2. Usual care

Outcomes

End of intervention = 2 months. Outcomes also at 8 months.

Short Physical Performance Battery

Gait speed

Barthel Index

Nottingham Extended Independent ADL

EuroQol 5D‐3L

Need for walking aid / assistance

Number of people who fell

Cost‐effectiveness

Notes

Funding: Norwegian Women’s Health Association and the Norwegian Extra Foundation for Health and Rehabilitation through the EXTRA funds, the Norwegian Fund for Postgraduate Training in Physiotherapy, and the Liaison Committee between the Central Norway Regional Health Authority (RHA), Trondheim Municipality, and the Norwegian University of Science and Technology (NTNU).

Conflict of interest: nil

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: "The randomization was performed using a web‐based computerized randomization service... A stratified block randomization technique was used to ensure balanced group concerning intra‐capsular versus extra‐capsular fractures and pre‐fracture use of walking aid (rollator indoor or not)."

Allocation concealment (selection bias)

Low risk

Randomisation performed off‐site using a web‐based computerised randomisation service

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

"Assessors and personnel performing statistical analyses were blinded to participants’ group allocation." Participants were instructed not to provide information that could reveal group allocation to the researchers and assessors, and this information was repeated prior to each assessment.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Method of ascertainment of death unclear

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Health‐related quality of life: blinded assessors

Falls reported in retrospect by participants and staff who were aware of group allocation; therefore, high risk of bias for falls

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

Low risk

Less than 20% of data lost to follow‐up

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Low risk

Less than 20% of data lost to follow‐up

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

Low risk

Less than 20% of data lost to follow‐up

Selective reporting (reporting bias)

Unclear risk

TUG and strength are in protocol but were not measured on frailer participants "due to burden on the participants." Therefore, these measures were not reported in the results. This seems an adequate explanation and the majority of prespecified outcomes were measured.

Free from baseline imbalance bias?

Unclear risk

Intervention group more likely to live alone; mobility measures were balanced

Free from performance bias due to non‐trial interventions?

High risk

No control for social interaction effect, with 2x weekly physio visits in home and a high proportion of participants living alone

Method of ascertaining falls

Unclear risk

Number of new falls during the 12‐month follow‐up period was registered based on retrospective report

Tsauo 2005

Study characteristics

Methods

Randomised: method not specified

Participants

People recently discharged from an acute orthopaedic unit, National Taiwan University Hospital, Taiwan
Period of study: October 2000 to September 2001
54 participants
Inclusion: people recently discharged from hospital after surgery for a hip fracture; agreement to participate from participant and surgeon; written informed consent
Exclusion: individual or family rejected further treatment or follow‐up; did not have transport or were not in hospital neighbourhood; were unable to co‐operate due to cognitive problems; or had ongoing medical litigation
Age (of 25 completers): mean 73 years (range not given)
% male (of 25 completers): 20
Number lost to follow‐up: 29 (25 lost and 4 excluded due to low compliance)

Interventions

Commenced after hospital discharge (mean 11 days)
1. Home‐based individualised physical therapy programme delivered in 8 visits over 3 months and involving strengthening exercises, range‐of‐motion exercises, balance training, functional training (such as sit‐to‐stand, ambulation and stair‐climbing training), practice of transfer techniques, adjustment of walking aids and adaptation and modification of the home environment. 5 exercises were taught at each visit, initially in 3 sets of 10 repetitions a day for each item, progressed at the visits.
versus
2. Practice of an exercise programme given at the bedside before discharge

All participants had bedside physiotherapy during their hospital stay.

Outcomes

Length of follow‐up: 6 months

Strength
Harris Hip Score

Walking speed
Quality of life: assessed 4 domains of the WHOQOL‐BREF (physical health, psychosocial, social relationship, environment)
Adverse events: wound infection

Notes

Article notes that most people in Taiwan do not receive physiotherapy after they leave hospital because there is no insurance payout for such services.

Funding: supported by the National Science Council (grant nos. NSC‐89‐2320‐B‐002‐051‐ M5, NSC‐90‐2320‐B‐002‐012‐M56).

Conflict of interest: none

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

"Patients were randomized". The method of randomisation was not described.

Allocation concealment (selection bias)

Unclear risk

"Patients were randomized". No methods for concealing allocation were described.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Therapists conducting the intervention and participants were not blinded to the group assignment. Impact of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

High risk

No blinding was reported.

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

No blinding was reported; unknown risk of bias.

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

High risk

No blinding was reported.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

Baseline 3‐month and 6‐month follow‐up data were only available for 25 of the 54 trial participants and an intention‐to‐treat analysis was not carried out. 4 poor compliers with the intervention were excluded.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Baseline 3‐month and 6‐month follow‐up data were only available for 25 of the 54 trial participants and an intention‐to‐treat analysis was not carried out. 4 poor compliers with the intervention were excluded.

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

Baseline 3‐month and 6‐month follow‐up data were only available for 25 of the 54 trial participants and an intention‐to‐treat analysis was not carried out. 4 poor compliers with the intervention were excluded.

Selective reporting (reporting bias)

Unclear risk

The outcomes recorded appeared to be reported.

Free from baseline imbalance bias?

Unclear risk

Baseline data were only available for 25 of the 54 trial participants. For these 25 participants, only diabetes differed significantly between the 2 groups. The authors reported that the number and characteristics of the 25 participants (4 others were excluded for low compliance) lost to follow‐up were similar between the two groups.

Free from performance bias due to non‐trial interventions?

Low risk

There appeared to be care programme comparability before discharge and identical follow‐up assessment procedures.

Van Ooijen 2016

Study characteristics

Methods

Randomised controlled trial

Participants

A ‘residential and rehabilitation center’ in Zorggroep Solis in Deventer, the Netherlands. This is where most people recovering from a hip fracture are referred to when they need additional temporary care before returning to their homes.

Period of study: January 2012 and December 2015.

70 participants

Number lost to follow‐up: 36

Inclusion: admission to Zorggroep Solis with a hip fracture related to falling, ≥ 65 years of age, Functional Ambulation Category score 2 or higher, expected duration of admission at Zorggroep Solis ≥ 6 weeks, ability to understand and execute simple instructions

Exclusion: not allowed to bear weight on the affected leg; moderate or severe cognitive impairments as indicated with a score below 18 on the MMSE; severe non‐corrected visual impairments limiting the correct perception of the direct environment; contraindication to physical activity; activity tolerance below 40 minutes with rest intervals

Age: mean (SD) 83.4 (6.7) years
% male: 14

Number lost to follow‐up: at 3 months = 19, at 6 months = 36

Interventions

Three‐arm trial. Interventions delivered by physical therapist. 1 therapist to 2 participants, with the participants taking turns to train. Provided verbal instructions or occasional physical assistance when necessary.

1. Control: usual physiotherapy = conventional physical therapy, including exercises of leg strength in sitting or standing, balance (e.g. stance), transfers (e.g. bed to chair, chair to toilet, chair to chair, sit to stand and vice versa), overground walking (e.g. parallel bars, inside, outside, obstacles) and activities of daily living. These training sessions followed locally‐implemented guidelines regarding the treatment of hip fractures and aimed to facilitate the participant’s return to home.

  • Start, time since fracture, median days (min‐max): 13 (7–65).

  • 5 sessions/week for 6 weeks (total 30 sessions). Sessions = 40‐minute duration (with 20 minutes of practice and 20 minutes of rest).

2. Conventional treadmill. 15 sessions = conventional physiotherapy, 15 sessions = treadmill (TM) walking. TM walking used no body‐weight support other than the handrail. Walking at a speed that was reported as comfortable. Focus was initially on the quality and safety aspects of walking and gradually shifted towards walking faster and longer.

  • Start, time since fracture, median days (min‐max): 13 (6–63).

  • 5 sessions/week for 6 weeks (total 30 sessions): 15 sessions = conventional physiotherapy, 15 sessions = treadmill. Sessions = 40‐minute duration (with 20 minutes of practice and 20 minutes of rest).

3. Adaptability treadmill: 15 sessions = conventional physiotherapy, 15 sessions = adaptability treadmill (TM) training. TM walking used no body‐weight support other than the handrail. Walking at a speed that was reported as comfortable. Focus on practicing walking adjustments in response to the visual context projected on the C‐Mill, e.g. visually‐guided stepping to targets, obstacle avoidance, speed variation. Walking adaptability games consisting of interactive stepping targets and obstacles.

  • Start, time since fracture, median days (min‐max): 14 (7–79)

  • 5 sessions/ week for 6 weeks, (total 30 sessions): 15 sessions = conventional physiotherapy, 15 sessions = treadmill. Sessions = 40‐minute duration (with 20 minutes of practice and 20 minutes of rest)

Outcomes

Immediately after 6‐week intervention, 4 weeks after intervention finished (10 weeks after randomisation), 52 weeks after intervention period (58 weeks after randomisation). 10 weeks after randomisation used in this analysis.

Elderly Mobility Scale

Performance Oriented Mobility Assessment

Timed Up and Go test (inadequate data to be included in analysis)

Walking speed

Falls

Nottingham Extended Activities of Daily Living Index

Hip Disability and Osteoarthritis Score ‐ Quality of Life

Mortality

Notes

Measured adherence

Funding: none noted

Conflict of interest: MR and PJB are inventors of rehabilitation treadmills that include visual context for foot placement. Vrije Universiteit Amsterdam granted this idea exclusively to ForceLink (Culemborg, the Netherlands, now part of Motekforce Link, Amsterdam, the Netherlands), an industrial partner of Vrije Universiteit Amsterdam. ForceLink is manufacturer of the C‐Mill and assignee of a patent for rehabilitation treadmills with visual context for foot placement, with MR and PJB listed as inventors. Vrije Universiteit Amsterdam received patent revenues, and transferred part of these revenues to spend them freely for their research endeavours. Vrije Universiteit Amsterdam used these revenues to finance a research project on the effectiveness of C‐Mill training. The present study is part of that research project. MR and PJB did not receive reimbursements, fees, funding or salary from ForceLink, nor do they benefit personally from patent revenues. ForceLink had no influence on the interpretation of the results, the final conclusions and their publication.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated block randomisation

Allocation concealment (selection bias)

Low risk

Quote: "Allocation concealment by opaque sequentially numbered envelopes"

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Subjects and therapists not blinded; effect of non‐blinding is unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Assessors blinded

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Low risk

Only relevant outcome death. Objective outcome and assessors blinded: risk of bias considered low

Blinding of outcome assessment (detection bias)
Participant/proxy‐reported outcomes

Unclear risk

Health‐related quality of life: assessors blinded

Falls ascertained by the same method in both groups. Participants reporting falls were not blind to group. Blinded assessors recorded and confirmed falls with participants. Unclear impact of lack of participant blinding

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

> 20% loss to follow‐up

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

High risk

Large loss to follow‐up, although ITT analysis conducted for deaths

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

35% had no falls follow‐up.

Selective reporting (reporting bias)

Low risk

Outcomes reported as per trial registration and published protocol

Free from baseline imbalance bias?

Low risk

Groups comparable at baseline

Free from performance bias due to non‐trial interventions?

Low risk

Groups use similarly qualified therapists and contract hours for delivery of intervention

Method of ascertaining falls

Low risk

Monthly falls calendar. Participants who did not return calendars or provided incomplete information were telephoned by blinded assessors.
 

Williams 2016

Study characteristics

Methods

Randomised controlled trial. Stratified by hospital and gender

Participants

3 main acute hospitals of Betsi Cadwaladr University Health Board (BCUHB) in North Wales (Wrexham Maelor, Ysbyty Glan Clwyd and Ysbyty Gwynedd)
Period of study: June 2014 to June 2016
61 participants randomised (62 recruited)
Inclusion: age 65 years or older; recent proximal hip fracture; surgical repair by replacement arthroplasty or internal fixation; living in their own home prior to hip fracture; capacity to give informed consent, as assessed by the clinical team in the acute hospital; people with postoperative delirium were approached if this was resolved prior to discharge from the acute hospital; living and receiving rehabilitation from the National Health Service in the area covered by BCUHB
Exclusion: living in residential or nursing homes prior to hip fracture; not able to understand Welsh or English
Age: mean (SD) 79.4 (7.6); range 66 to 99
% male: 25
Number lost to follow‐up: 13/62

Interventions

1. Intervention: usual care plus enhanced rehabilitation package, including 6 additional home‐based physiotherapy sessions delivered by a physiotherapist or technical instructor, novel information workbook and goal‐setting diary

2. Control: usual care

Outcomes

3 months:

Walking speed

Barthel Activities of Daily Living

Nottingham Extended Activities of Daily Living scale

Eight‐foot Get Up and Go test

Sit to Stand

Pain

EuroQol‐5D

Mortality

Notes

Measured adherence

‐ "Stratification by hospital was necessary as each hospital has differing usual care pathways and, due to the geography of the area, different therapy teams delivered the intervention in different areas".

‐ Timed Up and Go test and gait speed were only measured in people with unaided gait. Therefore they had very poor follow‐up (n = 24 of the 60 randomised, compared with n = 59 for primary outcome, the Barthel Index).
‐ The 3‐month follow‐up of TUG and gait speed were performed on average 3 weeks later in the control group than in the intervention group.

Funding: National Institute for Health Research’s Health Technology Assessment Programme

Conflict of interest: CS reports being a member of the NIHR HSDR board.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"The randomisation was performed by dynamic allocation to ensure that good balance in the allocation ratio of 1: 1 was maintained, both within each stratification variable and across the trial. Participants were stratified by (1) hospital and (2) gender".

Allocation concealment (selection bias)

Low risk

"Randomisation was achieved by secure web access to the remote randomisation centre at the North Wales Organisation for Randomised Trials in Health (NWORTH) at Bangor University. This system was set up, maintained and monitored independently of the trial statistician and other trial staff".

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Participants and intervention staff not blind to group allocation. Effect of non‐blinding unclear

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, some judgement

Low risk

Blinded assessors

Blinding of outcome assessment (detection bias)
Observer‐reported outcomes, no judgement

Unclear risk

Adverse events were reported to researchers; however, blinding is not clear. Method of detecting death is unclear.

Incomplete outcome data (attrition bias)
Observer‐reported outcomes, some judgement

High risk

More than 20% did not complete 3‐month follow‐up for physical function tests.

Incomplete outcome data (attrition bias)
Death, re‐admission, re‐operation, surgical complications, return to living at home

Unclear risk

20% withdrawals or loss to follow‐up; proportion followed up for death unclear

Incomplete outcome data (attrition bias)
Participant/proxy‐reported outcomes

High risk

More than 20% did not complete 3‐month follow‐up for pain outcome.

Selective reporting (reporting bias)

Low risk

All outcomes in trial registration are reported in results section

Free from baseline imbalance bias?

Unclear risk

"The proportions in the two groups were similar according to gender, living status, type of property, type of fracture, type of surgery and admitting hospital. The mean age of the intervention group was 2.9 years older than the control group. After the hospital admission, there was a small discrepancy between those discharged directly to their place of usual residence (34% in the intervention group; 53% in the control group), and those sent to a community hospital for rehabilitation (52% in the intervention group; 22% in the control group). The baseline scores of the outcome measures and physical function tests were similar between the 2 groups (table 3). However, the Nottingham Extended Activities of Daily Living score was 2.4 points higher in the control group".

Free from performance bias due to non‐trial interventions?

Unclear risk

Pragmatic, usual care varied as per protocol

ADL: activities of daily living; AGT: antigravity treadmill; CBT: cognitive behavioural therapy; EQ‐5D(‐3L): EuroQol Quality of Life Questionnaire Five‐Dimensional Classification (3 levels); ES: electrical stimulation; HRQoL: health‐related quality of life; ITT: intention to treat; IU: international units; MMSE: Mini Mental State Examination; N·m/kg: newton‐metre/kilogram; PAM: physical activity monitor; RM: repetition maximum; ROM: range of motion; SD: standard deviation; SF‐12/SF‐36: 12‐Item/36‐Item Short Form Health Survey; TENS: transcutaneous electrical nerve stimulation; TUG: Timed Up and Go test; VAS: visual analogue scale; WHOQOL‐BREF: World Health Organization abbreviated Quality of Life scale

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Adunsky 2011

Intervention not solely aimed at mobilisation

Aftab 2020

The intervention group received multifactorial multidisciplinary rehabilitation program 

Beckman 2021

Pseudo‐randomised

Berggren 2019

Intervention not solely aimed at mobilisation

Corna 2021

Intervention was conventional rehabilitation plus individualised, progressive aerobic exercise training with an arm crank ergometer for 30 minutes/day, 5 days/week for 3 weeks. Aerobic training was conducted on a commercial motorised arm crank ergometer. The difference between the intervention and control groups is not a mobilisation strategy.

Dallimore 2015

Proportion of participants receiving intervention after a hip fracture is unknown

Invernizzi 2019

Both groups undertook exercise. Difference between groups was amino acids

Kalron 2018

Hip fracture and total hip joint replacement. Outcomes not reported for hip fracture only

Karlsson 2016

Intervention included multiple components delivered by a multidisciplinary team

Kim 2020

Outcomes focused on strength and muscle activity; did not measure mobility

Lahtinen 2017

Compared interventions containing multiple components and compared two models of care

Laiz 2017

Primarily a vitamin D trial. Intervention participants also received instruction on exercises and a leaflet. This trial was excluded as the intervention did not target mobility. Compliance for vitamin D recorded but no mention of exercise compliance. The outcomes were limited to survival and complications (with no mobility focus).

Lehrl 2012

Participants underwent total hip arthroplasty; proportion with hip fracture unknown. Intervention was a video game with cognitive tasks, aiming to improve mental activation

Pfeiffer 2020

The intervention primarily focused on reducing falls and fear of falling; the intervention was largely cognitive and employed behavioural strategies that did not meet the intervention criteria for this review. 

Scheffers‐Barnhoorn 2019

Both the intervention and control groups received multidisciplinary geriatric rehabilitation including regular exercise training, with the between‐group difference in intervention being a cognitive‐behavioural strategy rather than a mobility‐training strategy.

Taraldsen 2015

Intervention was a care programme, rather than a mobility strategy

Wang 2020

The intervention was a model of care, with medical and therapy involvement, rather than a mobility strategy.

Wu 2010

Participants had acetabular not hip (proximal femur) fractures

Characteristics of studies awaiting classification [ordered by study ID]

Che 2020

Methods

Randomised controlled trial

Participants

78 people with old femoral neck fractures who underwent surgery in hospital between 2 September 2017 and 25 August 2019

Interventions

The control group underwent routine rehabilitation training, and the observation group performed early rehabilitation training.

Outcomes

Harris Hip Score, length of stay, pain, complications

Notes

A conference abstract has been published. We have emailed authors to request further details on the time post fracture, intervention, outcome measures and results.

Wu XY 2019

Methods

Randomised controlled trial

Participants

100 people undergoing cementless total hip arthroplasty for femoral neck fractures at Department of Orthopedics, Tianjin Hospital from March 2016 to April 2017

Interventions

"The trial group received early weight‐bearing exercise with the concept of enhanced recovery after surgery, and control group was given weight‐bearing exercise at 3 weeks with the traditional rehabilitation concept."

Outcomes

Visual analogue scale score, hip range of motion, Harris Hip Score, Short Form‐36, postoperative complications

Notes

Awaiting translation to English

Characteristics of ongoing studies [ordered by study ID]

ACTRN12617001345370

Study name

Recumbent bike riding for people with fractured neck of femur: a feasibility trial

Methods

Randomised controlled trial. Blinded outcomes assessor and investigators

Participants

People aged 18 years or above. Have had surgical correction of a fractured neck of femur. Be unable to walk 15 m with assistance at enrolment (within 4 days of surgery).

Aim: 60 participants

Interventions

1. Routine care plus bike training

2. Routine care

Outcomes

Trial feasibility; participant recruitment and retention, completion of outcome measures, documentation of any trial protocol deviations or variations, and feedback from trial staff about any issues encountered in the delivery of the protocol.

Intervention feasibility

Intervention safety

Trial feasibility

Modified Iowa Level of Assistance Scale

Discharge destination

Gait speed

Acute length of stay

Quality of life

Subacute length of stay

Starting date

Study start date: November 2017

Contact information

A/Prof Catherine Said

Physiotherapy Department

Austin Health

Studley Rd

Heidelberg, 3084

Victoria

Australia

+61 3 9496 3697

[email protected]

Notes

ACTRN12618000903280

Study name

The feasibility of prescribing a walking program to improve physical functioning of people living in the community after hip fracture: a phase II randomised controlled trial

Methods

Randomised controlled trial; blinded outcomes assessor

Participants

Aged 60 years or above; community‐dwelling and receiving services from the Community Rehabilitation Program at Eastern Health; had a hip fracture (S72.0–S72.2 according to the International Classification of Diseases 10th revision, ICD‐10) which was managed surgically; are able to walk independently with or without a gait aid; can communicate with conversational English.

Aim: 42 participants

Interventions

1. Intervention: usual care plus prescription of total 100 minutes of walking per week, of at least moderate intensity (at level 3 determined by the Rate of Perceived Exertion Scale from 0 to 10), in bouts of at least 10 minutes, for 12 weeks

2. Control: usual care without any additional prescription of physical activity

Outcomes

Follow‐up: 12 weeks post‐intervention

Primary outcome: feasibility

Secondary outcomes

  • Functional Autonomy Measurement System

  • The de Morton Mobility Index

  • Modified Falls Efficacy Scale

  • Ambulatory Self‐Confidence Questionnaire

  • Health‐related quality of life: Assessment of Quality of Life Instrument (AQoL) 8‐D

  • Measurement of physical activity using an accelerometer‐based activity monitor

Starting date

Study start date: July 2018

Estimated completion date: NR

Contact information

Prof Nicholas Taylor

Eastern Health ‐ La Trobe University

+61 3 9091 8874

[email protected]

Notes

Heiberg 2017

Study name

Recovery of physical functioning, activity level, and quality of life after hip fracture in the fragile elderly

Methods

Randomised controlled trial; blinded outcome assessors

Participants

People with an acute low‐energy hip fracture (intracapsular, trochanteric or subtrochanteric) and treated surgically, ≥ 65 years of age, living in their own homes prior to the fracture, and able to give informed consent.

Aim: 160 participants

Interventions

1. Functional training group

2. Usual care

Outcomes

Follow‐up: 12 months after surgery

Primary outcome measure: change in the performance‐based Short Physical Performance Battery

Secondary outcome measures

  • Change in the performance‐based measure Timed Up & Go test

  • Change in the performance‐based measure Hand grip strength

  • Descriptive performance‐based measurement of physical activity, an accelerometer

  • Pain in rest and while walking

  • EuroQol (European quality of life) health status measure

  • University of California Los Angeles activity scale

  • New Mobility Scale; Walking Habits

Starting date

Study start date: May 2016

Estimated completion date: December 2018

Contact information

Kristi E Heiberg, PhD

004790980258

[email protected]

Arnljot Tveit, PhD

[email protected]

Notes

ISRCTN32476360

Study name

Effects of transcutaneous electrical nerve stimulation on acute postoperative pain intensity, ambulation and mobility after hip fracture: a double‐blinded, randomised trial

Methods

Randomised trial. Double‐blinded

Participants

People aged over 50 years of age, with stable extracapsular proximal hip fraction (intertrochanteric or subtrochanteric); partial or full weight bearing instructions; ability to ambulate independently for at least 10 m with or without an assistive device prior to the fracture; ability to follow instructions; Mini Mental State Examination test score = 20

Aim: 80 participants

Interventions

1. Active transcutaneous electrical nerve stimulation (TENS) with a biphasic symmetric waveform at a continuous frequency of 100 Hz and phase duration of 200 µseconds

2. Sham TENS

Outcomes

Follow‐up: 5 days

Pain level at rest, at night and during ambulation

Ambulation status measures

Physical performance tests

Starting date

Start date: December 2014

Estimated completion date: December 2015

Contact information

Michal Elboim

Balfour 9

Nahariya 224216

Israel

Notes

jRCTs052190018

Study name

A pilot study of training using the Balance Exercise Assist Robot for the patients after the proximal femoral fractures surgery at the convalescent rehabilitation ward

Methods

Randomised controlled trial; open‐label

Participants

People aged 65 years to 95 years; more than one week after surgery; able to stand for more than 90 seconds; able to walk more than 10 m with supervision; able to stand still on the Balance Exercise Assist Robot; height: 140 cm to 190 cm; weight: 35 kg to 100 kg

Aim: 30 participants

Interventions

1. Conventional therapy (100 minutes per day) plus robotic training group using the balance exercise assist robot (80 minutes per day) for 21 days

2. Conventional therapy (100 minutes per day) plus conventional balance training (80 minutes per day) for 21 days

Outcomes

Follow‐up: not reported

Primary outcome: Functional Reach Test

Secondary outcomes

  • Muscle strength in lower extremity

  • Grip power

  • Berg Balance Scale

  • Gait speed (maximum)

  • Timed Up and Go test

  • Range of motion (hip, knee and ankle joints)

  • Pain

  • Mini Mental State Examination

  • Japanese version of Montreal Cognitive Assessment

  • Satisfaction with the exercise

Starting date

Study start date: April 2019

Contact information

Mikihiro Fujioka

Kyoto Takeda Hospital

11, Nishishichijo, Minamikinutacho, Shimogyo‐ku

+81‐75‐321‐7001

Kyoto, Japan

Notes

jRCTs052190022

Study name

A preliminary study of training using the Balance Exercise Assist Robot for the patients after the proximal femoral fractures surgery at the community‐based integrated care ward

Methods

Randomised controlled trial; open‐label

Participants

Aged 65 years to 90 years; one week after surgery; able to walk more than 10 m with supervision; able to stand still on the Balance Exercise Assist Robot; height: 140 cm to 190 cm, weight: 35 kg to 100 kg

Interventions

1. Conventional therapy (80 minutes per day) plus robotic training group using the balance exercise assist robot (40 minutes per day) for 13 days

2. Conventional therapy (80 minutes per day) plus conventional balance training (40 minutes per day) for 13 days

Outcomes

Primary Outcome: Functional Reach Test

Secondary outcomes

  • Muscle strength in lower extremity

  • Grip power

  • Berg Balance Scale

  • Gait speed (maximum)

  • Timed Up and Go test

  • Range of motion (hip, knee and ankle joints)

  • Pain

  • Mini Mental State Examination

  • Japanese version of Montreal Cognitive Assessment

  • Satisfaction with the exercise

Starting date

Study start date: April 2019

Estimated completion date: not reported

Contact information

Seiji Tokugawa

Ayabe City Hospital

+81‐773‐43‐0123

[email protected]

Tomoyoshi Obata

Ayabe City Hospital

obata.t@ayabe‐hsp.or.jp

Notes

KCT0004122

Study name

A randomised feasibility study of inpatient rehabilitation using advanced techniques in older people with fragility hip fracture

Methods

Randomised controlled trial; blinded outcomes assessor

Participants

Aged 65 or above; diagnosed with femoral neck, intertrochanteric fracture; hip operative methods include bipolar artificial joint replacement, total hip arthroplasty, open reduction

Aim: 20 participants

Interventions

1. Intervention: comprehensive rehabilitation using advanced rehabilitation equipment comprised of 30‐minute weightless treadmill walking exercise, strength and balance exercise with pneumatic or non‐pneumatic exercise equipment; twice a day for total 60 minutes per day

2. Control: 30‐minute aerobic exercise using general treadmill; twice a day for total 60 minutes per day

Treatment duration for both groups: 2 weeks

Outcomes

Follow‐up: 3 months post‐surgery

Primary outcome: efficacy using Koval

Secondary outcomes

  • Berg Balance Scale

  • 10‐Metre Walk Test

  • EQ‐5D

  • Timed Up and Go test

Starting date

Study start date: July 2019

Estimated completion date: Apri 2021

Contact information

Bo Ryun Kim

Jeju National University Hospital

+82‐64‐717‐2711

Notes

Lima 2016

Study name

Effectiveness of a physical exercise intervention program in improving functional mobility in older adults after hip fracture in later stage rehabilitation: a randomized clinical trial

Methods

Randomised controlled trial; blinded outcome assessor

Participants

After the first hip fragility fracture following a fall from standing height or while turning; surgically treated in the later stage of rehabilitation phase (6 months up to 2 years after the fracture).

Aim: 82 participants

Interventions

1. Home‐based physical exercise

2. Usual care

Outcomes

Follow‐up: 12 months

Primary outcome measure: lower extremity function (Short Physical Performance Battery)

Secondary outcome measures

  • Physiological risk of falls (Profile Physiological Assessment long version)

  • Functional performance (World Health Organization (WHO) Disability Assessment Schedule)

  • Quality of life

  • Physical activity intensity

  • Occurrence of falls

  • Gait speed

Starting date

Study start date: November 2014

Estimated completion date: December 2019

Contact information

Monica R Perracini, PhD

[email protected]

Camila A Lima

[email protected]

Notes

NCT01129219

Study name

Observation and progressive strength training after hip fracture

Methods

Randomised trial in 2:1 ratio at 12 weeks after fracture. Blinded outcomes assessor

Participants

Hip fracture patients. Enrolled 150 participants

Interventions

Started at 12 weeks post‐fracture. Participants randomised in a 2:1 manner to:
1. Intervention: progressive strength training, for 12 weeks.
After 12 weeks, randomisation to further intervention or not.
2. Control.

Outcomes

Follow‐up: 24 weeks
Primary outcome: Berg Balance Scale
Secondary outcome: strength via Sit to Stand test

Starting date

Start date: June 2007
Estimated completion date: December 2010

Contact information

Mette Martinsen
Oslo University Hospital
Oslo
Norway

Notes

NCT01174589

Study name

Training of patients with hip fracture

Methods

Randomised trial. Blinded outcomes assessor

Participants

Aged 60 years or over; hip fracture patients who are full weight bearing on the affected leg; living in own home with an independent walking ability; within 2 weeks after discharge from hospital

Aim: 120 participants

Interventions

1. 12 weeks of physical training consisting of muscle strength training of both legs, balance and coordination exercises 2 times a week
2. 6 weeks of physical training (as above)

Outcomes

Follow‐up: 24 weeks after baseline testing
Changes in knee‐extension strength
Changes in the Timed Up and Go test

Starting date

Start date: March 2010
Estimated completion date: June 2013

Contact information

Jan Overgaard
Maribo Health Center
Maribo, Denmark, 4930
email: [email protected]

Notes

NCT02305433

Study name

Effects of long‐term intensive home‐based physiotherapy on older people with an operated hip fracture or frailty (RCT)

Methods

Randomised controlled trial

Participants

Age 65 and over for frail persons and age 60 and over for hip fracture patients; home‐dwelling but an increased risk for disabilities or for institutional care; ability to walk inside own home with or without mobility aids; ability to communicate in Finnish; in case of hip fracture: the first operated hip fracture; in case of frailty: signs of frailty assessed by modified Fried's frailty criteria

421 participants

Interventions

1. Physiotherapy (physical exercise)

2. Usual care

Outcomes

Follow‐up: 12 months

Primary outcome measure: duration of time living at home

Secondary outcome measures

  • Change in physical functioning

  • Amount of falls;

  • Change in health‐related quality of life

  • Amount of use and costs of social and health services

  • All cause mortality

  • Change in severity of frailty

Starting date

Study start date: December 2014

Estimated completion date: December 2019

Contact information

Markku T Hupli, MD, PhD

South Karelia, Social and Health Care District

Notes

NCT02407444

Study name

A comparison of two physiotherapy treatment protocols, with and without cycling training, in elderly patients with hip fractures at their subacute stage following surgery

Methods

Randomised trial; blinded outcome assessor

Participants

People aged 65 years to 95 years. Proximal hip fracture with full or partial weight bearing indication. Surgical fixation (nailing or total hip replacement or hemiarthroplasty). Pre‐morbid function: walking independently or under supervision with or without assistance aid. Cognitive function: Mini Mental State Examination score above 21.

Aim: 60 participants

Interventions

1. Physiotherapy treatment and leg cycling

2. Physiotherapy treatment and music listening

Outcomes

Follow‐up: end of intervention at third week

Functional Independence Measure

Static balance test and weight‐bearing distribution while standing

Muscle strength

Pain intensity

Starting date

Study start date: July 2015

Completion date: December 2018

Contact information

Avital Hershkovitz, MD, PhD

97 2522342123

[email protected]

Hila Dahan, BPT

972542458459

[email protected]

"Beit‐ Rivka" geriatric rehabilitation hospital

Petach tiqva, Israel

Notes

NCT02815254

Study name

The effect of exercise in elderly hip fracture patients: a clinical randomised trial

Methods

Randomised trial; blinded outcome assessor

Participants

People aged 65 years or older. Fractura colli femoris, pertrochanter or subtrochanter. Discharged from hospital within 3 weeks since surgery. Need of minimum two weeks of rehabilitation. Life expectancy of more than one month. Able to walk at least 3 metres with walking aid. Willingness to participate. Able to follow instructions.

Aim: 130 participants

Interventions

1. Low‐intensity functional exercise

2. High‐intensity functional exercise

Outcomes

Follow‐up: 3 years

Short Physical Performance Battery

Starting date

Start date: November 2015

Completion date: October 2018

Contact information

Astrid Bergland

Braseth rehabilitation centre

Røyken, Norway, 3440

+47 45272760

[email protected]

Notes

NCT02938923

Study name

Combining testosterone therapy and exercise to improve function post hip fracture

Methods

Multicenter, randomised, placebo‐controlled trial. Blinded participants, care providers, investigators and outcomes assessors

Participants

Community‐dwelling or in assisted living prior to the hip fracture event. Female 65 years and older. Surgical repair of a non‐pathologic fracture of the proximal femur (including: intracapsular, intertrochanteric and subtrochanteric fractures) with a surgical repair date that is within 6 to 14 weeks at screening, and within 16 weeks at randomisation. Functional impairment at the time of screening, defined as a modified Physical Performance Score (mPPT) of 12 to 28. Serum total testosterone level < 40 ng/dL.

Aim: 300 participants

Interventions

1. Exercise plus testosterone gel

2. Exercise plus placebo gel

3. Enhanced usual care

Outcomes

Follow‐up: 6 months

Change in 6‐Minute Walk Test distance

Change in total lean body mass

Change in appendicular lean body mass

Change in 1 repetition maximum (1 RM) leg press strength

Change in Total Modified Physical Performance Test score

Change in Short Physical Performance Battery score

Change in Older Adult Resources and Services Activities of Daily Living Questionnaire ADL Total Score

Change in Functional Status Questionnaire Total Score

Change in Hip Rating Questionnaire Total Score

Change in Patient‐Reported Outcomes Measurement Information System Global Health score

Change in bone mineral density of the non‐fractured proximal femur

Starting date

Study start date: September 2017

Estimated completion date: May 2022

Contact information

Ellen F Binder, MD

Professor of Medicine, Washington University School of Medicine

314‐286‐2707

[email protected]

Kelly M Monroe, MSW

314‐273‐1160

[email protected]

Notes

RM: repetition maximum

NCT03030092

Study name

Maximal strength training following hip fracture surgery: impact on muscle mass, balance, walking efficiency and bone density

Methods

Randomised trial

Participants

People aged over 65 with hip fracture surgery

Aim: 40 participants

Interventions

1. Maximal strength training

2. Standard care

Outcomes

Follow‐up: 8 weeks

Walking efficiency

Muscle mass

Bone density

Balance

Starting date

Study start date: January 2017

Completion date: July 2018

Contact information

Molde University College

Notes

NCT04095338

Study name

Assistive robotic in the elderly: innovative models in the rehabilitation of the elderly with hip fractures through technological innovation

Methods

Randomised controlled trial; blinded outcomes assessor

Participants

Aged 65 or above; traumatic event within 60 days; Functional Ambulation Category score ≤ 2; Ranking scale score ≤ 3; Romberg test: negative; capacity to consent

Aim: 195 participants

Interventions

1. Experiment (virtual reality game): each session includes 30 minutes of traditional physical rehabilitation plus 20 minutes of virtual robotic training that simulates floor walking and stair climbing

2. Robotic treadmill: each session includes 30 minutes of traditional physical rehabilitation plus 20 minutes of robotic training on a treadmill

3. Control: 50 minutes of traditional physical rehabilitation per session

All groups: 2 sessions per week for 5 weeks

Outcomes

Follow‐up: 24 months post‐intervention

Primary outcome: difference in fall risk using the Tinetti Performance‐Oriented Mobility Assessment

Secondary outcomes

  • Difference in gait performance

  • Difference in fear of falling

Starting date

Study start date: November 2019

Estimated completion date: September 2022

Contact information

Roberta Bevilacqua

INRCA Research Hospital

Ancona, Italy, 60131

00390718004767

[email protected]

Notes

NCT04108793

Study name

Effectiveness of home‐based rehabilitation program in minimizing disability and secondary falls after a hip fracture: a randomized controlled trial

Methods

Randomised controlled trial; open‐label

Participants

Aged 60 or above; diagnosis of proximal femoral fracture; surgical procedure was bipolar hemiarthroplasty / total hip replacement and postoperative ambulatory status weight bearing as tolerated; able to walk independently with or without a walking frame prior to the fracture; history of fall

Aim: 224 participants

Interventions

1. Intervention: extended home‐based rehabilitation programme including progressive balance and lower limb strengthening exercises, twice a week for 12 weeks

2. Control: usual postoperative rehabilitation

Outcomes

Follow‐up: 2 years

Primary outcome: occurrence of secondary fall

Secondary outcome: physical mobility and mobility‐related disability

Starting date

Study start date: October 2019

Estimated completion date: October 2021

Contact information

Dr. Shahryar Noordin

Associate Professor and orthopedic surgeon

Aga Khan University

+92 34864384 ext 4384

[email protected]

Notes

NCT04207788

Study name

HIP fracture REhabilitation Programme for elderly with hip fracture (HIP‐REP)

Methods

Randomised controlled trial; blinded participants, care provider, investigator and outcomes assessor

Participants

Aged 65 years or older; recent proximal hip fracture (International Classification of Diseases codes S72.0 medial femur fracture, S72.1, pertrochanteric femur fracture, S72.2 subtrochanteric femur fracture); living at home prior to hip fracture in Herlev, Gentofte, Furesoe, Rudersdal or Lyngby‐Taarbæk municipalities; ability to give informed consent

Aim: 108 participants

Interventions

1. Usual care plus 5 add‐on individual activity‐focused interventions specific to the needs of elderly people with hip fracture

2. Usual care

Outcomes

Follow‐up: 6 months after baseline testing

Primary outcome: Assessment of Motor and Process Skills

Secondary outcomes:

  • European Quality of Life Questionnaire

  • Verbal Rating Scale

  • Functional Recovery Score

Starting date

Study start date: January 2020

Estimated completion date: August 2021

Contact information

Carsten Bogh Juh

Herlev and Gentofte Hospital

[email protected]

Notes

NCT04228068

Study name

A home‐based rehabilitation program for patients with hip fracture: a pilot randomized trial

Methods

Randomised controlled trial; blinded outcome assessors

Participants

Hip fracture patients who are 65 years or older and being discharged to home or retirement home

Aim: 40 participants

Interventions

1. Seven home visits in total over the first 12 weeks after returning home; 2 visits by the physiotherapist to assess, tailor the program and coach the participants in carrying out the exercises at home; the physiotherapy assistant to facilitate and progress the exercise program as prescribed by the physiotherapist every other week

2. Usual care

Outcomes

Follow‐up: 12 weeks post‐discharge to home

Lower Extremity Functional Scale

Short Physical Performance Battery

Starting date

Start date: March 2018

Estimated completion date: October 2020

Contact information

Mohammad Auais

Providence Care Hospital

Kingston, Ontario, Canada, K7M 3N6

[email protected] [mailto:mara%40queensu.ca?subject=NCT04228068, REH‐721‐18, The Stronger at Home Study]

Notes

NTR6794

Study name

COMplex Fracture Orthopedic Rehabilitation (COMFORT): real‐time visual biofeedback on weight bearing versus standard training methods in the treatment of proximal femur fractures in elderly: a randomised controlled trial

Methods

Randomised controlled trial; single‐blind

Participants

Age ≥ 60 years; participants rehabilitate from a proximal femur fracture following low‐energy trauma; prescribed unrestricted weight bearing after (surgical) treatment of their fracture; expected clinical rehabilitation duration of ≥ 2 weeks; bodyweight ≤ 120 kg

Aim: 186 participants

Interventions

1. Real‐time, visual feedback about weight bearing during 30 m walk

2. Control: active

Outcomes

Primary outcome measures

  • SensiStep parameters maximum peak load (in % bodyweight)

  • Step duration (in seconds)

Secondary outcomes

  • Spatio‐temporal gait parameters

  • Elderly Mobility Scale

  • Functional Ambulation Categories

  • Visual Analogue Scale

Starting date

Study start date: March 2017

Completion date: August 2018

Contact information

M. Raaben

M.Raaben‐[email protected]

Department of Surgery, UMC Utrecht, Suite G04.228

Heidelberglaan 100

3584 CX Utrecht

The Netherlands

Notes

UMIN000036379

Study name

Randomized controlled trial with parallel design on the effects of maximum voluntary velocity training in patients after femoral neck fracture surgery

Methods

Randomised controlled trial; double‐blind

Participants

Aged 65 or above; femoral neck or trochanteric fracture treated surgically; reside in home; independent pre‐fracture and the ability to walk indoors; New Mobility Score (NMS) of 2 or more

Aim: 26 participants

Interventions

1. Evidence‐based standardised rehabilitation programme plus high‐velocity knee extension and hip abduction exercises 2 weeks after surgery

2. Evidence‐based standardised rehabilitation programme plus low‐velocity knee extension and hip abduction exercises 2 weeks after surgery

Outcomes

Follow‐up: not reported

Primary outcome: knee extension maximum angular velocity of fracture side

Secondary outcomes

  • Knee extension strength

  • 30‐sec chair stand test

  • Timed Up and Go test

  • 10m maximum walking speed

  • New mobility score

Starting date

Study start date: March 2019

Estimated completion date: March 2020

Contact information

Yuuki Shimada

Department of Rehabilitation, Nakazuyagi Hospital

088‐625‐3535

[email protected]

Notes

Data and analyses

Open in table viewer
Comparison 1. In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1.1 Mobility (measured using mobility scales): combined data for all strategy types Show forest plot

7

507

Std. Mean Difference (IV, Random, 95% CI)

0.53 [0.10, 0.96]

Analysis 1.1

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

1.2 Mobility (failure to regain pre‐facture mobility): combined data for all strategy types Show forest plot

2

64

Risk Ratio (M‐H, Fixed, 95% CI)

0.48 [0.27, 0.85]

Analysis 1.2

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 2: Mobility (failure to regain pre‐facture mobility): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 2: Mobility (failure to regain pre‐facture mobility): combined data for all strategy types

1.3 Mobility (measured using self‐reported outcomes): combined data for all strategy types Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.3

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 3: Mobility (measured using self‐reported outcomes): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 3: Mobility (measured using self‐reported outcomes): combined data for all strategy types

1.4 Mobility (measured using mobility scales): gait, balance and function Show forest plot

6

463

Std. Mean Difference (IV, Random, 95% CI)

0.57 [0.07, 1.06]

Analysis 1.4

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

1.5 Mobility (measured using mobility scales): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.5

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 5: Mobility (measured using mobility scales): resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 5: Mobility (measured using mobility scales): resistance/strength training

1.6 Mobility (measured in seconds using TUG): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.6

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 6: Mobility (measured in seconds using TUG): resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 6: Mobility (measured in seconds using TUG): resistance/strength training

1.7 Mobility (measured using mobility scales) reporting individual outcome measures Show forest plot

8

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 1.7

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 7: Mobility (measured using mobility scales) reporting individual outcome measures

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 7: Mobility (measured using mobility scales) reporting individual outcome measures

1.7.1 Elderly Mobility Scale

2

95

Mean Difference (IV, Random, 95% CI)

0.49 [‐0.81, 1.79]

1.7.2 Physical Performance and Mobility Examination Score

2

227

Mean Difference (IV, Random, 95% CI)

0.34 [‐0.31, 0.99]

1.7.3 Berg Balance Scale

2

93

Mean Difference (IV, Random, 95% CI)

12.39 [8.79, 15.98]

1.7.4 Modified Iowa Level of Assistance

1

92

Mean Difference (IV, Random, 95% CI)

2.70 [‐0.94, 6.34]

1.7.5 Timed Up and Go

3

158

Mean Difference (IV, Random, 95% CI)

4.03 [‐6.17, 14.23]

1.7.6 Performance Oriented Mobility Assessment

1

51

Mean Difference (IV, Random, 95% CI)

0.90 [‐1.14, 2.94]

1.7.7 Koval Walking Ability score

1

41

Mean Difference (IV, Random, 95% CI)

1.53 [0.72, 2.34]

1.7.8 Western Ontario and McMaster Universities OA Index (self‐reported)

1

52

Mean Difference (IV, Random, 95% CI)

‐25.40 [‐28.72, ‐22.08]

1.8 Walking speed (measured as metres/time): combined data for all strategy types Show forest plot

6

360

Std. Mean Difference (IV, Fixed, 95% CI)

0.16 [‐0.05, 0.37]

Analysis 1.8

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 8: Walking speed (measured as metres/time): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 8: Walking speed (measured as metres/time): combined data for all strategy types

1.9 Walking speed (measured as metres/time): gait, balance and function Show forest plot

5

336

Std. Mean Difference (IV, Fixed, 95% CI)

0.15 [‐0.07, 0.36]

Analysis 1.9

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 9: Walking speed (measured as metres/time): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 9: Walking speed (measured as metres/time): gait, balance and function

1.10 Walking speed (measured as metres/time): electrical stimulation Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.10

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 10: Walking speed (measured as metres/time): electrical stimulation

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 10: Walking speed (measured as metres/time): electrical stimulation

1.11 Functioning (measured using functioning scales): combined data for all strategy types Show forest plot

7

379

Std. Mean Difference (IV, Random, 95% CI)

0.75 [0.24, 1.26]

Analysis 1.11

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 11: Functioning (measured using functioning scales): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 11: Functioning (measured using functioning scales): combined data for all strategy types

1.12 Functioning (measured using functioning scales): gait, balance and function Show forest plot

5

312

Std. Mean Difference (IV, Random, 95% CI)

0.56 [‐0.00, 1.13]

Analysis 1.12

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 12: Functioning (measured using functioning scales): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 12: Functioning (measured using functioning scales): gait, balance and function

1.13 Functioning (measured using functioning scales): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.13

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 13: Functioning (measured using functioning scales): resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 13: Functioning (measured using functioning scales): resistance/strength training

1.14 Functioning (measured using functioning scales): electrical stimulation Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.14

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 14: Functioning (measured using functioning scales): electrical stimulation

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 14: Functioning (measured using functioning scales): electrical stimulation

1.15 Health‐related quality of life (measured using HRQoL scales): gait, balance and function Show forest plot

4

314

Std. Mean Difference (IV, Random, 95% CI)

0.39 [‐0.07, 0.85]

Analysis 1.15

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 15: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 15: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

1.16 Mortality, short term: combined data for all strategy types Show forest plot

6

489

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.48, 2.30]

Analysis 1.16

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 16: Mortality, short term: combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 16: Mortality, short term: combined data for all strategy types

1.17 Mortality, short term: gait, balance and function Show forest plot

3

293

Risk Ratio (M‐H, Fixed, 95% CI)

1.43 [0.44, 4.66]

Analysis 1.17

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 17: Mortality, short term: gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 17: Mortality, short term: gait, balance and function

1.18 Mortality, short term: resistance/strength training Show forest plot

2

170

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.26, 2.62]

Analysis 1.18

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 18: Mortality, short term: resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 18: Mortality, short term: resistance/strength training

1.19 Mortality, short term: electrical stimulation Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.19

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 19: Mortality, short term: electrical stimulation

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 19: Mortality, short term: electrical stimulation

1.20 Mortality, long term: combined data for all strategy types Show forest plot

2

133

Risk Ratio (M‐H, Fixed, 95% CI)

1.22 [0.48, 3.12]

Analysis 1.20

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 20: Mortality, long term: combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 20: Mortality, long term: combined data for all strategy types

1.21 Mortality, long term: gait, balance and function Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.21

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 21: Mortality, long term: gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 21: Mortality, long term: gait, balance and function

1.22 Mortality, long term: resistance/strength training Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.22

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 22: Mortality, long term: resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 22: Mortality, long term: resistance/strength training

1.23 Adverse events (measured using dichotomous outcomes): combined data for all strategy types Show forest plot

7

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 1.23

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 23: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 23: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

1.23.1 Re‐admission

4

322

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.44, 1.11]

1.23.2 Re‐operation

1

80

Risk Ratio (M‐H, Fixed, 95% CI)

0.32 [0.01, 7.57]

1.23.3 Surgical complications

1

18

Risk Ratio (M‐H, Fixed, 95% CI)

Not estimable

1.23.4 Pain

3

245

Risk Ratio (M‐H, Fixed, 95% CI)

1.12 [0.80, 1.57]

1.23.5 Falls (number of people who experienced one or more falls)

1

50

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.32, 1.38]

1.23.6 Other: orthopaedic complication (as reason for withdrawal from study)

1

88

Risk Ratio (M‐H, Fixed, 95% CI)

1.50 [0.45, 4.95]

1.24 Adverse events (measured using rate of falls): all studies were gait, balance and function Show forest plot

3

Rate Ratio (IV, Fixed, 95% CI)

0.85 [0.64, 1.12]

Analysis 1.24

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 24: Adverse events (measured using rate of falls): all studies were gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 24: Adverse events (measured using rate of falls): all studies were gait, balance and function

1.25 Adverse events (measured using continuous measures of pain): combined data for all strategy types Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.25

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 25: Adverse events (measured using continuous measures of pain): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 25: Adverse events (measured using continuous measures of pain): combined data for all strategy types

1.26 Return to living at pre‐fracture residence: combined data for all strategy types Show forest plot

2

240

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.73, 1.56]

Analysis 1.26

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 26: Return to living at pre‐fracture residence: combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 26: Return to living at pre‐fracture residence: combined data for all strategy types

1.27 Return to living at pre‐fracture residence: additional study not included in main analysis Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.27

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 27: Return to living at pre‐fracture residence: additional study not included in main analysis

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 27: Return to living at pre‐fracture residence: additional study not included in main analysis

1.28 Return to living at pre‐fracture residence: gait, balance and function Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.28

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 28: Return to living at pre‐fracture residence: gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 28: Return to living at pre‐fracture residence: gait, balance and function

1.29 Return to living at pre‐fracture residence: resistance/strength training Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 1.29

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 29: Return to living at pre‐fracture residence: resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 29: Return to living at pre‐fracture residence: resistance/strength training

Open in table viewer
Comparison 2. In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

2.1 Walking, use of walking aid/need for assistance Show forest plot

2

230

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.74, 1.11]

Analysis 2.1

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 1: Walking, use of walking aid/need for assistance

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 1: Walking, use of walking aid/need for assistance

2.2 Balance (measured using functional reach test, cm) Show forest plot

2

121

Std. Mean Difference (IV, Fixed, 95% CI)

0.37 [0.01, 0.73]

Analysis 2.2

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 2: Balance (measured using functional reach test, cm)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 2: Balance (measured using functional reach test, cm)

2.3 Balance (measured using balance scale) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 2.3

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 3: Balance (measured using balance scale)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 3: Balance (measured using balance scale)

2.4 Balance (measured using ability to tandem stand) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 2.4

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 4: Balance (measured using ability to tandem stand)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 4: Balance (measured using ability to tandem stand)

2.5 Balance (measured using step test; number of steps) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 2.5

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 5: Balance (measured using step test; number of steps)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 5: Balance (measured using step test; number of steps)

2.6 Balance (measured using self‐reported outcomes) Show forest plot

2

226

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.71, 1.29]

Analysis 2.6

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 6: Balance (measured using self‐reported outcomes)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 6: Balance (measured using self‐reported outcomes)

2.7 Sit to stand (measured as number of stand ups/second) Show forest plot

2

227

Mean Difference (IV, Fixed, 95% CI)

0.04 [0.01, 0.07]

Analysis 2.7

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 7: Sit to stand (measured as number of stand ups/second)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 7: Sit to stand (measured as number of stand ups/second)

2.8 Strength Show forest plot

8

498

Std. Mean Difference (IV, Fixed, 95% CI)

0.11 [‐0.07, 0.28]

Analysis 2.8

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 8: Strength

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 8: Strength

2.9 Activities of daily living (measured using ADL scales) Show forest plot

5

206

Std. Mean Difference (IV, Random, 95% CI)

0.87 [0.35, 1.38]

Analysis 2.9

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 9: Activities of daily living (measured using ADL scales)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 9: Activities of daily living (measured using ADL scales)

2.10 Resource use (measured by length of hospital stay) Show forest plot

4

335

Mean Difference (IV, Fixed, 95% CI)

‐0.83 [‐3.94, 2.28]

Analysis 2.10

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 10: Resource use (measured by length of hospital stay)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 10: Resource use (measured by length of hospital stay)

2.11 Resource use (measured by use of community services) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 2.11

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 11: Resource use (measured by use of community services)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 11: Resource use (measured by use of community services)

Open in table viewer
Comparison 3. In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

3.1 Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (mortality) Show forest plot

1

273

Risk Ratio (M‐H, Fixed, 95% CI)

0.74 [0.43, 1.29]

Analysis 3.1

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (mortality)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (mortality)

3.2 Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (mortality) Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

3.20 [0.14, 75.55]

Analysis 3.2

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (mortality)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (mortality)

3.3 Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (adverse events) Show forest plot

1

594

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.54, 1.37]

Analysis 3.3

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (adverse events)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (adverse events)

3.3.1 Avascular necrosis

1

112

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.33, 1.42]

3.3.2 Infection

1

270

Risk Ratio (M‐H, Fixed, 95% CI)

0.65 [0.11, 3.81]

3.3.3 Non‐union

1

212

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.56, 2.03]

3.4 Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (return to living at home) Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.72, 1.02]

Analysis 3.4

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (return to living at home)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (return to living at home)

3.5 Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (walking aid/assistance) Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.29, 0.89]

Analysis 3.5

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (walking aid/assistance)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (walking aid/assistance)

Open in table viewer
Comparison 4. Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

4.1 Mobility (measured using mobility scales): combined data for all strategy types Show forest plot

7

761

Std. Mean Difference (IV, Random, 95% CI)

0.32 [0.11, 0.54]

Analysis 4.1

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

4.2 Mobility (measured using Timed Up and Go, seconds): combined data for all strategy types Show forest plot

3

375

Mean Difference (IV, Fixed, 95% CI)

‐1.98 [‐5.59, 1.63]

Analysis 4.2

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 2: Mobility (measured using Timed Up and Go, seconds): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 2: Mobility (measured using Timed Up and Go, seconds): combined data for all strategy types

4.3 Mobility (measured using 6‐Minute Walk Test, metres): combined data for all strategy types Show forest plot

4

396

Mean Difference (IV, Fixed, 95% CI)

28.66 [10.88, 46.44]

Analysis 4.3

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 3: Mobility (measured using 6‐Minute Walk Test, metres): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 3: Mobility (measured using 6‐Minute Walk Test, metres): combined data for all strategy types

4.4 Mobility (measured using mobility scales): gait, balance and function Show forest plot

5

621

Std. Mean Difference (IV, Fixed, 95% CI)

0.20 [0.05, 0.36]

Analysis 4.4

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

4.5 Mobility (measured using Timed Up and Go, seconds): gait, balance and function Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.5

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 5: Mobility (measured using Timed Up and Go, seconds): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 5: Mobility (measured using Timed Up and Go, seconds): gait, balance and function

4.6 Mobility (measured using Timed Up and Go, seconds): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.6

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 6: Mobility (measured using Timed Up and Go, seconds): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 6: Mobility (measured using Timed Up and Go, seconds): resistance/strength training

4.7 Mobility (measured using 6‐Minute Walk Test, metres): resistance/strength training Show forest plot

3

198

Mean Difference (IV, Fixed, 95% CI)

55.65 [28.58, 82.72]

Analysis 4.7

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 7: Mobility (measured using 6‐Minute Walk Test, metres): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 7: Mobility (measured using 6‐Minute Walk Test, metres): resistance/strength training

4.8 Mobility (measured using 6‐Minute Walk Test, metres): endurance training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.8

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 8: Mobility (measured using 6‐Minute Walk Test, metres): endurance training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 8: Mobility (measured using 6‐Minute Walk Test, metres): endurance training

4.9 Mobility (measured using mobility scales): multiple component Show forest plot

2

104

Std. Mean Difference (IV, Fixed, 95% CI)

0.94 [0.53, 1.34]

Analysis 4.9

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 9: Mobility (measured using mobility scales): multiple component

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 9: Mobility (measured using mobility scales): multiple component

4.10 Mobility (measured using 6‐Minute Walk Test, metres): multiple component Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.10

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 10: Mobility (measured using 6‐Minute Walk Test, metres): multiple component

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 10: Mobility (measured using 6‐Minute Walk Test, metres): multiple component

4.11 Mobility (measured using mobility scales): other type of exercise (non‐weight bearing exercise) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.11

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 11: Mobility (measured using mobility scales): other type of exercise (non‐weight bearing exercise)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 11: Mobility (measured using mobility scales): other type of exercise (non‐weight bearing exercise)

4.12 Mobility (measured using Timed Up and Go, seconds): other type of exercise OT +/‐ sensor) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.12

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 12: Mobility (measured using Timed Up and Go, seconds): other type of exercise OT +/‐ sensor)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 12: Mobility (measured using Timed Up and Go, seconds): other type of exercise OT +/‐ sensor)

4.13 Mobility (measured using mobility scales) reporting individual outcome measures Show forest plot

14

Mean Difference (IV, Random, 95% CI)

Subtotals only

Analysis 4.13

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 13: Mobility (measured using mobility scales) reporting individual outcome measures

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 13: Mobility (measured using mobility scales) reporting individual outcome measures

4.13.1 Modified Physical Performance Test

1

80

Mean Difference (IV, Random, 95% CI)

5.70 [2.74, 8.66]

4.13.2 Physical Performance and Mobility Examination Score

1

105

Mean Difference (IV, Random, 95% CI)

0.32 [‐0.42, 1.05]

4.13.3 Short Physical Performance Battery

4

552

Mean Difference (IV, Random, 95% CI)

0.68 [0.15, 1.21]

4.13.4 Performance Oriented Mobility Assessment

1

24

Mean Difference (IV, Random, 95% CI)

4.90 [2.11, 7.69]

4.13.5 Timed Up and Go

3

366

Mean Difference (IV, Random, 95% CI)

1.69 [‐2.74, 6.12]

4.13.6 6 Minute Walk Test

4

396

Mean Difference (IV, Random, 95% CI)

33.98 [7.08, 60.89]

4.14 Mobility (measured using self‐report, continuous scales): combined data for all strategy types Show forest plot

2

355

Mean Difference (IV, Fixed, 95% CI)

1.46 [‐0.62, 3.53]

Analysis 4.14

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 14: Mobility (measured using self‐report, continuous scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 14: Mobility (measured using self‐report, continuous scales): combined data for all strategy types

4.15 Mobility (measured using self‐reported, dichotomous outcome): combined data for all strategy types Show forest plot

1

108

Risk Ratio (M‐H, Fixed, 95% CI)

0.45 [0.29, 0.72]

Analysis 4.15

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 15: Mobility (measured using self‐reported, dichotomous outcome): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 15: Mobility (measured using self‐reported, dichotomous outcome): combined data for all strategy types

4.16 Walking speed: combined data for all strategy types Show forest plot

14

1067

Std. Mean Difference (IV, Fixed, 95% CI)

0.16 [0.04, 0.29]

Analysis 4.16

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 16: Walking speed: combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 16: Walking speed: combined data for all strategy types

4.17 Walking speed: gait, balance and function Show forest plot

7

511

Std. Mean Difference (IV, Fixed, 95% CI)

0.08 [‐0.09, 0.25]

Analysis 4.17

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 17: Walking speed: gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 17: Walking speed: gait, balance and function

4.18 Walking speed: resistance/strength training Show forest plot

3

197

Std. Mean Difference (IV, Fixed, 95% CI)

0.29 [‐0.01, 0.58]

Analysis 4.18

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 18: Walking speed: resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 18: Walking speed: resistance/strength training

4.19 Walking speed: endurance Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.19

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 19: Walking speed: endurance

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 19: Walking speed: endurance

4.20 Walking speed: multiple component Show forest plot

3

285

Std. Mean Difference (IV, Random, 95% CI)

0.53 [‐0.13, 1.18]

Analysis 4.20

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 20: Walking speed: multiple component

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 20: Walking speed: multiple component

4.21 Walking speed: other (post‐discharge physio telephone support and coaching) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.21

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 21: Walking speed: other (post‐discharge physio telephone support and coaching)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 21: Walking speed: other (post‐discharge physio telephone support and coaching)

4.22 Walking speed: other (non‐weight bearing) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.22

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 22: Walking speed: other (non‐weight bearing)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 22: Walking speed: other (non‐weight bearing)

4.23 Walking speed subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 4.23

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 23: Walking speed subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 23: Walking speed subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

4.23.1 People with cognitive impairment included

2

304

Std. Mean Difference (IV, Fixed, 95% CI)

0.07 [‐0.16, 0.29]

4.23.2 People with cognitive impairment excluded

12

762

Std. Mean Difference (IV, Fixed, 95% CI)

0.19 [0.04, 0.34]

4.24 Walking speed: subgrouped by outpatient v secondary and social care setting Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 4.24

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 24: Walking speed: subgrouped by outpatient v secondary and social care setting

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 24: Walking speed: subgrouped by outpatient v secondary and social care setting

4.24.1 Outpatient

2

229

Std. Mean Difference (IV, Fixed, 95% CI)

0.35 [0.08, 0.62]

4.24.2 Secondary and social care

12

838

Std. Mean Difference (IV, Fixed, 95% CI)

0.11 [‐0.02, 0.25]

4.25 Walking speed subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 4.25

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 25: Walking speed subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 25: Walking speed subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

4.25.1 Mean age in study 80 years or less

8

536

Std. Mean Difference (IV, Fixed, 95% CI)

0.12 [‐0.05, 0.30]

4.25.2 Mean age in study > 80 years

6

530

Std. Mean Difference (IV, Fixed, 95% CI)

0.18 [0.01, 0.36]

4.26 Functioning (measured using functioning scales): combined data for all strategy types Show forest plot

9

936

Std. Mean Difference (IV, Fixed, 95% CI)

0.23 [0.10, 0.36]

Analysis 4.26

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 26: Functioning (measured using functioning scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 26: Functioning (measured using functioning scales): combined data for all strategy types

4.27 Functioning (measured using functioning scales): gait, balance and function Show forest plot

4

432

Std. Mean Difference (IV, Fixed, 95% CI)

0.17 [‐0.02, 0.36]

Analysis 4.27

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 27: Functioning (measured using functioning scales): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 27: Functioning (measured using functioning scales): gait, balance and function

4.28 Functioning (measured using functioning scales): resistance/strength training Show forest plot

2

246

Std. Mean Difference (IV, Fixed, 95% CI)

0.29 [0.03, 0.55]

Analysis 4.28

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 28: Functioning (measured using functioning scales): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 28: Functioning (measured using functioning scales): resistance/strength training

4.29 Functioning (measured using functioning scales): multiple components Show forest plot

2

107

Std. Mean Difference (IV, Fixed, 95% CI)

0.34 [‐0.04, 0.72]

Analysis 4.29

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 29: Functioning (measured using functioning scales): multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 29: Functioning (measured using functioning scales): multiple components

4.30 Functioning (measured using functioning scales): other: OT +/‐ sensor Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.30

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 30: Functioning (measured using functioning scales): other: OT +/‐ sensor

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 30: Functioning (measured using functioning scales): other: OT +/‐ sensor

4.31 Health‐related quality of life (measured using HRQoL scales): combined data for all strategy types Show forest plot

10

785

Std. Mean Difference (IV, Fixed, 95% CI)

0.14 [‐0.00, 0.29]

Analysis 4.31

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 31: Health‐related quality of life (measured using HRQoL scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 31: Health‐related quality of life (measured using HRQoL scales): combined data for all strategy types

4.32 Health‐related quality of life (measured using HRQoL scales): gait, balance and function Show forest plot

4

316

Std. Mean Difference (IV, Random, 95% CI)

0.08 [‐0.37, 0.53]

Analysis 4.32

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 32: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 32: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

4.33 Health‐related quality of life (measured using HRQoL scales): resistance/strength training Show forest plot

3

197

Std. Mean Difference (IV, Fixed, 95% CI)

0.15 [‐0.14, 0.45]

Analysis 4.33

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 33: Health‐related quality of life (measured using HRQoL scales): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 33: Health‐related quality of life (measured using HRQoL scales): resistance/strength training

4.34 Health‐related quality of life (measured using HRQoL scales): endurance Show forest plot

1

22

Mean Difference (IV, Random, 95% CI)

9.50 [‐8.56, 27.56]

Analysis 4.34

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 34: Health‐related quality of life (measured using HRQoL scales): endurance

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 34: Health‐related quality of life (measured using HRQoL scales): endurance

4.35 Health‐related quality of life (measured using HRQoL scales): multiple components Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.35

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 35: Health‐related quality of life (measured using HRQoL scales): multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 35: Health‐related quality of life (measured using HRQoL scales): multiple components

4.36 Health‐related quality of life subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types Show forest plot

10

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 4.36

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 36: Health‐related quality of life subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 36: Health‐related quality of life subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

4.36.1 People with cognitive impairment included

1

120

Std. Mean Difference (IV, Fixed, 95% CI)

0.00 [‐0.36, 0.36]

4.36.2 People with cognitive impairment excluded

9

665

Std. Mean Difference (IV, Fixed, 95% CI)

0.17 [0.01, 0.33]

4.37 Health‐related quality of life subgrouped by outpatient v secondary and social care setting Show forest plot

10

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 4.37

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 37: Health‐related quality of life subgrouped by outpatient v secondary and social care setting

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 37: Health‐related quality of life subgrouped by outpatient v secondary and social care setting

4.37.1 Outpatient

2

233

Std. Mean Difference (IV, Fixed, 95% CI)

0.18 [‐0.09, 0.45]

4.37.2 Secondary and social care

8

552

Std. Mean Difference (IV, Fixed, 95% CI)

0.13 [‐0.04, 0.30]

4.38 Health‐related quality of life subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategy Show forest plot

10

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 4.38

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 38: Health‐related quality of life subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategy

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 38: Health‐related quality of life subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategy

4.38.1 Mean age in study 80 years or less

4

184

Std. Mean Difference (IV, Fixed, 95% CI)

0.25 [‐0.05, 0.55]

4.38.2 Mean age in study > 80 years

6

601

Std. Mean Difference (IV, Fixed, 95% CI)

0.11 [‐0.05, 0.27]

4.39 Mortality, short term: combined data for all strategy types Show forest plot

7

737

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.49, 2.06]

Analysis 4.39

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 39: Mortality, short term: combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 39: Mortality, short term: combined data for all strategy types

4.40 Mortality, short term: gait, balance and function Show forest plot

3

264

Risk Ratio (M‐H, Fixed, 95% CI)

1.12 [0.46, 2.72]

Analysis 4.40

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 40: Mortality, short term: gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 40: Mortality, short term: gait, balance and function

4.41 Mortality, short term: resistance/strength training Show forest plot

2

123

Risk Ratio (M‐H, Fixed, 95% CI)

1.40 [0.19, 10.03]

Analysis 4.41

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 41: Mortality, short term: resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 41: Mortality, short term: resistance/strength training

4.42 Mortality, short term: multiple components Show forest plot

2

290

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.08, 4.55]

Analysis 4.42

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 42: Mortality, short term: multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 42: Mortality, short term: multiple components

4.43 Mortality, short term: other: non‐weight bearing Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

0.50 [0.03, 7.59]

Analysis 4.43

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 43: Mortality, short term: other: non‐weight bearing

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 43: Mortality, short term: other: non‐weight bearing

4.44 Mortality, long term: combined data for all strategy types Show forest plot

4

588

Risk Ratio (M‐H, Fixed, 95% CI)

0.73 [0.39, 1.37]

Analysis 4.44

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 44: Mortality, long term: combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 44: Mortality, long term: combined data for all strategy types

4.45 Mortality, long term: gait, balance and function Show forest plot

2

254

Risk Ratio (M‐H, Fixed, 95% CI)

0.75 [0.34, 1.67]

Analysis 4.45

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 45: Mortality, long term: gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 45: Mortality, long term: gait, balance and function

4.46 Mortality, long term: multiple components Show forest plot

2

334

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.25, 1.96]

Analysis 4.46

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 46: Mortality, long term: multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 46: Mortality, long term: multiple components

4.47 Adverse events (measured using dichotomous outcomes): combined data for all strategy types Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 4.47

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 47: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 47: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

4.47.1 Re‐admission

2

206

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.52, 1.42]

4.47.2 Re‐operation

1

173

Risk Ratio (M‐H, Fixed, 95% CI)

0.46 [0.20, 1.08]

4.47.3 Surgical complications

1

25

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.06, 13.18]

4.48 Adverse events (measured using re‐admission rate: combined for all strategy types Show forest plot

1

Rate Ratio (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.48

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 48: Adverse events (measured using re‐admission rate: combined for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 48: Adverse events (measured using re‐admission rate: combined for all strategy types

4.49 Adverse events (measured using rate of falls): combined for all strategy types Show forest plot

3

Rate Ratio (IV, Fixed, 95% CI)

0.79 [0.63, 0.99]

Analysis 4.49

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 49: Adverse events (measured using rate of falls): combined for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 49: Adverse events (measured using rate of falls): combined for all strategy types

4.50 Adverse events (measured using rate of falls): gait, balance and function Show forest plot

2

Rate Ratio (IV, Fixed, 95% CI)

0.78 [0.62, 0.99]

Analysis 4.50

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 50: Adverse events (measured using rate of falls): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 50: Adverse events (measured using rate of falls): gait, balance and function

4.51 Adverse events (measured using rate of falls): other (additional phone support and coaching) Show forest plot

1

Rate Ratio (IV, Fixed, 95% CI)

Totals not selected

Analysis 4.51

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 51: Adverse events (measured using rate of falls): other (additional phone support and coaching)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 51: Adverse events (measured using rate of falls): other (additional phone support and coaching)

4.52 Adverse events (measured as number of people who experienced 1 or more falls) Show forest plot

4

Risk Ratio (IV, Fixed, 95% CI)

1.03 [0.85, 1.25]

Analysis 4.52

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 52: Adverse events (measured as number of people who experienced 1 or more falls)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 52: Adverse events (measured as number of people who experienced 1 or more falls)

4.53 Adverse events (measured using continuous measure of pain) Show forest plot

3

242

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.04 [‐0.29, 0.22]

Analysis 4.53

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 53: Adverse events (measured using continuous measure of pain)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 53: Adverse events (measured using continuous measure of pain)

Open in table viewer
Comparison 5. Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

5.1 Walking (measured as use of walking aid/need for assistance) Show forest plot

4

314

Risk Ratio (M‐H, Random, 95% CI)

0.46 [0.16, 1.31]

Analysis 5.1

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 1: Walking (measured as use of walking aid/need for assistance)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 1: Walking (measured as use of walking aid/need for assistance)

5.2 Walking (measured using self‐reported outcomes) Show forest plot

2

182

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.28, 1.06]

Analysis 5.2

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 2: Walking (measured using self‐reported outcomes)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 2: Walking (measured using self‐reported outcomes)

5.3 Balance (measured using functional reach test, cm) Show forest plot

2

144

Mean Difference (IV, Fixed, 95% CI)

1.30 [‐1.70, 4.31]

Analysis 5.3

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 3: Balance (measured using functional reach test, cm)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 3: Balance (measured using functional reach test, cm)

5.4 Balance (measured using timed standing in various positions) Show forest plot

2

234

Std. Mean Difference (IV, Random, 95% CI)

0.24 [‐0.37, 0.86]

Analysis 5.4

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 4: Balance (measured using timed standing in various positions)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 4: Balance (measured using timed standing in various positions)

5.5 Balance (measured using balance scale) Show forest plot

2

212

Std. Mean Difference (IV, Random, 95% CI)

0.28 [‐0.52, 1.08]

Analysis 5.5

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 5: Balance (measured using balance scale)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 5: Balance (measured using balance scale)

5.6 Balance (measured using continuous self‐reported meaure) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 5.6

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 6: Balance (measured using continuous self‐reported meaure)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 6: Balance (measured using continuous self‐reported meaure)

5.7 Balance (measured using dichotomous self‐reported measure) Show forest plot

2

148

Risk Ratio (M‐H, Fixed, 95% CI)

0.82 [0.69, 0.98]

Analysis 5.7

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 7: Balance (measured using dichotomous self‐reported measure)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 7: Balance (measured using dichotomous self‐reported measure)

5.8 Sit to stand (measured as number of stand ups/second) Show forest plot

5

457

Mean Difference (IV, Random, 95% CI)

‐6.49 [‐12.23, ‐0.75]

Analysis 5.8

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 8: Sit to stand (measured as number of stand ups/second)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 8: Sit to stand (measured as number of stand ups/second)

5.9 Strength Show forest plot

14

1121

Std. Mean Difference (IV, Fixed, 95% CI)

0.30 [0.18, 0.42]

Analysis 5.9

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 9: Strength

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 9: Strength

5.10 Strength subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 5.10

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 10: Strength subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 10: Strength subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

5.10.1 People with cognitive impairment included

2

230

Std. Mean Difference (IV, Fixed, 95% CI)

0.07 [‐0.19, 0.33]

5.10.2 People with cognitive impairment excluded

12

891

Std. Mean Difference (IV, Fixed, 95% CI)

0.37 [0.23, 0.50]

5.11 Strength subgrouped by stage of rehabilitation Show forest plot

12

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 5.11

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 11: Strength subgrouped by stage of rehabilitation

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 11: Strength subgrouped by stage of rehabilitation

5.11.1 Outpatient

2

227

Std. Mean Difference (IV, Fixed, 95% CI)

0.67 [0.39, 0.95]

5.11.2 Secondary and social care

12

890

Std. Mean Difference (IV, Fixed, 95% CI)

0.39 [0.25, 0.52]

5.12 Strength subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

Analysis 5.12

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 12: Strength subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 12: Strength subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

5.12.1 Mean age in study 80 years or less

8

464

Std. Mean Difference (IV, Fixed, 95% CI)

0.35 [0.16, 0.54]

5.12.2 Mean age in study > 80 years

6

657

Std. Mean Difference (IV, Fixed, 95% CI)

0.27 [0.11, 0.43]

5.13 Activities of daily living (measured using ADL scales) Show forest plot

6

683

Std. Mean Difference (IV, Random, 95% CI)

‐0.01 [‐0.26, 0.23]

Analysis 5.13

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 13: Activities of daily living (measured using ADL scales)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 13: Activities of daily living (measured using ADL scales)

5.14 Self‐reported measures of lower limb/hip function Show forest plot

2

106

Std. Mean Difference (IV, Random, 95% CI)

0.78 [‐0.20, 1.77]

Analysis 5.14

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 14: Self‐reported measures of lower limb/hip function

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 14: Self‐reported measures of lower limb/hip function

Open in table viewer
Comparison 6. Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

6.1 Resistance/strength training v endurance training (mobility measured using 6‐Minute Walk Test Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 6.1

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Resistance/strength training v endurance training (mobility measured using 6‐Minute Walk Test

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Resistance/strength training v endurance training (mobility measured using 6‐Minute Walk Test

6.2 Resistance/strength training v endurance training (walking speed) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 6.2

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Resistance/strength training v endurance training (walking speed)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Resistance/strength training v endurance training (walking speed)

6.3 Resistance/strength training v endurance training (health‐related quality of life) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 6.3

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Resistance/strength training v endurance training (health‐related quality of life)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Resistance/strength training v endurance training (health‐related quality of life)

6.4 Resistance/strength training v endurance training (strength) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Totals not selected

Analysis 6.4

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Resistance/strength training v endurance training (strength)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Resistance/strength training v endurance training (strength)

6.5 Gait, balance and function v other (muscle contraction in supine) (mobility measured using mobility scale) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 6.5

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Gait, balance and function v other (muscle contraction in supine) (mobility measured using mobility scale)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Gait, balance and function v other (muscle contraction in supine) (mobility measured using mobility scale)

6.6 Gait, balance and function v other (muscle contraction in supine) (walking speed) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 6.6

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 6: Gait, balance and function v other (muscle contraction in supine) (walking speed)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 6: Gait, balance and function v other (muscle contraction in supine) (walking speed)

6.7 Gait, balance and function v other (muscle contraction in supine) (mortality) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 6.7

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 7: Gait, balance and function v other (muscle contraction in supine) (mortality)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 7: Gait, balance and function v other (muscle contraction in supine) (mortality)

6.8 Gait, balance and function v other (muscle contraction in supine) (Adverse events: pain) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 6.8

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 8: Gait, balance and function v other (muscle contraction in supine) (Adverse events: pain)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 8: Gait, balance and function v other (muscle contraction in supine) (Adverse events: pain)

6.8.1 Pain from fracture

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.8.2 Pain during exercise

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.9 Gait, balance and function v other (muscle contraction in supine) (Adverse events: number of people who fell) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 6.9

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 9: Gait, balance and function v other (muscle contraction in supine) (Adverse events: number of people who fell)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 9: Gait, balance and function v other (muscle contraction in supine) (Adverse events: number of people who fell)

6.10 Gait, balance and function v other (muscle contraction in supine) (Balance, observed) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 6.10

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 10: Gait, balance and function v other (muscle contraction in supine) (Balance, observed)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 10: Gait, balance and function v other (muscle contraction in supine) (Balance, observed)

6.11 Gait, balance and function v other (muscle contraction in supine) (Balance, self‐reported) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Analysis 6.11

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 11: Gait, balance and function v other (muscle contraction in supine) (Balance, self‐reported)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 11: Gait, balance and function v other (muscle contraction in supine) (Balance, self‐reported)

6.12 Gait, balance and function v other (muscle contraction in supine) (strength) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 6.12

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 12: Gait, balance and function v other (muscle contraction in supine) (strength)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 12: Gait, balance and function v other (muscle contraction in supine) (strength)

Study flow diagram

Figuras y tablas -
Figure 1

Study flow diagram

Risk of bias summary: review authors' judgements about each risk of bias domain for each included studyNote: a 'Yes' (+) judgement means that review authors considered there was a low risk of bias associated with the item, whereas a 'No' (‐) means that there was a high risk of bias. Assessments that resulted in an 'Unclear' (?) verdict often reflected a lack of information upon which to judge the domain. However, lack of information on blinding for mobility outcomes was always taken to imply that there was no blinding and rated as a 'No'; similarly for unblinded staff/self‐reported outcomes (health‐related quality of life, pain, falls, patient‐reported questionnaires and satisfaction), lack of information on blinding of researchers was rated as 'No', data collated by blinded researchers was rated 'Unclear'. An empty square (no judgement) indicates the domain was not applicable to that study.

Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias domain for each included study

Note: a 'Yes' (+) judgement means that review authors considered there was a low risk of bias associated with the item, whereas a 'No' (‐) means that there was a high risk of bias. Assessments that resulted in an 'Unclear' (?) verdict often reflected a lack of information upon which to judge the domain. However, lack of information on blinding for mobility outcomes was always taken to imply that there was no blinding and rated as a 'No'; similarly for unblinded staff/self‐reported outcomes (health‐related quality of life, pain, falls, patient‐reported questionnaires and satisfaction), lack of information on blinding of researchers was rated as 'No', data collated by blinded researchers was rated 'Unclear'. An empty square (no judgement) indicates the domain was not applicable to that study.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies

Figuras y tablas -
Figure 3

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies

Funnel plot of comparison 4: post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes. Outcome 4.16: walking speed: combined data for all strategy types

Figuras y tablas -
Figure 4

Funnel plot of comparison 4: post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes. Outcome 4.16: walking speed: combined data for all strategy types

Funnel plot of comparison 4: post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes. Outcome 4.31: health‐related quality of life (measured using HRQoL scales): combined data for all strategy types

Figuras y tablas -
Figure 5

Funnel plot of comparison 4: post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes. Outcome 4.31: health‐related quality of life (measured using HRQoL scales): combined data for all strategy types

Funnel plot of comparison 5: post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes. Outcome: 5.9 strength

Figuras y tablas -
Figure 6

Funnel plot of comparison 5: post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes. Outcome: 5.9 strength

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

Figuras y tablas -
Analysis 1.1

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 2: Mobility (failure to regain pre‐facture mobility): combined data for all strategy types

Figuras y tablas -
Analysis 1.2

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 2: Mobility (failure to regain pre‐facture mobility): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 3: Mobility (measured using self‐reported outcomes): combined data for all strategy types

Figuras y tablas -
Analysis 1.3

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 3: Mobility (measured using self‐reported outcomes): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

Figuras y tablas -
Analysis 1.4

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 5: Mobility (measured using mobility scales): resistance/strength training

Figuras y tablas -
Analysis 1.5

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 5: Mobility (measured using mobility scales): resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 6: Mobility (measured in seconds using TUG): resistance/strength training

Figuras y tablas -
Analysis 1.6

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 6: Mobility (measured in seconds using TUG): resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 7: Mobility (measured using mobility scales) reporting individual outcome measures

Figuras y tablas -
Analysis 1.7

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 7: Mobility (measured using mobility scales) reporting individual outcome measures

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 8: Walking speed (measured as metres/time): combined data for all strategy types

Figuras y tablas -
Analysis 1.8

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 8: Walking speed (measured as metres/time): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 9: Walking speed (measured as metres/time): gait, balance and function

Figuras y tablas -
Analysis 1.9

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 9: Walking speed (measured as metres/time): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 10: Walking speed (measured as metres/time): electrical stimulation

Figuras y tablas -
Analysis 1.10

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 10: Walking speed (measured as metres/time): electrical stimulation

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 11: Functioning (measured using functioning scales): combined data for all strategy types

Figuras y tablas -
Analysis 1.11

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 11: Functioning (measured using functioning scales): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 12: Functioning (measured using functioning scales): gait, balance and function

Figuras y tablas -
Analysis 1.12

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 12: Functioning (measured using functioning scales): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 13: Functioning (measured using functioning scales): resistance/strength training

Figuras y tablas -
Analysis 1.13

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 13: Functioning (measured using functioning scales): resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 14: Functioning (measured using functioning scales): electrical stimulation

Figuras y tablas -
Analysis 1.14

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 14: Functioning (measured using functioning scales): electrical stimulation

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 15: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

Figuras y tablas -
Analysis 1.15

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 15: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 16: Mortality, short term: combined data for all strategy types

Figuras y tablas -
Analysis 1.16

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 16: Mortality, short term: combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 17: Mortality, short term: gait, balance and function

Figuras y tablas -
Analysis 1.17

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 17: Mortality, short term: gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 18: Mortality, short term: resistance/strength training

Figuras y tablas -
Analysis 1.18

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 18: Mortality, short term: resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 19: Mortality, short term: electrical stimulation

Figuras y tablas -
Analysis 1.19

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 19: Mortality, short term: electrical stimulation

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 20: Mortality, long term: combined data for all strategy types

Figuras y tablas -
Analysis 1.20

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 20: Mortality, long term: combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 21: Mortality, long term: gait, balance and function

Figuras y tablas -
Analysis 1.21

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 21: Mortality, long term: gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 22: Mortality, long term: resistance/strength training

Figuras y tablas -
Analysis 1.22

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 22: Mortality, long term: resistance/strength training

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 23: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

Figuras y tablas -
Analysis 1.23

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 23: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 24: Adverse events (measured using rate of falls): all studies were gait, balance and function

Figuras y tablas -
Analysis 1.24

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 24: Adverse events (measured using rate of falls): all studies were gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 25: Adverse events (measured using continuous measures of pain): combined data for all strategy types

Figuras y tablas -
Analysis 1.25

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 25: Adverse events (measured using continuous measures of pain): combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 26: Return to living at pre‐fracture residence: combined data for all strategy types

Figuras y tablas -
Analysis 1.26

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 26: Return to living at pre‐fracture residence: combined data for all strategy types

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 27: Return to living at pre‐fracture residence: additional study not included in main analysis

Figuras y tablas -
Analysis 1.27

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 27: Return to living at pre‐fracture residence: additional study not included in main analysis

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 28: Return to living at pre‐fracture residence: gait, balance and function

Figuras y tablas -
Analysis 1.28

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 28: Return to living at pre‐fracture residence: gait, balance and function

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 29: Return to living at pre‐fracture residence: resistance/strength training

Figuras y tablas -
Analysis 1.29

Comparison 1: In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes, Outcome 29: Return to living at pre‐fracture residence: resistance/strength training

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 1: Walking, use of walking aid/need for assistance

Figuras y tablas -
Analysis 2.1

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 1: Walking, use of walking aid/need for assistance

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 2: Balance (measured using functional reach test, cm)

Figuras y tablas -
Analysis 2.2

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 2: Balance (measured using functional reach test, cm)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 3: Balance (measured using balance scale)

Figuras y tablas -
Analysis 2.3

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 3: Balance (measured using balance scale)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 4: Balance (measured using ability to tandem stand)

Figuras y tablas -
Analysis 2.4

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 4: Balance (measured using ability to tandem stand)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 5: Balance (measured using step test; number of steps)

Figuras y tablas -
Analysis 2.5

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 5: Balance (measured using step test; number of steps)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 6: Balance (measured using self‐reported outcomes)

Figuras y tablas -
Analysis 2.6

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 6: Balance (measured using self‐reported outcomes)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 7: Sit to stand (measured as number of stand ups/second)

Figuras y tablas -
Analysis 2.7

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 7: Sit to stand (measured as number of stand ups/second)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 8: Strength

Figuras y tablas -
Analysis 2.8

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 8: Strength

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 9: Activities of daily living (measured using ADL scales)

Figuras y tablas -
Analysis 2.9

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 9: Activities of daily living (measured using ADL scales)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 10: Resource use (measured by length of hospital stay)

Figuras y tablas -
Analysis 2.10

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 10: Resource use (measured by length of hospital stay)

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 11: Resource use (measured by use of community services)

Figuras y tablas -
Analysis 2.11

Comparison 2: In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes, Outcome 11: Resource use (measured by use of community services)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (mortality)

Figuras y tablas -
Analysis 3.1

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (mortality)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (mortality)

Figuras y tablas -
Analysis 3.2

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (mortality)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (adverse events)

Figuras y tablas -
Analysis 3.3

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (adverse events)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (return to living at home)

Figuras y tablas -
Analysis 3.4

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (return to living at home)

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (walking aid/assistance)

Figuras y tablas -
Analysis 3.5

Comparison 3: In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (walking aid/assistance)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

Figuras y tablas -
Analysis 4.1

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 1: Mobility (measured using mobility scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 2: Mobility (measured using Timed Up and Go, seconds): combined data for all strategy types

Figuras y tablas -
Analysis 4.2

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 2: Mobility (measured using Timed Up and Go, seconds): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 3: Mobility (measured using 6‐Minute Walk Test, metres): combined data for all strategy types

Figuras y tablas -
Analysis 4.3

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 3: Mobility (measured using 6‐Minute Walk Test, metres): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

Figuras y tablas -
Analysis 4.4

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 4: Mobility (measured using mobility scales): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 5: Mobility (measured using Timed Up and Go, seconds): gait, balance and function

Figuras y tablas -
Analysis 4.5

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 5: Mobility (measured using Timed Up and Go, seconds): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 6: Mobility (measured using Timed Up and Go, seconds): resistance/strength training

Figuras y tablas -
Analysis 4.6

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 6: Mobility (measured using Timed Up and Go, seconds): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 7: Mobility (measured using 6‐Minute Walk Test, metres): resistance/strength training

Figuras y tablas -
Analysis 4.7

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 7: Mobility (measured using 6‐Minute Walk Test, metres): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 8: Mobility (measured using 6‐Minute Walk Test, metres): endurance training

Figuras y tablas -
Analysis 4.8

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 8: Mobility (measured using 6‐Minute Walk Test, metres): endurance training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 9: Mobility (measured using mobility scales): multiple component

Figuras y tablas -
Analysis 4.9

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 9: Mobility (measured using mobility scales): multiple component

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 10: Mobility (measured using 6‐Minute Walk Test, metres): multiple component

Figuras y tablas -
Analysis 4.10

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 10: Mobility (measured using 6‐Minute Walk Test, metres): multiple component

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 11: Mobility (measured using mobility scales): other type of exercise (non‐weight bearing exercise)

Figuras y tablas -
Analysis 4.11

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 11: Mobility (measured using mobility scales): other type of exercise (non‐weight bearing exercise)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 12: Mobility (measured using Timed Up and Go, seconds): other type of exercise OT +/‐ sensor)

Figuras y tablas -
Analysis 4.12

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 12: Mobility (measured using Timed Up and Go, seconds): other type of exercise OT +/‐ sensor)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 13: Mobility (measured using mobility scales) reporting individual outcome measures

Figuras y tablas -
Analysis 4.13

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 13: Mobility (measured using mobility scales) reporting individual outcome measures

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 14: Mobility (measured using self‐report, continuous scales): combined data for all strategy types

Figuras y tablas -
Analysis 4.14

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 14: Mobility (measured using self‐report, continuous scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 15: Mobility (measured using self‐reported, dichotomous outcome): combined data for all strategy types

Figuras y tablas -
Analysis 4.15

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 15: Mobility (measured using self‐reported, dichotomous outcome): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 16: Walking speed: combined data for all strategy types

Figuras y tablas -
Analysis 4.16

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 16: Walking speed: combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 17: Walking speed: gait, balance and function

Figuras y tablas -
Analysis 4.17

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 17: Walking speed: gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 18: Walking speed: resistance/strength training

Figuras y tablas -
Analysis 4.18

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 18: Walking speed: resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 19: Walking speed: endurance

Figuras y tablas -
Analysis 4.19

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 19: Walking speed: endurance

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 20: Walking speed: multiple component

Figuras y tablas -
Analysis 4.20

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 20: Walking speed: multiple component

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 21: Walking speed: other (post‐discharge physio telephone support and coaching)

Figuras y tablas -
Analysis 4.21

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 21: Walking speed: other (post‐discharge physio telephone support and coaching)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 22: Walking speed: other (non‐weight bearing)

Figuras y tablas -
Analysis 4.22

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 22: Walking speed: other (non‐weight bearing)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 23: Walking speed subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Figuras y tablas -
Analysis 4.23

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 23: Walking speed subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 24: Walking speed: subgrouped by outpatient v secondary and social care setting

Figuras y tablas -
Analysis 4.24

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 24: Walking speed: subgrouped by outpatient v secondary and social care setting

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 25: Walking speed subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

Figuras y tablas -
Analysis 4.25

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 25: Walking speed subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 26: Functioning (measured using functioning scales): combined data for all strategy types

Figuras y tablas -
Analysis 4.26

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 26: Functioning (measured using functioning scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 27: Functioning (measured using functioning scales): gait, balance and function

Figuras y tablas -
Analysis 4.27

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 27: Functioning (measured using functioning scales): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 28: Functioning (measured using functioning scales): resistance/strength training

Figuras y tablas -
Analysis 4.28

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 28: Functioning (measured using functioning scales): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 29: Functioning (measured using functioning scales): multiple components

Figuras y tablas -
Analysis 4.29

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 29: Functioning (measured using functioning scales): multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 30: Functioning (measured using functioning scales): other: OT +/‐ sensor

Figuras y tablas -
Analysis 4.30

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 30: Functioning (measured using functioning scales): other: OT +/‐ sensor

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 31: Health‐related quality of life (measured using HRQoL scales): combined data for all strategy types

Figuras y tablas -
Analysis 4.31

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 31: Health‐related quality of life (measured using HRQoL scales): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 32: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

Figuras y tablas -
Analysis 4.32

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 32: Health‐related quality of life (measured using HRQoL scales): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 33: Health‐related quality of life (measured using HRQoL scales): resistance/strength training

Figuras y tablas -
Analysis 4.33

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 33: Health‐related quality of life (measured using HRQoL scales): resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 34: Health‐related quality of life (measured using HRQoL scales): endurance

Figuras y tablas -
Analysis 4.34

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 34: Health‐related quality of life (measured using HRQoL scales): endurance

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 35: Health‐related quality of life (measured using HRQoL scales): multiple components

Figuras y tablas -
Analysis 4.35

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 35: Health‐related quality of life (measured using HRQoL scales): multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 36: Health‐related quality of life subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Figuras y tablas -
Analysis 4.36

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 36: Health‐related quality of life subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 37: Health‐related quality of life subgrouped by outpatient v secondary and social care setting

Figuras y tablas -
Analysis 4.37

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 37: Health‐related quality of life subgrouped by outpatient v secondary and social care setting

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 38: Health‐related quality of life subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategy

Figuras y tablas -
Analysis 4.38

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 38: Health‐related quality of life subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategy

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 39: Mortality, short term: combined data for all strategy types

Figuras y tablas -
Analysis 4.39

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 39: Mortality, short term: combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 40: Mortality, short term: gait, balance and function

Figuras y tablas -
Analysis 4.40

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 40: Mortality, short term: gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 41: Mortality, short term: resistance/strength training

Figuras y tablas -
Analysis 4.41

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 41: Mortality, short term: resistance/strength training

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 42: Mortality, short term: multiple components

Figuras y tablas -
Analysis 4.42

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 42: Mortality, short term: multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 43: Mortality, short term: other: non‐weight bearing

Figuras y tablas -
Analysis 4.43

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 43: Mortality, short term: other: non‐weight bearing

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 44: Mortality, long term: combined data for all strategy types

Figuras y tablas -
Analysis 4.44

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 44: Mortality, long term: combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 45: Mortality, long term: gait, balance and function

Figuras y tablas -
Analysis 4.45

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 45: Mortality, long term: gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 46: Mortality, long term: multiple components

Figuras y tablas -
Analysis 4.46

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 46: Mortality, long term: multiple components

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 47: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

Figuras y tablas -
Analysis 4.47

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 47: Adverse events (measured using dichotomous outcomes): combined data for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 48: Adverse events (measured using re‐admission rate: combined for all strategy types

Figuras y tablas -
Analysis 4.48

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 48: Adverse events (measured using re‐admission rate: combined for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 49: Adverse events (measured using rate of falls): combined for all strategy types

Figuras y tablas -
Analysis 4.49

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 49: Adverse events (measured using rate of falls): combined for all strategy types

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 50: Adverse events (measured using rate of falls): gait, balance and function

Figuras y tablas -
Analysis 4.50

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 50: Adverse events (measured using rate of falls): gait, balance and function

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 51: Adverse events (measured using rate of falls): other (additional phone support and coaching)

Figuras y tablas -
Analysis 4.51

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 51: Adverse events (measured using rate of falls): other (additional phone support and coaching)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 52: Adverse events (measured as number of people who experienced 1 or more falls)

Figuras y tablas -
Analysis 4.52

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 52: Adverse events (measured as number of people who experienced 1 or more falls)

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 53: Adverse events (measured using continuous measure of pain)

Figuras y tablas -
Analysis 4.53

Comparison 4: Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes, Outcome 53: Adverse events (measured using continuous measure of pain)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 1: Walking (measured as use of walking aid/need for assistance)

Figuras y tablas -
Analysis 5.1

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 1: Walking (measured as use of walking aid/need for assistance)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 2: Walking (measured using self‐reported outcomes)

Figuras y tablas -
Analysis 5.2

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 2: Walking (measured using self‐reported outcomes)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 3: Balance (measured using functional reach test, cm)

Figuras y tablas -
Analysis 5.3

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 3: Balance (measured using functional reach test, cm)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 4: Balance (measured using timed standing in various positions)

Figuras y tablas -
Analysis 5.4

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 4: Balance (measured using timed standing in various positions)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 5: Balance (measured using balance scale)

Figuras y tablas -
Analysis 5.5

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 5: Balance (measured using balance scale)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 6: Balance (measured using continuous self‐reported meaure)

Figuras y tablas -
Analysis 5.6

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 6: Balance (measured using continuous self‐reported meaure)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 7: Balance (measured using dichotomous self‐reported measure)

Figuras y tablas -
Analysis 5.7

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 7: Balance (measured using dichotomous self‐reported measure)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 8: Sit to stand (measured as number of stand ups/second)

Figuras y tablas -
Analysis 5.8

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 8: Sit to stand (measured as number of stand ups/second)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 9: Strength

Figuras y tablas -
Analysis 5.9

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 9: Strength

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 10: Strength subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Figuras y tablas -
Analysis 5.10

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 10: Strength subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 11: Strength subgrouped by stage of rehabilitation

Figuras y tablas -
Analysis 5.11

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 11: Strength subgrouped by stage of rehabilitation

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 12: Strength subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

Figuras y tablas -
Analysis 5.12

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 12: Strength subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 13: Activities of daily living (measured using ADL scales)

Figuras y tablas -
Analysis 5.13

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 13: Activities of daily living (measured using ADL scales)

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 14: Self‐reported measures of lower limb/hip function

Figuras y tablas -
Analysis 5.14

Comparison 5: Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes, Outcome 14: Self‐reported measures of lower limb/hip function

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Resistance/strength training v endurance training (mobility measured using 6‐Minute Walk Test

Figuras y tablas -
Analysis 6.1

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 1: Resistance/strength training v endurance training (mobility measured using 6‐Minute Walk Test

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Resistance/strength training v endurance training (walking speed)

Figuras y tablas -
Analysis 6.2

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 2: Resistance/strength training v endurance training (walking speed)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Resistance/strength training v endurance training (health‐related quality of life)

Figuras y tablas -
Analysis 6.3

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 3: Resistance/strength training v endurance training (health‐related quality of life)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Resistance/strength training v endurance training (strength)

Figuras y tablas -
Analysis 6.4

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 4: Resistance/strength training v endurance training (strength)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Gait, balance and function v other (muscle contraction in supine) (mobility measured using mobility scale)

Figuras y tablas -
Analysis 6.5

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 5: Gait, balance and function v other (muscle contraction in supine) (mobility measured using mobility scale)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 6: Gait, balance and function v other (muscle contraction in supine) (walking speed)

Figuras y tablas -
Analysis 6.6

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 6: Gait, balance and function v other (muscle contraction in supine) (walking speed)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 7: Gait, balance and function v other (muscle contraction in supine) (mortality)

Figuras y tablas -
Analysis 6.7

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 7: Gait, balance and function v other (muscle contraction in supine) (mortality)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 8: Gait, balance and function v other (muscle contraction in supine) (Adverse events: pain)

Figuras y tablas -
Analysis 6.8

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 8: Gait, balance and function v other (muscle contraction in supine) (Adverse events: pain)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 9: Gait, balance and function v other (muscle contraction in supine) (Adverse events: number of people who fell)

Figuras y tablas -
Analysis 6.9

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 9: Gait, balance and function v other (muscle contraction in supine) (Adverse events: number of people who fell)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 10: Gait, balance and function v other (muscle contraction in supine) (Balance, observed)

Figuras y tablas -
Analysis 6.10

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 10: Gait, balance and function v other (muscle contraction in supine) (Balance, observed)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 11: Gait, balance and function v other (muscle contraction in supine) (Balance, self‐reported)

Figuras y tablas -
Analysis 6.11

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 11: Gait, balance and function v other (muscle contraction in supine) (Balance, self‐reported)

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 12: Gait, balance and function v other (muscle contraction in supine) (strength)

Figuras y tablas -
Analysis 6.12

Comparison 6: Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes, Outcome 12: Gait, balance and function v other (muscle contraction in supine) (strength)

Summary of findings 1. Summary of findings: in‐hospital studies

Mobility strategies compared with control (e.g. usual care) after hip fracture surgery in the in‐hospital setting

Patient or population: adults following hip fracture surgery

Settings: in‐hospital

Intervention: mobility strategiesa

Comparison: usual in‐hospital careb

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Controlc

Intervention

Mobilityd ‐ overall analysis 

 

Using different mobility scales: MILA (range 0 to 36), EMS (range 0 to 20), BBS (range 0 to 56), PPME (range 0 to 12), Koval (range 1 to 7). Higher values indicate better mobility (except MILA and Koval, where scale was inverted for consistency with other measures).

 

Follow‐up: range 5 days to 4 months

In the control group, the mean scores for the outcomes were: MILA = 19.2; EMS = 16.3 to 17; BBS = 26; PPME = 6.8 to 9.1; Koval = 4.

SMD 0.53 higher (0.10 higher to 0.96 higher) 

 

 

SMD 0.53 (0.10 to 0.96)

507 (7)

⊕⊕⊝⊝
Lowe

Re‐expressing the results using the 12‐point PPME, the intervention group scored 1.46 points higher (95% CI 0.28 to 2.64). MID for the PPME is typically 1.13 to 2.15 (de Morton 2008).

 

Based on Cohen’s effect sizesf, mobility strategies may cause a moderate increase in mobility compared with control (SMD 0.53).

 

Types of intervention in included trials: gait, balance and functional exercise: 6 studies; resistance exercise: 1 study

 

Walking speedg ‐ overall analysis

 

Measured using metres/second (m/s) and metres/minute (m/min). A higher score indicates faster walking.

 

Follow‐up: range 2 weeks to 4 months

The mean walking speed score in the control group ranged from 0.19 m/s to 0.72 m/s, and was 24.4 m/min.

SMD 0.16 higher (0.05 lower to 0.37 higher)

SMD 0.16 (‐0.05 to 0.37)

360 (6)

⊕⊕⊕⊝

Moderateh

Overall, there is moderate‐certainty evidence of a small increase in walking (based on Cohen's effect sizes) compared with control (SMD 0.16); however, the confidence interval includes both slower and faster walking.

 

Re‐expressing the results using gait speed (m/s) showed an increase of 0.04 m/s in the intervention group (MD 0.04, 95% CI ‐0.01 to 0.08). Small meaningful change for gait speed is 0.04 m/s to 0.06 m/s (Perera 2006).

 

Types of intervention in included trials: gait, balance and functional exercise: 5 studies; electrical stimulation: 1 study

Functioningi ‐ overall analysis

 

Using different scales: mBI (range 0 to 20), BI (range 0 to 100), FIM (range 18 to 126), NEADL (range 0 to 66). A higher score indicates better functioning.

 

Follow‐up: range 3 weeks to 4 months

In the control group, the mean scores for the outcomes were: mBI: 18; BI: 95; FIM: 69 to 81; NEADL 33.4

SMD 0.75 higher (0.24 higher to 1.26 higher)

SMD 0.75

(0.24 to 1.26)

 

 

 

379 (7)

⊕⊝⊝⊝
Verylowj

We are uncertain whether mobility strategies improve functioning as the certainty of the evidence is very low.

 

Re‐expressing the results using the BI, the intervention group scored 4.4 points higher (95% CI

1.4 to 7.38). MID for the BI (post‐ hip surgery) is typically 9.8 (Unnanuntana 2018).

 

Types of intervention in included trials: gait, balance and functional exercise: 5 studies; resistance exercise: 1 study.

HRQoL

 

Using EQ‐5D (range 0 to 1) and HOOS (range 0 to 100). A higher score indicates better quality of life.

 

Follow‐up: range 10 weeks to 6 months

In the control group, the mean scores for the outcomes were: EQ‐5D (range 0.54 to 0.62), HOOS 50.37

SMD 0.26 higher (0.07 lower to 0.85 higher)

SMD 0.39 (‐0.07, 0.85)

 

 

314 (4)

⊕⊝⊝⊝
Verylowk

 

We are uncertain whether mobility strategies improve HRQoL as the certainty of the evidence is very low.

 

We calculated SMD for 3 trials with EQ‐5D and 1 trial with HOOS.

 

Re‐expressing the results using the EQ‐5D (0 to 1 scale), there was an increase in quality of life of 0.03 in the intervention group (95% CI ‐0.02 to 0.22). MID for the EQ‐5D is typically 0.074 (Walters 2005).

 

Types of intervention in included trials: gait, balance and functional exercise: 4 studies.

 

Mortality

 

Follow‐up: short‐term range 10 days to 6 months; long‐term = 12 months

Short term: 45 per 1000

 

 

 

 

Short term: 48 per 1000 (22 to 104)

 

 

 

Short term:

RR 1.06 (0.48 to 2.30)

 

 

Short term: 489 (6)

 

 

 

⊕⊕⊝⊝
Lowm

It is unclear whether mobility strategies reduce mortality as the certainty of evidence is low and the 95% CI includes both a reduction and an increase in the risk of mortality, in both the short term and the long term.

 

Types of intervention in included trials: gait, balance and functional exercise: 4 studies; resistance exercise: 3 studies; electrical stimulation: 1 study.

Long term:

116 per 1000l

Long term: 142 per 1000 (56 to 362)

Long term:

RR 1.22 (0.48 to 3.12)

Long term:

133 (2)

⊕⊕⊝⊝
Lowm

Adverse event: number of people who were re‐admitted

 

Follow‐up: range 5 days to 4 months

229 per 1000k

160 (36 to 254)

RR 0.70 (0.44 to 1.11)

322 (4)

⊕⊕⊝⊝
Lown

It is unclear whether mobility strategies reduce re‐admission compared with usual care, as the CI includes both a reduction and an increase in the risk of re‐admission.

 

Types of intervention in included trials: gait, balance and functional exercise: 3 studies; resistance exercise: 1 study

Number of people who returned to living at pre‐fracture residence

 

Follow‐up: range 10 days to 4 months

705 per 1000k

754 per 1000 (452 to 1099)

RR 1.07 (0.73 to 1.56)

240 (2)

⊕⊕⊝⊝
Lowo

 

It is unclear whether mobility strategies increase the odds of returning to living at the pre‐fracture residence: there is low‐certainty evidence and the CI includes both a reduction and an increase in the risk of re‐admission.

 

Types of intervention in included trials: gait, balance and functional exercise: 1 study; resistance exercise: 1 study.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
BBS: Berg Balance Scale; BI: Barthel Index; CI: confidence interval; EMS: Elderly Mobility Scale; EQ‐5D: EuroQoL‐5 dimension questionnaire; FIM: Functional Independence Measure; HRQoL: health‐related quality of life; HOOS: Hip Disability and Osteoarthritis Outcome Score; HRQoL: health‐related quality of life; Koval: Koval Walking Ability Score; mBI: modified Barthel Index; MD: mean difference; MID: minimal important difference; MILA: Modified Iowa Level of Assistance; NEADL: Nottingham Extended Activities of Daily Living; PPME: Physical Performance and Mobility Examination; RR: risk ratio; SMD: standardised mean difference

GRADE Working Group grades of evidence

High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.

Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.

Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

aMobility strategies may include exercises, physical training and muscle stimulation, used at various stages in rehabilitation, which aim to improve walking and minimise functional impairments.
bA control intervention may be: usual orthopaedic, medical care or allied health care.
cThe all‐studies population risk was based on the number of events and the number of participants in the control groups of studies included in this review reporting this outcome. 
dMobility, measuring the ability of a person to move. Scales may measure a number of aspects of mobility (e.g. sit to stand, walking, turning, stairs).eDowngraded by one level due to risk of bias (removing studies with high risk of bias in one or more items had a marked impact on results, with the confidence intervals (CIs) crossing zero). Downgraded one level for imprecision, with wide CI. Not downgraded for inconsistency; the substantial heterogeneity (I2 = 84%) is explained by inclusion of Monticone 2018 and the large between‐group difference in the volume and intensity of functional exercise undertaken, compared with other studies. Removing Monticone 2018 reduced I2 to 44%, and it changed the effect size from SMD 0.53 (95% CI 0.10 to 0.96) to SMD 0.29 (95% CI 0.03 to 0.55).
fCohen's effect size 0.2 is described as small, 0.5 as medium/moderate effect, 0.8 as large effect (Sawilowsky 2009).
gWalking speed, measured using distance/time.
hNot downgraded due to risk of bias (as removing studies with high risk of bias in one or more items had no impact on results, with similar point estimate and CIs). Downgraded due to imprecision, with CI crossing zero.
iFunctioning, using functioning scales.
jDowngraded by one level due to risk of bias (removing studies with high risk of bias in one or more items had a marked impact on results), downgraded one level due to substantial heterogeneity (I2 = 81%), and downgraded one level due to imprecision (n = 315).
kDowngraded by one level due to risk of bias (removing the studies with high risk of bias in one or more items had a marked impact on results), one level for imprecision (small number of trials and participants, wide CI) and one level due to substantial heterogeneity (I2 = 71%).
lOur illustrative risks for dichotomous outcomes were based on the proportion calculated from the number of people who experienced the event divided by the number of people in the group, for the control group in those trials included in the analysis for that outcome.
mWe downgraded both the short‐term and long‐term analyses by one level due to risk of bias (removing studies with high risk of bias in one or more items had a marked impact on results) and one level for imprecision (few events and wide CI).
nDowngraded one level for imprecision (few events and wide CI) and one level because a large number of studies included in the review did not contribute to this adverse event outcome.
oDowngraded one level for imprecision (few events and wide CI) and one level because a large number of studies included in the review did not contribute to the outcome.

Figuras y tablas -
Summary of findings 1. Summary of findings: in‐hospital studies
Summary of findings 2. Summary of findings: different types of intervention on mobility outcome, in‐hospital

Different types of mobility strategies compared with control after hip fracture surgery, on mobility, in the in‐hospital setting

Patient or population: adults following hip fracture surgery

Settings: in‐hospital

Comparison: usual in‐hospital carea

Outcome: mobility, measured using mobility scales, 6‐Minute Walk Test and Timed Up and Go testb

Intervention type (according to ProFaNE)c

Mobility outcome

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Intervention

Gait, balance and functional training

 

 

Follow‐up: range 5 days to 4 months

Mobility scales, using different mobility scales: MILA (range 0 to 36), EMS (range 0 to 20), BBS (range 0 to 56), PPME (range 0 to 12), Koval (range 1 to 7). Higher values indicate better mobility (except MILA and Koval, where scale was inverted for consistency with other outcomes).

In the control group, the mean scores for the outcomes were: MILA = 19.2; EMS = 16.3; BBS = 26; PPME = 6.8 to 9.1; Koval = 4.

SMD 0.57 higher (0.07 higher to 1.06 higher).

SMD 0.57 (0.07 to 1.06)

 

 

463 (6)

⊕⊕⊕⊝
Moderated

Interventions classified as gait, balance and functional training probably cause a moderatee increase in mobility compared with control (SMD 0.57).

 

Re‐expressing the results using the 12‐point PPME, the intervention group scored 1.56 points higher (95% CI 0.02 to 2.92). MID for the PPME is typically 1.13 to 2.15 (de Morton 2008).

Resistance/strength training

 

Follow‐up: range 10 days to 4 months

Mobility scales, using EMS (range 0 to 20). Higher values indicate better mobility

The meanf score on the EMS in the control group was 17.

MD 1 point higher on the EMS (0.81 lower to 2.81 higher).

MD 1.0 (‐0.81 to 2.81)

44 (1)

⊕⊕⊝⊝
Lowg

It is unclear whether resistance/strength training interventions increase mobility as the certainty of evidence is low and the 95% CI includes both a reduction and an increase in mobility.

 

TUG (lower score = faster)

The mean TUG time in the control group was 25.4 seconds.

MD 1.5 second faster TUG time (6.4 seconds faster to 3.4 seconds slower)

MD ‐1.5 (‐6.4 to 3.4)

74 (1)

⊕⊕⊝⊝
Lowh

It is unclear whether resistance/strength training interventions improve TUG as the certainty of evidence is low and the 95% CI includes both a reduction and an increase in score.

Flexibility

 

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being flexibility.

3D (Tai Chi, dance)

 

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being 3D.

General physical activity

 

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being general physical activity.

Endurance

 

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being endurance training.

Multiple types of exercise

 

 

 

 

0

 

0 studies contained a mobility strategy categorised as containing multiple types of exercise.

Electrical stimulation

 

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being electrical stimulation.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
BBS: Berg Balance Scale; CI: confidence interval; EMS: Elderly Mobility Scale; Koval: Koval Walking Ability Score; MD: mean difference; MID: minimally important difference; MILA: Modified Iowa Level of Assistance; PPME: Physical Performance and Mobility Examination; SMD: standardised mean difference; TUG: Timed Up and Go test

GRADE Working Group grades of evidence

High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.

Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.

Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

aA control intervention may be: usual orthopaedic, medical care or allied health care.
bMobility, measuring the ability of a person to move. Scales may measure a number of aspects of mobility (e.g. sit to stand, walking, turning, stairs). A higher score indicates better mobility.
cMobility strategies involve postoperative care programmes such as immediate or delayed weight bearing after surgery, and any other mobilisation strategies, such as exercises, physical training and muscle stimulation, used at various stages in rehabilitation, which aim to improve walking and minimise functional impairments. We categorised the exercise and physical training strategies using the Prevention of Falls Network Europe (ProFaNE) guidelines, see Appendix 1. These categories are gait, balance and functional training; strength/resistance training; flexibility; 3D (Tai Chi, dance); general physical activity; endurance; multiple types of exercise; other. Electrical stimulation is an additional intervention type.
dDowngraded one level for inconsistency (unexplained heterogeneity, I2 = 84%).
eCohen's effect size 0.2 is described as small, 0.5 as medium/moderate effect, 0.8 as large effect (Sawilowsky 2009).
fMean was estimated from median for the single study.
gDowngraded one level for risk of bias and one level for imprecision.
hDowngraded one level for risk of bias and one level for imprecision.

Figuras y tablas -
Summary of findings 2. Summary of findings: different types of intervention on mobility outcome, in‐hospital
Summary of findings 3. Summary of findings: post‐hospital studies

Mobility strategies compared with control (e.g. usual care) after hip fracture surgery in the post‐hospital setting

Patient or population: adults following hip fracture surgery

Settings: post‐hospital

Intervention: mobility strategiesa

Comparison: non‐provision controlb

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Controlc

Intervention

Mobilityd ‐ overall analysis

 

Using different mobility scales: mPPT (range 0 to 36), POMA (range 0 to 30), SPPB (range 0 to 12), PPME (range 0 to 12). A higher score indicates better mobility.

 

Follow‐up: range 2 months to 12 months

In the control group, the mean scores for the outcomes were: mPPT (23.3), POMA (20.7), SPPB (range 6 to 7.72), PPME (10.1)

SMD 0.32 higher (0.11 higher to 0.54 higher)

SMD 0.32 (0.11 to 0.54)

 

 

761 (7)

⊕⊕⊕⊕
Highe

Overall, there is a small (based on Cohen's effect sizesf) increase in mobility compared with control (SMD 0.32).

 

Re‐expressing the results using the 12‐point SPPB, the intervention group scored 0.89 points higher (95% CI 0.30 to 1.50). Small meaningful change for SPPB: 0.27 to 0.55 points; substantial meaningful change: 0.99 to 1.34 points (Perera 2006).

 

Types of intervention in included trials: gait, balance and functional exercise: 5 studies; multiple types: 2 studies.

Walking speedg ‐ overall analysis

 

Measured using metres/second (m/s) and metres/minute (m/min). A higher score indicates faster walking.

 

Follow‐up: range 1 month to 12 months

The mean walking speed score in the control group ranged from 0.44 m/s to 0.97 m/s, and 20 m/min to 59.4 m/min.

SMD 0.16 higher (0.04 higher to 0.29 higher)

SMD 0.16 (0.04 to 0.29)

1067 (14)

⊕⊕⊕⊕
Highh

 

There is a small increase in walking speed compared with control (SMD 0.16).

 

Re‐expressing the results using gait speed (m/sec), there was an increase in gait speed of 0.05 m/s in the intervention group (MD 0.05, 95% CI 0.01 to 0.09). Small meaningful change for walking speed is 0.04 to 0.06 m/s (Perera 2006).

 

Types of intervention in included trials: gait, balance and functional exercise: 7 studies; resistance exercise: 3 studies; endurance exercise: 1 study; multiple types: 3 studies.

Functioningi ‐ overall analysis

 

Using different functioning scales: FSQ (range 0 to 36), BI (range 0 to 100), AM‐PAC daily activity (range 9 to 101), COPM (range 0 to 20), LEFS (range 0 to 80), NEADL (range 0 to 66). A higher score indicates better functioning.

 

Follow‐up: range 3 months to 12 months

In the control group, the mean scores for the outcomes were: FSQ (24.8), BI (94.5), AM‐PAC (58.6), COPM (6.54), LEFS (28.8), NEADL (range 14.2 to 43.2).

SMD 0.23 higher (0.10 higher to 0.36 higher)

SMD 0.23 (0.10 to 0.36)

936 (9)

⊕⊕⊕⊕
Highj

Overall, there is a small increase in functioning compared with control (SMD 0.23).

 

Re‐expressing the results using the BI, the intervention group scored 1.4 points higher (95% CI 0.6 to 2.1). MID for the BI (post‐hip surgery) is typically 9.8 (Unnanuntana 2018).

 

Types of intervention in included trials: gait, balance and functional exercise: 4 studies; resistance exercise: 2 studies; multiple types: 2 studies; other: 1 study

HRQoL

using EQ‐ 5D (range 0 to 1), SF‐36 (range 0 to 100), SF‐12 (range 0 to 100), and WHOQOL‐BREF (range 0 to 130). A higher score indicates better quality of life.

 

Follow‐up: range 3 months to 6 months

In the control group, the mean scores for the outcomes were: EQ‐5D (range 0.6 to 0.75), SF‐36 (range 48 to 63), SF‐12 (45.5), WHOQOL‐BREF (13.2).

SMD 0.14 higher (0.00 lower to 0.29 higher)

SMD 0.14 (0.00 to 0.29)

785 (10)

⊕⊕⊕⊝
Moderatek

 

SMD was calculated for 5 trials with EQ‐5D, 3 trials with SF‐36, 1 trial with SF‐12, 1 trial with WHOQOL‐BREF.

 

Re‐expressing the results using the EQ‐5D (0 to 1 scale), there was an increase in quality of life of 0.01 in the intervention group (95% CI ‐0.007 to 0.08). MID for the EQ‐5D is typically 0.074 (Walters 2005).

 

Re‐expressing the results using the SF‐36 (0 to 100 scale), there was an increase in quality of life of 3 points in the intervention group (95% CI ‐0.6 to 5.7). MID for SF‐36 typically 3 to 5 (Walters 2003).

 

Mobility strategies probably make little important difference to patient‐reported health‐related quality of life compared with control.

 

Types of intervention in included trials: gait, balance and functional exercise: 4 studies; resistance exercise: 3 studies; endurance exercise: 1 study; multiple types: 1 study; other: 1 study

Mortality

 

Follow‐up: range 3 months to 12 months

Short term: 35 per 1000l

Short term: 35 per 1000 (14 to 72)

Short term: RR 1.01 (0.49 to 2.06)

 

 

Short term: 737 (8)

 

 

 

⊕⊕⊕⊝
Moderatem

Overall, there is moderate‐certainty evidence that mobility strategies probably make little or no difference to mortality compared to control in the short term.

 

It is unclear whether mobility strategies reduce mortality in the long term as the certainty of evidence is low and the 95% CI includes both a reduction in the risk of mortality and an increase in the risk of mortality.

 

Types of intervention in included trials: gait, balance and functional exercise: 3 studies; resistance exercise: 3 studies; multiple types: 5 studies.

Long term: 71 per 1000l

Long term: 52 per 1000 (28 to 97)

 

Long term: RR 0.73 (0.39 to 1.37)

Long term:

588 (4)

⊕⊕⊝⊝
Lown

Adverse event: number of people who were re‐admitted

 

Follow‐up: range 1 month to 12 months

231 per 1000l

199 (120 to 328)

RR 0.86 (0.52 to 1.42)

206 (2)

⊕⊕⊝⊝
Lowo

The evidence is of low certainty: the intervention may decrease the number of re‐admissions by 14%; however, the 95% CI includes the possibility of both a 48% reduction and a 42% increase.

 

Types of intervention in included trials: multiple types: 1 study; other: 1 study.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
AM‐PAC: Activity Measure for Post Acute Care; BI: Barthel Index; CI: confidence interval; COPM: Canadian Occupational Performance Measure; EQ5D: EuroQoL‐5Dl; FSQ: Functional StaRR: risk ratio; HRQoL: Health‐Related Quality of Life; LEFS: Lower Extremity Functional Scale; MID: minimal important difference; MD: mean difference; mPPT: modified Physical Performance Test; tus Questionnaire; NEADL: Nottingham Extended Activities of Daily Living; PME: Physical Performance and Mobility Examination; POMA: Performance Oriented Mobility Assessment; PWHOQOL BREF: World Health Organization Quality of LIfe short version; SMD: standardised mean difference; SF12: Short Form‐12 SF36: Short Form‐36; SPPB: Short Physical Performance Battery.

GRADE Working Group grades of evidence

High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.

Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.

Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

a Postoperative care programmes such as exercises, physical training and muscle stimulation, used at various stages in rehabilitation, which aim to improve walking and minimise functional impairments.
bA non‐provision control is defined as no intervention, usual care, sham exercise (the exercise was intended to be a control, or appeared to be of insufficient intensity and progression to have beneficial effects on mobility) or a social visit.
cThe all‐studies population risk was based on the number of events and the number of participants in the control group.
dMobility, measuring the ability of a person to move. Scales may measure a number of aspects of mobility (e.g. sit to stand, walking, turning, stairs).
eNot downgraded for risk of bias, as point estimate increased from 0.32 to 0.38 and CI remained close to zero (95% CI from (0.11 to 0.54) to (‐0.04 to 0.79)) upon removal of the trials at a high risk of bias in one or more items.
fCohen's effect size 0.2 is described as small, 0.5 as medium/moderate effect, 0.8 as large effect (Sawilowsky 2009).
gWalking speed, measured using distance/time.
hNot downgraded for risk of bias, as point estimate reduced from 0.16 to 0.14 and CI remained close to zero (95% CI from (0.04 to 0.29) to (‐0.08 to 0.36) upon removal of the trials at a high risk of bias in one or more items.
iFunctioning, using functioning scales.
jNot downgraded for risk of bias, as point estimate increased and CI remained above zero upon removal of the trials at a high risk of bias in one or more domains.
kDowngraded one level for risk of bias (removing studies with high risk of bias in one or more domains had a marked impact on results).
lOur illustrative risks for dichotomous outcomes were based on the proportion calculated from the number of people who experienced the event divided by the number of people in the group, for the control group in those trials included in the analysis for that outcome.
mNot downgraded for risk of bias, as results were essentially unchanged with removal of the trials at a high risk of bias in one or more domains. Downgraded by one level due to imprecision (few events and wide CI).
nDowngraded one level for risk of bias (removing studies with high risk of bias in one or more domains had an important impact on results) and one level for imprecision (few events and wide CI).
oWe downgraded one level for risk of bias, as both trials were at a high risk of bias in one or more domains. Downgraded one level for imprecision (few events and wide CI).

Figuras y tablas -
Summary of findings 3. Summary of findings: post‐hospital studies
Summary of findings 4. Summary of findings: different types of intervention on mobility outcome, post‐hospital

Different types of mobility strategies compared with control after hip fracture surgery, on mobility, in the post‐hospital setting

Patient or population: adults following hip fracture surgery

Settings: post‐hospital

Comparison: non‐provision controla

Outcome: mobilityb

Intervention type (according to ProFaNE)c

Mobility outcome

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Intervention

Gait, balance and functional training

 

Follow‐up: range 2 months to 12 months

Mobility scales, using different scales: SPPB (range 0 to 12), PPME (range 0 to 12). A higher score indicates better mobility.

In the control group, the mean scores for the outcomes were: SPPB (range 6 to 7.72), PPME (10.1).

SMD 0.20 higher (0.05 higher to 0.36 higher)

 SMD 0.20 (95% CI 0.05 to 0.36)

 

 

 

621 (5)

⊕⊕⊕⊕
Highd

Interventions classified as gait, balance and functional training cause a smalle increase in mobility compared with control.

 

Re‐expressing the results using the 12‐point SPPB, the intervention group scored 0.55 points higher (95% CI 0.14 to 1.0). Small meaningful change for SPPB: 0.27 to 0.55 points; substantial meaningful change: 0.99 to 1.34 points (Perera 2006).

 

TUG (lower score = faster)

The mean TUG time in the control group was 30.22 seconds.

 

MD 7.57 seconds faster (19.25 seconds faster to 4.11 seconds slower)

MD ‐7.57 (‐19.25 to 4.11)

 

 

128 (1)

⊕⊝⊝⊝
Very lowf

Gait, balance and functional training may increase TUG speed by 7.57 seconds; however, the 95% confidence interval includes both a reduction and increase in TUG.

 

6 Minute Walk Test

 

 

 

0

 

 

Resistance/strength training 

Follow‐up: range 10 weeks to 3 months

Mobility scales

 

 

 

0

 

 

 

TUG

The mean TUG time in the control group was 20 seconds.

MD 6 seconds faster (12.95 seconds faster to 0.95 seconds slower)

MD ‐6.00 (‐12.95, 0.95)

96 (1)

⊕⊕⊝⊝
Lowg

Resistance/strength training may increase TUG speed by 6 seconds; however, the 95% confidence interval includes both a reduction and increase in TUG.

 

6MWT

The mean 6MWT distance in the control group was 243 m.

MD 56 metres further (29 metres further to 83 metres further)

MD 55.65 (28.58 to 82.72)

198 (3)

⊕⊕⊝⊝
Lowh

Resistance/strength training may increase 6MWT by 53 metres.

MID for the 6MWT (adults with pathology) is typically 14.0 to 30.5m (Bohannon 2017).

Flexibility

All

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being flexibility.

3D (Tai Chi, dance)

All

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being 3D.

General physical activity

All

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being general physical activity.

Endurance 

Follow‐up: 3 months

Mobility scales

 

 

 

0

 

 

 

TUG

 

 

 

0

 

 

 

6MWT

The mean 6MWT distance in the control group was 266 m.

MD 12.7 metres further (72 metres less to 97 metres further).

MD 12.70 (‐72.12, 97.52)

21 (1)

⊕⊝⊝⊝
Very lowi

We are uncertain whether endurance training improves mobility as the certainty of the evidence is very low.

Multiple primary types of exercise 

 

Follow‐up: range 2 months to 6 months

Mobility scales, using different mobility scales: mPPT (range 0 to 36), POMA (range 0 to 30).

In the control group, the mean scores for the outcomes were: mPPT (23.3), POMA (range 20.7).

SMD 0.94 higher (0.53 higher to 1.34 higher)

SMD 0.94 (0.53 to 1.34)

104 (2)

⊕⊕⊕⊝
Moderatej

Interventions that contain multiple types of exercise probably leads to a moderate increase in mobility.

 

Re‐expressing the results using the 12‐point SPPB, the intervention group scored 2.6 points higher (95% CI 1.47 to 3.71). Substantial meaningful change for SPPB: 0.99 to 1.34 points (Perera 2006).

 

TUG

 

 

 

0

 

 

 

6MWT

The mean 6MWT distance in the control group was 233.1 m. 

MD 9 metres further (15 metres less to 33 metres further)

9.30 (‐14.62 to 33.22)

187 (1)

⊕⊕⊝⊝
Lowk

Interventions containing strength training and endurance training may increase 6MWT by 9 metres.

MID for the 6MWT (adults with pathology) is typically 14.0 to 30.5m (Bohannon 2017).

Electrical stimulation

 

 

 

 

0

 

0 studies contained a mobility strategy categorised as primarily being electrical stimulation

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
6MWT: 6‐Minute Walk Test; CI: confidence interval; MID: minimal important difference; mPPT: modified Physical Performance Test; POMA: Performance Oriented Mobility Assessment; PPME: Physical Performance and Mobility Examination; SMD: standardised mean difference; SPPB: Short Physical Performance Battery; TUG: Timed Up and Go test.

GRADE Working Group grades of evidence

High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.

Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.

Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

aA non‐provision control is defined as no intervention, usual care, sham exercise (the exercise was intended to be a control, or appeared to be of insufficient intensity and progression to have beneficial effects on mobility) or a social visit.
bMobility, measuring the ability of a person to move. Scales may measure a number of aspects of mobility (e.g. sit to stand, walking, turning, stairs). A higher score indicates better mobility.
cMobility strategies involve postoperative care programmes such as immediate or delayed weight bearing after surgery, and any other mobilisation strategies, such as exercises, physical training and muscle stimulation, used at various stages in rehabilitation, which aim to improve walking and minimise functional impairments. We categorised the exercise and physical training strategies using the Prevention of Falls Network Europe (ProFaNE) guidelines, see Appendix 1. These categories are gait, balance and functional training; strength/resistance training; flexibility; 3D (Tai Chi, dance); general physical activity; endurance; multiple types of exercise; other. Electrical stimulation is an additional intervention type.
dNot downgraded for risk of bias (removing studies with high risk of bias in one or more domains had no important impact on results).
eCohen's effect size 0.2 is described as small, 0.5 as medium/moderate effect, 0.8 as large effect (Sawilowsky 2009).
fDowngraded one level for risk of bias and two levels for imprecision.
gDowngraded two levels for imprecision.
hDowngraded one level for risk of bias (all studies had high risk of bias for at least one item) and one level for imprecision.
iDowngraded one level for risk of bias (removing studies with high risk of bias in one or more domains had an important impact on results) and two levels for imprecision).
jDowngraded for imprecision.
kDowngraded one level for risk of bias and one level for imprecision.

Figuras y tablas -
Summary of findings 4. Summary of findings: different types of intervention on mobility outcome, post‐hospital
Table 1. Key characteristics of participants and intervention approach

Study ID

Age (mean)

% women

Gait speed in control group at follow‐up (m/s)

Duration of intervention (weeks)

Type of intervention (ProFaNE)

Intervention delivered by expert health provider

Exclusion criterion based on impaired cognition

Baker 1991

84

100%

0.43

Not specified

Balance, gait & functional

Yes

No

Binder 2004

80

74%

0.99

24

Balance, gait & functional; resistance

Yes

Yes

Bischoff‐Ferrari 2010

84

79%

NR

52

Balance, gait & functional

Yes

Yes

Braid 2008

81

92%

NR

6

Electrical stimulation

Yes

Yes

Gorodetskyi 2007

71

67%

NR

1.5

Electrical stimulation

Yes

No

Graham 1968

NR

NR

NR

Early WB v late WB

Balance, gait & functional

Unclear

No

Hauer 2002

81

100%

0.44

12

Balance, gait & functional; resistance

Unclear

Yes

Karumo 1977

73

75%

NR

4.7

Balance, gait & functional

Yes

No

Kimmel 2016

81

64%

NR

1

Balance, gait & functional

Yes

No

Kronborg 2017

80

77%

NR

10 days (or discharge, if discharged prior)

Resistance

Yes

Yes

Lamb 2002

84

100%

0.43

6

Electrical stimulation

No

Yes

Langford 2015

83

63%

0.83

16

Other (telephone support and coaching)

Yes

Yes

Latham 2014

78

69%

NR

24

Balance, gait & functional

Yes

Yes

Lauridsen 2002

80

100%

NR

2

Balance, gait & functional

Yes

No

Magaziner 2019

81

77%

0.74

16

Resistance; endurance

Yes

No

Mangione 2005

79

73%

0.65

12

Resistance; endurance

Yes

Yes

Mangione 2010

81

81%

0.91

10

Resistance

Yes

Yes

Miller 2006

84

77%

0.5

12

Resistance

Yes

Yes

Mitchell 2001

80

84%

0.42

6

Balance, gait & functional; resistance

Unclear

Yes

Monticone 2018

77

71%

NR

3

Balance, gait & functional

Yes

Yes

Moseley 2009

84

81%

0.6

16

Balance, gait & functional

Yes

Yes

Oh 2020
 

79

68%

NR

2

Balance, gait & functional
 

Yes

Yesa

Ohoka 2015

90

100%

0.35

12

Balance, gait & functional

Yes

No

Oldmeadow 2006

79

68%

NR

1

Balance, gait & functional

Yes

No

Orwig 2011

82

100%

NR

52

Resistance; endurance; other (self‐efficacy‐based motivational component)

No

Yes

Pol 2019

80

89%

NR

12

Other (cognitive behavioural therapy (CBT), CBT plus sensory monitoring)

Yes

No

Resnick 2007

81

100%

NR

52

Resistance; endurance; other (motivational interventions)

No

Yes

Salpakoski 2015

80

78%

0.97

52

Balance, gait & functional

Yes

Yes

Sherrington 1997

79

79%

0.5

4

Balance, gait & functional

Yes

Yes

Sherrington 2003

81

68%

0.19

2

Balance, gait & functional

Yes

Yes

Sherrington 2004

(WB group; NWB group)

79

80%

0.55; 0.62

16

Balance, gait & functional; other (specific group of muscle contractions in supine)

Yes

Yes

Sherrington 2020

78

76%

0.83

52

Balance, gait & functional

Yes

Yes

Stasi 2019

78

75%

NR

12

Resistance

Yes

No

Suwanpasu 2014

75

66%

NR

6

Other (physical activity enhancing program, based on Resnick's self‐efficacy model)

No

No

Sylliaas 2011

82

83%

0.51

12

Resistance

Yes

Yes

Sylliaas 2012

82

81%

0.8

12

Resistance

Yes

Yes

Taraldsen 2019

83

77%

0.62

10

Balance, gait & functional

Yes

No

Tsauo 2005

73

80%

0.33

12

Balance, gait & functional

Yes

Yes

Van Ooijen 2016

83

73%

0.72

6

Balance, gait & functional

Yes

Yes

Williams 2016

79

75%

0.8

12

Balance, gait & functional; other (workbook and goal setting diary)

Yes

Yes

NR: not reported; NWB: non‐weight bearing; WB: weight bearing
aParticipants with severe cognitive dysfunction (obey command ≤ 1 step ) were excluded. At baseline, 21/38 participants had cognitive dysfunction, defined using Mini‐Mental State Examination score adjusted with age and education level.

Figuras y tablas -
Table 1. Key characteristics of participants and intervention approach
Table 2. Study design, length of follow‐up, setting and trial size

Study ID

Setting

Length of follow‐up (months)

No. randomised

No. analysed

% lost to follow‐up

Baker 1991

Inpatient

Until discharge from hospital

40

40

0%

Binder 2004

Post‐hospital

6

90

80

11%

Bischoff‐Ferrari 2010

Post‐hospital

12

173

128

26%

Braid 2008

Inpatienta

3.5

26

18

31%

Gorodetskyi 2007

Inpatient

10 days

60

60

0%

Graham 1968

Inpatient

12

273

212

22%

Hauer 2002

Post‐hospital

6

28

24

14%

Karumo 1977

Inpatient

3

100

87

13%

Kimmel 2016

Inpatient

6

92

92

0%

Kronborg 2017

Inpatient

10 days

90

74

18%

Lamb 2002

Inpatienta

3

27

24

11%

Langford 2015

Post‐hospitalb

4 months

30

26

13%

Latham 2014

Post‐hospital

9

232

195

16%

Lauridsen 2002

Inpatient

Until discharge from hospital

88

60

32%

Magaziner 2019

Post‐hospital

4

201

187

7%

Mangione 2005c

Post‐hospital

3

41

33

20%

Mangione 2010

Post‐hospital

12

26

26

0%

Miller 2006c

Inpatienta

3

63

63

0%

Mitchell 2001

Inpatient

4

80

44

45%

Monticone 2018

Inpatienta

12 (3 weeks used in analysis)

52

52

0%

Moseley 2009

Inpatienta

4

160

150

6%

Oh 2020
 

Inpatient

6

45

41

16%

Ohoka 2015

Inpatient

3

27

18

33%

Oldmeadow 2006

Inpatient

0.25

60

60

0%

Orwig 2011

Post‐hospital

12

180

180

0%

Pol 2019c,d

Post‐hospital

4

240

151

37%

Resnick 2007c

Post‐hospital

12

155

113

27%

Salpakoski 2015

Post‐hospital

12

81

75

7%

Sherrington 1997

Post‐hospital

1

44

40

9%

Sherrington 2003

Inpatient

0.5

80

77

4%

Sherrington 2004c

Post‐hospital

4

120

105

13%

Sherrington 2020

Post‐hospital

12

336

159

53%

Stasi 2019

Post‐hospitalb

3

100

96

4%

Suwanpasu 2014

Post‐hospital

1.5

46

46

0%

Sylliaas 2011

Post‐hospital

3

150

150

0%

Sylliaas 2012

Post‐hospital

3

95

90

5%

Taraldsen 2019

Post‐hospital

2

143

123

14%

Tsauo 2005

Post‐hospital

3

54

25

54%

Van Ooijen 2016c

Inpatient

13 (4 weeks used in analysis)

70

51

27%

Williams 2016

Post‐hospital

3

61

24

61%

aIntervention delivered in hospital and after discharge. Majority of intervention delivered in inpatient setting
bIntervention started as inpatient. Majority of intervention delivered in post‐hospital setting
cThree study arms
dCluster‐randomised trial

Figuras y tablas -
Table 2. Study design, length of follow‐up, setting and trial size
Table 3. Assessment of items relating to applicability of trial findings

Clearly defined study population?

Interventions sufficiently described?

Main outcomes sufficiently
described?

Appropriate timing of outcome measurement?
(Yes ≥ 6 months)

Assessment of compliance with interventions

Baker 1991

Yes

Partial: frequency and intensity of gait retraining not described

Yes

No: only followed up until discharge: mean stay in rehabilitation hospital for intervention group was 54 days.

No: although mention of treadmill participants aiming to exceed previous performance on the treadmill

Binder 2004

Yes

Yes

Yes

Partial: although 6 months follow‐up, it was only until the end of the intervention.

Yes: in both groups

Bischoff‐Ferrari 2010

Yes

Yes

Yes

Yes

Yes

Braid 2008

Yes

Partial: usual post‐discharge
physiotherapy not described

Yes

Partial: 14 weeks. Intervention ended after 6 weeks.

Partial: compliance and tolerance to electrical stimulation only reported for intervention group

Gorodetskyi 2007

Yes

Yes

Yes (although limited)

No: 10 days marking end of treatment.

Yes: it is stated that intervention was received by all participants

Graham 1968

Partial: inadequate description; excluded post‐randomisation if unsuitable to walk at 2 weeks

Partial: little description of rehabilitation

Partial: no record of mobility outcomes

Yes: 1 year

No

Hauer 2002

Yes

Yes

Partial: however, clarification on some outcome measures was obtained via contact with trial author

Yes: 6 months (3 months after the end of the intervention). Two year follow‐up results reported for whole study population

Yes: in both groups

Karumo 1977

Partial: no mention of exclusion criteria. Though the inclusion criteria were a displaced femoral neck fracture, the implants used for some participants (9 Jewett nails, 1 Rush nail, 1 Kuntscher nail) suggest that some extracapsular fractures were included.

Yes

Partial: incomplete descriptions

No: 9 weeks only for function (3 months for mortality)

No

Kimmel 2016

Yes

Yes

Yes

No: length of follow‐up is Day 5 or discharge if discharged before Day 5

No

Kronborg 2017

Yes

Yes

Yes

No: 10 days or discharge if sooner

Yes: in both groups

Lamb 2002

Yes

Yes

Yes

Partial: 13 weeks from surgery.

Yes: “All of the women used their stimulators for more than 75% of the cumulative time requested”

Langford 2015

Yes

Yes

Yes

Partial

No

Latham 2014

Yes

Yes

Yes

Partial: 9 months

Yes: compliance with interventions assessed: "adherence was 98%”

Lauridsen 2002

Yes

Yes

Yes

No: primary outcome = length of training period; otherwise until discharge

Yes: in terms of the interventions (although not the components)

Magaziner 2019

Yes

Yes

Yes

Partial: 40 weeks

Yes

Mangione 2005

Yes

Yes

Yes

No: 12 weeks for the two intervention groups but 8 weeks only for the control group.

Partial: only compliance of the intervention groups recorded

Mangione 2010

Yes

Yes

Yes

Partial: majority followed up for 16 weeks

Yes

Miller 2006

Yes

Yes

Yes

Partial: 12 weeks only for mobility outcomes. One year follow‐up data for mortality, re‐admissions and admission to higher level of care

Partial: only compliance of the intervention groups recorded

Mitchell 2001

Yes

Yes

Yes

Partial: 16 weeks follow‐up. Intervention ended at 6 weeks

Partial: only compliance with intervention recorded

Monticone 2018

Yes

Partial: dosage about open kinetic chain exercises in the control group not described

Yes

Partial

Yes: “Physiotherapists’ systematic checking of the exercise

administration manual revealed excellent compliance

rates in both groups".

Moseley 2009

Yes

Yes

Yes

Partial: 16 weeks follow‐up.

Yes: “Participants completed exercise diaries which were analysed to ascertain adherence to the programmes.”
Care provider visits also documented

Oh 2020
 

Yes

Yes

Yes

Partial: 6 months follow‐up (5 months after the end of intervention)

No

Ohoka 2015

Yes

No: standard physical therapy not described. Intensity of treadmill training not described

Yes

Partial: average of approximately 6 months

No

Oldmeadow 2006

Yes

Yes

Yes

No: only until acute hospital discharge. Mobility outcomes at 7 days

Yes: time to first walk recorded in both groups

Orwig 2011

Yes

Yes

Yes

Yes. Outcomes were assessed at 2, 6, and 12 months after hip fracture

Yes. Hours spent exercising quantified

Pol 2019

Yes

Yes

Yes

Partial

Yes

Resnick 2007

Yes

Yes

Yes

No: although follow‐up was 12 months from fracture, this coincided with the end of treatment

Partial: no data for usual care group

Salpakoski 2015

Yes

Partial: control standard care did not have specific dosage for the exercise “5‐7 exercises for the lower limbs”

Yes

Partial

Partial: only compliance in intervention group reported but reported “None of the participants were followed

for compliance” in control

Sherrington 1997

Yes

Partial: "Usual care" not described

Yes

No: final assessment at 1 month (27 to 43 days)

Partial: only the intervention group completed diaries and were asked about the specific exercises. However, all participants were asked about general exercise.

Sherrington 2003

Yes

Yes

Yes

No: 2 weeks follow‐up only

Partial: some data available but not regarding weight bearing

Sherrington 2004

Yes

Yes

Yes

Partial: 4 months follow‐up only

Partial: compliance data collected for the two exercise groups but not for the control group.

Sherrington 2020

Yes

Yes

Yes

Yes: 12 months

Partial: compliance data collected for intervention group via diaries

Stasi 2019

Yes

Yes

No

Partial: 6 months

No

Suwanpasu 2014

No

No

Unclear

No: 6 weeks after discharge

No

Sylliaas 2011

Yes

Yes

Yes

No: intervention is only 12 weeks following an observation period of 12 weeks

No: not assessed

Sylliaas 2012

Yes

Yes

Yes

Partial: although is 36 weeks after fracture, trial 1 starts 12 weeks after fracture, final follow‐up is 24 weeks after start of 2011 intervention

No: not assessed

Taraldsen 2019

Yes

Yes

Yes

Yes: T3 = 48 to 56 weeks

Yes

Tsauo 2005

Yes

Yes

Yes

Yes: 6 months' follow‐up.

No. However, 4 participants in the intervention group were excluded because of poor compliance.

Van Ooijen 2016

Yes

Yes

Yes

Partial: 12 months' follow‐up for some but not all outcomes

No, included in protocol bot not reported

Williams 2016

Yes

Yes

Yes

No: 3 months

No

Figuras y tablas -
Table 3. Assessment of items relating to applicability of trial findings
Comparison 1. In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1.1 Mobility (measured using mobility scales): combined data for all strategy types Show forest plot

7

507

Std. Mean Difference (IV, Random, 95% CI)

0.53 [0.10, 0.96]

1.2 Mobility (failure to regain pre‐facture mobility): combined data for all strategy types Show forest plot

2

64

Risk Ratio (M‐H, Fixed, 95% CI)

0.48 [0.27, 0.85]

1.3 Mobility (measured using self‐reported outcomes): combined data for all strategy types Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.4 Mobility (measured using mobility scales): gait, balance and function Show forest plot

6

463

Std. Mean Difference (IV, Random, 95% CI)

0.57 [0.07, 1.06]

1.5 Mobility (measured using mobility scales): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.6 Mobility (measured in seconds using TUG): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.7 Mobility (measured using mobility scales) reporting individual outcome measures Show forest plot

8

Mean Difference (IV, Random, 95% CI)

Subtotals only

1.7.1 Elderly Mobility Scale

2

95

Mean Difference (IV, Random, 95% CI)

0.49 [‐0.81, 1.79]

1.7.2 Physical Performance and Mobility Examination Score

2

227

Mean Difference (IV, Random, 95% CI)

0.34 [‐0.31, 0.99]

1.7.3 Berg Balance Scale

2

93

Mean Difference (IV, Random, 95% CI)

12.39 [8.79, 15.98]

1.7.4 Modified Iowa Level of Assistance

1

92

Mean Difference (IV, Random, 95% CI)

2.70 [‐0.94, 6.34]

1.7.5 Timed Up and Go

3

158

Mean Difference (IV, Random, 95% CI)

4.03 [‐6.17, 14.23]

1.7.6 Performance Oriented Mobility Assessment

1

51

Mean Difference (IV, Random, 95% CI)

0.90 [‐1.14, 2.94]

1.7.7 Koval Walking Ability score

1

41

Mean Difference (IV, Random, 95% CI)

1.53 [0.72, 2.34]

1.7.8 Western Ontario and McMaster Universities OA Index (self‐reported)

1

52

Mean Difference (IV, Random, 95% CI)

‐25.40 [‐28.72, ‐22.08]

1.8 Walking speed (measured as metres/time): combined data for all strategy types Show forest plot

6

360

Std. Mean Difference (IV, Fixed, 95% CI)

0.16 [‐0.05, 0.37]

1.9 Walking speed (measured as metres/time): gait, balance and function Show forest plot

5

336

Std. Mean Difference (IV, Fixed, 95% CI)

0.15 [‐0.07, 0.36]

1.10 Walking speed (measured as metres/time): electrical stimulation Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.11 Functioning (measured using functioning scales): combined data for all strategy types Show forest plot

7

379

Std. Mean Difference (IV, Random, 95% CI)

0.75 [0.24, 1.26]

1.12 Functioning (measured using functioning scales): gait, balance and function Show forest plot

5

312

Std. Mean Difference (IV, Random, 95% CI)

0.56 [‐0.00, 1.13]

1.13 Functioning (measured using functioning scales): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14 Functioning (measured using functioning scales): electrical stimulation Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.15 Health‐related quality of life (measured using HRQoL scales): gait, balance and function Show forest plot

4

314

Std. Mean Difference (IV, Random, 95% CI)

0.39 [‐0.07, 0.85]

1.16 Mortality, short term: combined data for all strategy types Show forest plot

6

489

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.48, 2.30]

1.17 Mortality, short term: gait, balance and function Show forest plot

3

293

Risk Ratio (M‐H, Fixed, 95% CI)

1.43 [0.44, 4.66]

1.18 Mortality, short term: resistance/strength training Show forest plot

2

170

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.26, 2.62]

1.19 Mortality, short term: electrical stimulation Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.20 Mortality, long term: combined data for all strategy types Show forest plot

2

133

Risk Ratio (M‐H, Fixed, 95% CI)

1.22 [0.48, 3.12]

1.21 Mortality, long term: gait, balance and function Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.22 Mortality, long term: resistance/strength training Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.23 Adverse events (measured using dichotomous outcomes): combined data for all strategy types Show forest plot

7

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

1.23.1 Re‐admission

4

322

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.44, 1.11]

1.23.2 Re‐operation

1

80

Risk Ratio (M‐H, Fixed, 95% CI)

0.32 [0.01, 7.57]

1.23.3 Surgical complications

1

18

Risk Ratio (M‐H, Fixed, 95% CI)

Not estimable

1.23.4 Pain

3

245

Risk Ratio (M‐H, Fixed, 95% CI)

1.12 [0.80, 1.57]

1.23.5 Falls (number of people who experienced one or more falls)

1

50

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.32, 1.38]

1.23.6 Other: orthopaedic complication (as reason for withdrawal from study)

1

88

Risk Ratio (M‐H, Fixed, 95% CI)

1.50 [0.45, 4.95]

1.24 Adverse events (measured using rate of falls): all studies were gait, balance and function Show forest plot

3

Rate Ratio (IV, Fixed, 95% CI)

0.85 [0.64, 1.12]

1.25 Adverse events (measured using continuous measures of pain): combined data for all strategy types Show forest plot

2

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.26 Return to living at pre‐fracture residence: combined data for all strategy types Show forest plot

2

240

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.73, 1.56]

1.27 Return to living at pre‐fracture residence: additional study not included in main analysis Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.28 Return to living at pre‐fracture residence: gait, balance and function Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.29 Return to living at pre‐fracture residence: resistance/strength training Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 1. In‐hospital rehabilitation: mobilisation strategy versus usual care, critical outcomes
Comparison 2. In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

2.1 Walking, use of walking aid/need for assistance Show forest plot

2

230

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.74, 1.11]

2.2 Balance (measured using functional reach test, cm) Show forest plot

2

121

Std. Mean Difference (IV, Fixed, 95% CI)

0.37 [0.01, 0.73]

2.3 Balance (measured using balance scale) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

2.4 Balance (measured using ability to tandem stand) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

2.5 Balance (measured using step test; number of steps) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

2.6 Balance (measured using self‐reported outcomes) Show forest plot

2

226

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.71, 1.29]

2.7 Sit to stand (measured as number of stand ups/second) Show forest plot

2

227

Mean Difference (IV, Fixed, 95% CI)

0.04 [0.01, 0.07]

2.8 Strength Show forest plot

8

498

Std. Mean Difference (IV, Fixed, 95% CI)

0.11 [‐0.07, 0.28]

2.9 Activities of daily living (measured using ADL scales) Show forest plot

5

206

Std. Mean Difference (IV, Random, 95% CI)

0.87 [0.35, 1.38]

2.10 Resource use (measured by length of hospital stay) Show forest plot

4

335

Mean Difference (IV, Fixed, 95% CI)

‐0.83 [‐3.94, 2.28]

2.11 Resource use (measured by use of community services) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 2. In‐hospital rehabilitation: mobilisation strategy versus usual care, other important outcomes
Comparison 3. In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

3.1 Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (mortality) Show forest plot

1

273

Risk Ratio (M‐H, Fixed, 95% CI)

0.74 [0.43, 1.29]

3.2 Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (mortality) Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

3.20 [0.14, 75.55]

3.3 Weight‐bearing at 2 wks v weight‐bearing at 12 weeks (adverse events) Show forest plot

1

594

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.54, 1.37]

3.3.1 Avascular necrosis

1

112

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.33, 1.42]

3.3.2 Infection

1

270

Risk Ratio (M‐H, Fixed, 95% CI)

0.65 [0.11, 3.81]

3.3.3 Non‐union

1

212

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.56, 2.03]

3.4 Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (return to living at home) Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.72, 1.02]

3.5 Early assisted ambulation (< 48 hrs) v delayed assisted ambulation (walking aid/assistance) Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.29, 0.89]

Figuras y tablas -
Comparison 3. In‐hospital rehabilitation: comparing different intervention strategies, critical outcomes
Comparison 4. Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

4.1 Mobility (measured using mobility scales): combined data for all strategy types Show forest plot

7

761

Std. Mean Difference (IV, Random, 95% CI)

0.32 [0.11, 0.54]

4.2 Mobility (measured using Timed Up and Go, seconds): combined data for all strategy types Show forest plot

3

375

Mean Difference (IV, Fixed, 95% CI)

‐1.98 [‐5.59, 1.63]

4.3 Mobility (measured using 6‐Minute Walk Test, metres): combined data for all strategy types Show forest plot

4

396

Mean Difference (IV, Fixed, 95% CI)

28.66 [10.88, 46.44]

4.4 Mobility (measured using mobility scales): gait, balance and function Show forest plot

5

621

Std. Mean Difference (IV, Fixed, 95% CI)

0.20 [0.05, 0.36]

4.5 Mobility (measured using Timed Up and Go, seconds): gait, balance and function Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.6 Mobility (measured using Timed Up and Go, seconds): resistance/strength training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.7 Mobility (measured using 6‐Minute Walk Test, metres): resistance/strength training Show forest plot

3

198

Mean Difference (IV, Fixed, 95% CI)

55.65 [28.58, 82.72]

4.8 Mobility (measured using 6‐Minute Walk Test, metres): endurance training Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.9 Mobility (measured using mobility scales): multiple component Show forest plot

2

104

Std. Mean Difference (IV, Fixed, 95% CI)

0.94 [0.53, 1.34]

4.10 Mobility (measured using 6‐Minute Walk Test, metres): multiple component Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.11 Mobility (measured using mobility scales): other type of exercise (non‐weight bearing exercise) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.12 Mobility (measured using Timed Up and Go, seconds): other type of exercise OT +/‐ sensor) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.13 Mobility (measured using mobility scales) reporting individual outcome measures Show forest plot

14

Mean Difference (IV, Random, 95% CI)

Subtotals only

4.13.1 Modified Physical Performance Test

1

80

Mean Difference (IV, Random, 95% CI)

5.70 [2.74, 8.66]

4.13.2 Physical Performance and Mobility Examination Score

1

105

Mean Difference (IV, Random, 95% CI)

0.32 [‐0.42, 1.05]

4.13.3 Short Physical Performance Battery

4

552

Mean Difference (IV, Random, 95% CI)

0.68 [0.15, 1.21]

4.13.4 Performance Oriented Mobility Assessment

1

24

Mean Difference (IV, Random, 95% CI)

4.90 [2.11, 7.69]

4.13.5 Timed Up and Go

3

366

Mean Difference (IV, Random, 95% CI)

1.69 [‐2.74, 6.12]

4.13.6 6 Minute Walk Test

4

396

Mean Difference (IV, Random, 95% CI)

33.98 [7.08, 60.89]

4.14 Mobility (measured using self‐report, continuous scales): combined data for all strategy types Show forest plot

2

355

Mean Difference (IV, Fixed, 95% CI)

1.46 [‐0.62, 3.53]

4.15 Mobility (measured using self‐reported, dichotomous outcome): combined data for all strategy types Show forest plot

1

108

Risk Ratio (M‐H, Fixed, 95% CI)

0.45 [0.29, 0.72]

4.16 Walking speed: combined data for all strategy types Show forest plot

14

1067

Std. Mean Difference (IV, Fixed, 95% CI)

0.16 [0.04, 0.29]

4.17 Walking speed: gait, balance and function Show forest plot

7

511

Std. Mean Difference (IV, Fixed, 95% CI)

0.08 [‐0.09, 0.25]

4.18 Walking speed: resistance/strength training Show forest plot

3

197

Std. Mean Difference (IV, Fixed, 95% CI)

0.29 [‐0.01, 0.58]

4.19 Walking speed: endurance Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.20 Walking speed: multiple component Show forest plot

3

285

Std. Mean Difference (IV, Random, 95% CI)

0.53 [‐0.13, 1.18]

4.21 Walking speed: other (post‐discharge physio telephone support and coaching) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.22 Walking speed: other (non‐weight bearing) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.23 Walking speed subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.23.1 People with cognitive impairment included

2

304

Std. Mean Difference (IV, Fixed, 95% CI)

0.07 [‐0.16, 0.29]

4.23.2 People with cognitive impairment excluded

12

762

Std. Mean Difference (IV, Fixed, 95% CI)

0.19 [0.04, 0.34]

4.24 Walking speed: subgrouped by outpatient v secondary and social care setting Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.24.1 Outpatient

2

229

Std. Mean Difference (IV, Fixed, 95% CI)

0.35 [0.08, 0.62]

4.24.2 Secondary and social care

12

838

Std. Mean Difference (IV, Fixed, 95% CI)

0.11 [‐0.02, 0.25]

4.25 Walking speed subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.25.1 Mean age in study 80 years or less

8

536

Std. Mean Difference (IV, Fixed, 95% CI)

0.12 [‐0.05, 0.30]

4.25.2 Mean age in study > 80 years

6

530

Std. Mean Difference (IV, Fixed, 95% CI)

0.18 [0.01, 0.36]

4.26 Functioning (measured using functioning scales): combined data for all strategy types Show forest plot

9

936

Std. Mean Difference (IV, Fixed, 95% CI)

0.23 [0.10, 0.36]

4.27 Functioning (measured using functioning scales): gait, balance and function Show forest plot

4

432

Std. Mean Difference (IV, Fixed, 95% CI)

0.17 [‐0.02, 0.36]

4.28 Functioning (measured using functioning scales): resistance/strength training Show forest plot

2

246

Std. Mean Difference (IV, Fixed, 95% CI)

0.29 [0.03, 0.55]

4.29 Functioning (measured using functioning scales): multiple components Show forest plot

2

107

Std. Mean Difference (IV, Fixed, 95% CI)

0.34 [‐0.04, 0.72]

4.30 Functioning (measured using functioning scales): other: OT +/‐ sensor Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.31 Health‐related quality of life (measured using HRQoL scales): combined data for all strategy types Show forest plot

10

785

Std. Mean Difference (IV, Fixed, 95% CI)

0.14 [‐0.00, 0.29]

4.32 Health‐related quality of life (measured using HRQoL scales): gait, balance and function Show forest plot

4

316

Std. Mean Difference (IV, Random, 95% CI)

0.08 [‐0.37, 0.53]

4.33 Health‐related quality of life (measured using HRQoL scales): resistance/strength training Show forest plot

3

197

Std. Mean Difference (IV, Fixed, 95% CI)

0.15 [‐0.14, 0.45]

4.34 Health‐related quality of life (measured using HRQoL scales): endurance Show forest plot

1

22

Mean Difference (IV, Random, 95% CI)

9.50 [‐8.56, 27.56]

4.35 Health‐related quality of life (measured using HRQoL scales): multiple components Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

4.36 Health‐related quality of life subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types Show forest plot

10

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.36.1 People with cognitive impairment included

1

120

Std. Mean Difference (IV, Fixed, 95% CI)

0.00 [‐0.36, 0.36]

4.36.2 People with cognitive impairment excluded

9

665

Std. Mean Difference (IV, Fixed, 95% CI)

0.17 [0.01, 0.33]

4.37 Health‐related quality of life subgrouped by outpatient v secondary and social care setting Show forest plot

10

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.37.1 Outpatient

2

233

Std. Mean Difference (IV, Fixed, 95% CI)

0.18 [‐0.09, 0.45]

4.37.2 Secondary and social care

8

552

Std. Mean Difference (IV, Fixed, 95% CI)

0.13 [‐0.04, 0.30]

4.38 Health‐related quality of life subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategy Show forest plot

10

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

4.38.1 Mean age in study 80 years or less

4

184

Std. Mean Difference (IV, Fixed, 95% CI)

0.25 [‐0.05, 0.55]

4.38.2 Mean age in study > 80 years

6

601

Std. Mean Difference (IV, Fixed, 95% CI)

0.11 [‐0.05, 0.27]

4.39 Mortality, short term: combined data for all strategy types Show forest plot

7

737

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.49, 2.06]

4.40 Mortality, short term: gait, balance and function Show forest plot

3

264

Risk Ratio (M‐H, Fixed, 95% CI)

1.12 [0.46, 2.72]

4.41 Mortality, short term: resistance/strength training Show forest plot

2

123

Risk Ratio (M‐H, Fixed, 95% CI)

1.40 [0.19, 10.03]

4.42 Mortality, short term: multiple components Show forest plot

2

290

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.08, 4.55]

4.43 Mortality, short term: other: non‐weight bearing Show forest plot

1

60

Risk Ratio (M‐H, Fixed, 95% CI)

0.50 [0.03, 7.59]

4.44 Mortality, long term: combined data for all strategy types Show forest plot

4

588

Risk Ratio (M‐H, Fixed, 95% CI)

0.73 [0.39, 1.37]

4.45 Mortality, long term: gait, balance and function Show forest plot

2

254

Risk Ratio (M‐H, Fixed, 95% CI)

0.75 [0.34, 1.67]

4.46 Mortality, long term: multiple components Show forest plot

2

334

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.25, 1.96]

4.47 Adverse events (measured using dichotomous outcomes): combined data for all strategy types Show forest plot

4

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

4.47.1 Re‐admission

2

206

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.52, 1.42]

4.47.2 Re‐operation

1

173

Risk Ratio (M‐H, Fixed, 95% CI)

0.46 [0.20, 1.08]

4.47.3 Surgical complications

1

25

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.06, 13.18]

4.48 Adverse events (measured using re‐admission rate: combined for all strategy types Show forest plot

1

Rate Ratio (IV, Fixed, 95% CI)

Totals not selected

4.49 Adverse events (measured using rate of falls): combined for all strategy types Show forest plot

3

Rate Ratio (IV, Fixed, 95% CI)

0.79 [0.63, 0.99]

4.50 Adverse events (measured using rate of falls): gait, balance and function Show forest plot

2

Rate Ratio (IV, Fixed, 95% CI)

0.78 [0.62, 0.99]

4.51 Adverse events (measured using rate of falls): other (additional phone support and coaching) Show forest plot

1

Rate Ratio (IV, Fixed, 95% CI)

Totals not selected

4.52 Adverse events (measured as number of people who experienced 1 or more falls) Show forest plot

4

Risk Ratio (IV, Fixed, 95% CI)

1.03 [0.85, 1.25]

4.53 Adverse events (measured using continuous measure of pain) Show forest plot

3

242

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.04 [‐0.29, 0.22]

Figuras y tablas -
Comparison 4. Post‐hospital rehabilitation: mobilisation strategy versus control, critical outcomes
Comparison 5. Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

5.1 Walking (measured as use of walking aid/need for assistance) Show forest plot

4

314

Risk Ratio (M‐H, Random, 95% CI)

0.46 [0.16, 1.31]

5.2 Walking (measured using self‐reported outcomes) Show forest plot

2

182

Risk Ratio (M‐H, Random, 95% CI)

0.55 [0.28, 1.06]

5.3 Balance (measured using functional reach test, cm) Show forest plot

2

144

Mean Difference (IV, Fixed, 95% CI)

1.30 [‐1.70, 4.31]

5.4 Balance (measured using timed standing in various positions) Show forest plot

2

234

Std. Mean Difference (IV, Random, 95% CI)

0.24 [‐0.37, 0.86]

5.5 Balance (measured using balance scale) Show forest plot

2

212

Std. Mean Difference (IV, Random, 95% CI)

0.28 [‐0.52, 1.08]

5.6 Balance (measured using continuous self‐reported meaure) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

5.7 Balance (measured using dichotomous self‐reported measure) Show forest plot

2

148

Risk Ratio (M‐H, Fixed, 95% CI)

0.82 [0.69, 0.98]

5.8 Sit to stand (measured as number of stand ups/second) Show forest plot

5

457

Mean Difference (IV, Random, 95% CI)

‐6.49 [‐12.23, ‐0.75]

5.9 Strength Show forest plot

14

1121

Std. Mean Difference (IV, Fixed, 95% CI)

0.30 [0.18, 0.42]

5.10 Strength subgrouped by studies with cognitive impairment included v studies with cognitive impairment not included, combined data for all strategy types Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

5.10.1 People with cognitive impairment included

2

230

Std. Mean Difference (IV, Fixed, 95% CI)

0.07 [‐0.19, 0.33]

5.10.2 People with cognitive impairment excluded

12

891

Std. Mean Difference (IV, Fixed, 95% CI)

0.37 [0.23, 0.50]

5.11 Strength subgrouped by stage of rehabilitation Show forest plot

12

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

5.11.1 Outpatient

2

227

Std. Mean Difference (IV, Fixed, 95% CI)

0.67 [0.39, 0.95]

5.11.2 Secondary and social care

12

890

Std. Mean Difference (IV, Fixed, 95% CI)

0.39 [0.25, 0.52]

5.12 Strength subgrouped by mean age ≤ 80 years v > 80 years, combined data for all strategies Show forest plot

14

Std. Mean Difference (IV, Fixed, 95% CI)

Subtotals only

5.12.1 Mean age in study 80 years or less

8

464

Std. Mean Difference (IV, Fixed, 95% CI)

0.35 [0.16, 0.54]

5.12.2 Mean age in study > 80 years

6

657

Std. Mean Difference (IV, Fixed, 95% CI)

0.27 [0.11, 0.43]

5.13 Activities of daily living (measured using ADL scales) Show forest plot

6

683

Std. Mean Difference (IV, Random, 95% CI)

‐0.01 [‐0.26, 0.23]

5.14 Self‐reported measures of lower limb/hip function Show forest plot

2

106

Std. Mean Difference (IV, Random, 95% CI)

0.78 [‐0.20, 1.77]

Figuras y tablas -
Comparison 5. Post‐hospital rehabilitation: mobilisation strategy versus control, other important outcomes
Comparison 6. Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

6.1 Resistance/strength training v endurance training (mobility measured using 6‐Minute Walk Test Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

6.2 Resistance/strength training v endurance training (walking speed) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

6.3 Resistance/strength training v endurance training (health‐related quality of life) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

6.4 Resistance/strength training v endurance training (strength) Show forest plot

1

Mean Difference (IV, Random, 95% CI)

Totals not selected

6.5 Gait, balance and function v other (muscle contraction in supine) (mobility measured using mobility scale) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

6.6 Gait, balance and function v other (muscle contraction in supine) (walking speed) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

6.7 Gait, balance and function v other (muscle contraction in supine) (mortality) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.8 Gait, balance and function v other (muscle contraction in supine) (Adverse events: pain) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.8.1 Pain from fracture

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.8.2 Pain during exercise

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.9 Gait, balance and function v other (muscle contraction in supine) (Adverse events: number of people who fell) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.10 Gait, balance and function v other (muscle contraction in supine) (Balance, observed) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

6.11 Gait, balance and function v other (muscle contraction in supine) (Balance, self‐reported) Show forest plot

1

Risk Ratio (M‐H, Fixed, 95% CI)

Totals not selected

6.12 Gait, balance and function v other (muscle contraction in supine) (strength) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 6. Post‐hospital rehabilitation: comparing different intervention strategies, critical outcomes